<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbio.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbio.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Research Foundation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2012.00148</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Review Article</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The <italic>Acinetobacter baumannii</italic> Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Roca</surname> <given-names>Ignasi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Espinal</surname> <given-names>Paula</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Vila-Farr&#x000E9;s</surname> <given-names>Xavier</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Vila</surname> <given-names>Jordi</given-names></name>
<xref ref-type="author-notes" rid="fn001">&#x0002A;</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Clinical Microbiology, School of Medicine, IDIBAPS and Barcelona Centre for International Health Research, Hospital Cl&#x000ED;nic-Universitat de Barcelona</institution> <country>Barcelona, Spain</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Stefania Stefani, University of Catania, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Ilda Santos Sanches, Universidade nova de Lisboa, Portugal; Paolo Visca, University Roma Tre, Italy</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Jordi Vila, Department of Clinical Microbiology, Hospital Clinic of Barcelona, Villarroel, 170, 08036 Barcelona, Spain. e-mail: <email>jvila&#x00040;ub.edu</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Frontiers in Antimicrobials, Resistance and Chemotherapy, a specialty of Frontiers in Microbiology.</p></fn>
</author-notes>
<pub-date pub-type="epreprint">
<day>29</day>
<month>01</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>04</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="collection">
<year>2012</year>
</pub-date>
<volume>3</volume>
<elocation-id>148</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>11</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>03</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2012 Roca, Espinal, Vila-Farr&#x000E9;s and Vila.</copyright-statement>
<copyright-year>2012</copyright-year>
<license license-type="open-access" xlink:href="http://www.frontiersin.org/licenseagreement"><p>This is an open-access article distributed under the terms of the <uri xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non Commercial License</uri>, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.</p></license>
</permissions>
<abstract>
<p>During the past few decades <italic>Acinetobacter baumannii</italic> has evolved from being a commensal dweller of health-care facilities to constitute one of the most annoying pathogens responsible for hospitalary outbreaks and it is currently considered one of the most important nosocomial pathogens. In a prevalence study of infections in intensive care units conducted among 75 countries of the five continents, this microorganism was found to be the fifth most common pathogen. Two main features contribute to the success of <italic>A. baumannii</italic>: (i) <italic>A. baumannii</italic> exhibits an outstanding ability to accumulate a great variety of resistance mechanisms acquired by different mechanisms, either mutations or acquisition of genetic elements such as plasmids, integrons, transposons, or resistant islands, making this microorganism multi- or pan-drug-resistant and (ii) The ability to survive in the environment during prolonged periods of time which, combined with its innate resistance to desiccation and disinfectants, makes <italic>A. baumannii</italic> almost impossible to eradicate from the clinical setting. In addition, its ability to produce biofilm greatly contributes to both persistence and resistance. In this review, the pathogenesis of the infections caused by this microorganism as well as the molecular bases of antibacterial resistance and clinical aspects such as treatment and potential future therapeutic strategies are discussed in depth.</p>
</abstract>
<kwd-group>
<kwd><italic>Acinetobacter baumannii</italic></kwd>
<kwd>antimicrobial resistance</kwd>
<kwd>pathogenesis</kwd>
<kwd>biofilm</kwd>
<kwd>antimicrobial peptides</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="356"/>
<page-count count="30"/>
<word-count count="30692"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction">
<title>Introduction</title>
<p>The <italic>Acinetobacter</italic> genus comprises Gram-negative non-fermenting coccobacilli with 25 validly named species and 9 genomic species defined by genomic DNA&#x02013;DNA hybridization (Espinal et al., <xref ref-type="bibr" rid="B82">2011b</xref>). Although <italic>Acinetobacter pittii</italic> and <italic>Acinetobacter nosocomialis</italic> (formerly <italic>Acinetobacter</italic> genomic species 3 and gen. sp. 13TU, respectively (Nemec et al., <xref ref-type="bibr" rid="B219">2011</xref>) are emerging as important pathogens and have been involved in a number of outbreaks in intensive care units, <italic>Acinetobacter baumannii</italic> is, undoubtedly the species showing the highest clinical relevance, mainly in the nosocomial setting. In fact, the three clinically important members of this group, also known as the <italic>A. baumannii</italic> (Ab) group (Peleg et al., <xref ref-type="bibr" rid="B238">2008</xref>), are phenotypically related and cannot be differentiated by currently available identification systems. Indeed, <italic>A. pittii</italic> and <italic>A. nosocomialis</italic> are often erroneously identified as <italic>A. baumannii</italic> by routine commercial systems (Bernards et al., <xref ref-type="bibr" rid="B17">1996</xref>). In a recent report by Espinal et al. (<xref ref-type="bibr" rid="B83">2011c</xref>) the use of MALDI&#x02013;TOF mass spectrometry to differentiate the three species was analyzed, showing that <italic>A. nosocomialis</italic> was misidentified as <italic>A. baumannii</italic>. Inclusion of specific signature profiles for <italic>A. nosocomialis</italic> within the Bruker database allowed the correct identification of this genomic species, thus, MALDI&#x02013;TOF MS spectra can be used as a fast, simple, and reliable method to identify members of the Ab group. Two main features contribute to the success of <italic>A. baumannii</italic>: (i) They normally exhibit multidrug resistance (MDR), acquired by different mechanisms, either mutations or acquisition of genetic elements such as plasmids, transposons, or resistant islands, and (ii) The ability to survive in the environment, in which, the production of biofilm plays an important role (discussed below). Several reviews dealing with the taxonomy, epidemiology, and infection of <italic>A. baumannii</italic> have been published on recent years (Dijkshoorn et al., <xref ref-type="bibr" rid="B68">2007</xref>; Peleg et al., <xref ref-type="bibr" rid="B238">2008</xref>; Towner, <xref ref-type="bibr" rid="B316">2009</xref>; Visca et al., <xref ref-type="bibr" rid="B333">2011</xref>). The review presented here provides an updated overview of the clinical and treatment aspects as well as the pathogenesis of antimicrobial resistance in <italic>A. baumannii</italic>. In addition, future potential therapeutic alternatives are discussed.</p>
</sec>
<sec>
<title>Pathogenesis and Virulence Factors of <italic>Acinetobacter baumannii</italic></title>
<p>Multiple bacterial virulence factors are required for the pathogenesis of infections caused by <italic>A. baumannii</italic>. These factors enable microorganisms to colonize/infect the host efficiently. However, very little information is known about the virulence factors in <italic>A. baumannii</italic> and host responses to infection (Cerqueira and Peleg, <xref ref-type="bibr" rid="B37">2011</xref>). Considering that <italic>A. baumannii</italic> is a multidrug-resistant microorganism, identification of the virulence factors, and the pathogenicity mechanisms could contribute to the development of novel therapeutic alternatives for the control of <italic>Acinetobacter</italic> infections.</p>
<sec>
<title>Motility and adherence</title>
<p><italic>Acinetobacter baumannii</italic>, has been described as non-motile (Tomaras et al., <xref ref-type="bibr" rid="B315">2003</xref>). Its name is derived from the Greek &#x0201C;akineto,&#x0201D; which means motionless or non-motile and was given due to the lack of flagella (McBride, <xref ref-type="bibr" rid="B197">2010</xref>). Analysis of new <italic>A. baumannii</italic> genome sequences has revealed an absence of flagellar genes, therefore swarming, which is mediated by flagella (Clemmer et al., <xref ref-type="bibr" rid="B47">2011</xref>), is unlikely in this microorganism. However, <italic>A. baumannii</italic> spreads rapidly over surfaces probably as the result of twitching motility, a form of surface translocation previously described in <italic>Acinetobacter calcoaceticus</italic> (Henrichsen and Blom, <xref ref-type="bibr" rid="B115">1975</xref>). Twitching motility mediated by the extension and retraction of type IV pili is controlled by a large number of genes, some involved in the assembly of type IV pili (<italic>pilA, pilB, pilC, pilF, pilM, pilN, pilO, pilP, pilQ, pilZ, pilW</italic>), twitching (<italic>pilR, pilS, pilT, pilU</italic>), and the pilin filament (<italic>pilA</italic>; Mattick, <xref ref-type="bibr" rid="B195">2002</xref>; Jarrell and McBride, <xref ref-type="bibr" rid="B133">2008</xref>). Although there is no current experimental evidence of the actual involvement of type IV pili in <italic>A. baumannii</italic> motility, a recent publication by Eijkelkamp et al. (<xref ref-type="bibr" rid="B78">2011</xref>) has shown the presence of several genes associated with the synthesis of type IV pili in the genomes of fully sequenced <italic>A. baumannii</italic> strains. The authors have also demonstrated a positive correlation between the degree of sequence conservation of the gene encoding the pilin subunit PilA and the twitching phenotype exhibited. Moreover, type IV pili has also been related to twitching motility in other non-flagellated gamma-proteobacteria (De La Fuente et al., <xref ref-type="bibr" rid="B63">2007</xref>).</p>
<p>Twitching motility is also controlled by a range of signal transduction systems, including two-component sensor-regulators and a complex chemosensory system (Mattick, <xref ref-type="bibr" rid="B195">2002</xref>). In a recent study, Clemmer et al. (<xref ref-type="bibr" rid="B47">2011</xref>) found that the motility exhibited by <italic>A. baumannii</italic> was partially dependent on a functional <italic>pilT</italic> gene. The loss of this gene in the <italic>A. baumannii</italic> M2 strain resulted in a 54% reduction in motility, suggesting that twitching represents a significant component of the overall motility in <italic>A. baumannii</italic>.</p>
</sec>
<sec>
<title>Biofilm</title>
<p>Adherence to host cells represents the initial step of colonization or infection. During colonization, bacteria may form microcolonies which result in a highly structured microbial community, called biofilm. Biofilm constitutes a structural community of multiple bacterial cells associated with a biotic or abiotic surface, enclosed in a polymeric matrix (comprised of carbohydrates, nucleic acids, proteins, and other macromolecules; Costerton, <xref ref-type="bibr" rid="B52">1995</xref>), constituting a protective mechanism to survive in harsh environments and during host infection. These bacteria become more resistant to antimicrobial stressors, antibiotics, or cleaning than their planktonic counterparts and therefore the ability to generate biofilms represents an important virulence factor (Donlan, <xref ref-type="bibr" rid="B72">2002</xref>; Wroblewska et al., <xref ref-type="bibr" rid="B342">2008</xref>; de Breij et al., <xref ref-type="bibr" rid="B62">2009</xref>; Gaddy and Actis, <xref ref-type="bibr" rid="B96">2009</xref>).</p>
<p>Biofilm can be influenced by common factors such as nutrient availability, bacterial appendages, bacterial surface components, quorum sensing (QS), macromolecular secretions (Irie and Parsek, <xref ref-type="bibr" rid="B131">2008</xref>; Gaddy and Actis, <xref ref-type="bibr" rid="B96">2009</xref>; Bhargava et al., <xref ref-type="bibr" rid="B20">2010</xref>), and complex regulatory networks including two-component regulatory systems and transcriptional regulators which are related to the expression of biofilm-associated gene products in response to environmental signals (Stanley and Lazazzera, <xref ref-type="bibr" rid="B309">2004</xref>). Tomaras et al. (<xref ref-type="bibr" rid="B315">2003</xref>) demonstrated that the ability of <italic>A. baumannii</italic> strain ATCC 19606<sup>T</sup> to form pili and to adhere and form biofilm on abiotic surfaces depends on the expression of the <italic>csuE</italic> gene, which is a component of the CsuA/BABCDE chaperone-usher complex important for the assembly and production of pili involved in adhesion to surfaces. Inactivation of <italic>csuE</italic> results in the abolition of pili production and biofilm formation suggesting that CsuA/BABCDE-mediated pili play a role in the initial steps of biofilm formation. The expression of this operon is controlled by a two-component regulatory system including a sensor kinase encoded by <italic>bfmS</italic> and a response regulator encoded by <italic>bfmR</italic>. Inactivation of <italic>bfmR</italic> results in a loss of expression of the <italic>csu</italic> operon and, therefore, abolition of pili production and biofilm formation on abiotic surfaces. Additionally, the coupling of pili to host cell receptors may induce the production of inflammatory mediators such as chemokines and cytokines (Sauer et al., <xref ref-type="bibr" rid="B291">2000</xref>).</p>
<p>In addition to the CsuA/BABCDE-mediated pili, de Breij et al. (<xref ref-type="bibr" rid="B62">2009</xref>) found that <italic>A. baumannii</italic> ATCC19606<sup>T</sup> produces a CsuA/BABCDE-independent short pilus, which may be involved in the adherence of the bacteria to biotic surfaces, such as human respiratory cells.</p>
<p>For the development of mature biofilm structures, an ortholog of a staphylococcal biofilm-associated protein (Bap) was found in <italic>A. baumannii</italic> strain 307-0294. Transposon inactivation of this protein involved in cell&#x02013;cell interactions resulted in destabilization of the mature biofilm on abiotic or biotic surfaces (Loehfelm et al., <xref ref-type="bibr" rid="B176">2008</xref>).</p>
<p>Several studies have shown that some <italic>A. baumannii</italic> strains can adhere to human cells and form biofilm on abiotic surfaces. <italic>A. baumannii</italic> survives on fingertips and inanimate objects such as glass, plastic, and other environmental surfaces, even after exposure to dry conditions and nutrient starvation during extended periods of time (Jawad et al., <xref ref-type="bibr" rid="B134">1996</xref>; Wendt et al., <xref ref-type="bibr" rid="B337">1997</xref>; Lee et al., <xref ref-type="bibr" rid="B159">2006b</xref>; de Breij et al., <xref ref-type="bibr" rid="B62">2009</xref>; Espinal et al., <xref ref-type="bibr" rid="B84">2012</xref>). The survival of <italic>A. baumannii</italic> has also been attributed to resistance of this microorganism to antimicrobial drugs and desiccation (Jawad et al., <xref ref-type="bibr" rid="B135">1998</xref>; Tomaras et al., <xref ref-type="bibr" rid="B315">2003</xref>). Since <italic>A. baumannii</italic> can produce biofilm, the resistance phenotype could be attributed to the ability of <italic>A. baumannii</italic> clinical strains to form biofilms on abiotic surfaces, particularly in strains isolated from catheter-related urinary tract or bloodstream infections or even from a case of shunt-related meningitis (Tomaras et al., <xref ref-type="bibr" rid="B315">2003</xref>; Rodr&#x000ED;guez-Ba&#x000F1;o et al., <xref ref-type="bibr" rid="B278">2008</xref>; Gaddy and Actis, <xref ref-type="bibr" rid="B96">2009</xref>). In a recent study, Espinal et al. (<xref ref-type="bibr" rid="B84">2012</xref>) performed survival assays with biofilm- and non-biofilm-forming strains on glass coverslips in a desiccated environment. The survival times for the biofilm-forming strains were longer than for the non-biofilm-forming strains (36 versus 15&#x02009;days, respectively, <italic>P</italic>&#x02009;&#x0003C;&#x02009;0.001), demonstrating that <italic>A. baumannii</italic> strains can attach to glass coverslips and also form biofilm, allowing their survival under dry conditions for much longer lengths of time than non-biofilm-forming strains and may contribute to its persistence in the hospital environment, increasing the probability of causing nosocomial infections and outbreaks. A few previous reports have described the ability of clinical isolates of <italic>A. baumannii</italic> to attach to and form biofilms on glass surfaces comprising an amorphous material similar to exopolysaccharide (Vidal et al., <xref ref-type="bibr" rid="B325">1996</xref>; Tomaras et al., <xref ref-type="bibr" rid="B315">2003</xref>; Espinal et al., <xref ref-type="bibr" rid="B84">2012</xref>). Scanning and transmission electron microscopy (Figure <xref ref-type="fig" rid="F1">1</xref>) studies have shown appendages and a polysaccharide layer covering the cells only in biofilm-forming strains (Espinal et al., <xref ref-type="bibr" rid="B84">2012</xref>). This highly hydrated layer may prevent lethal desiccation and, thus, protect against variations in humidity as well as contribute to mechanical stability, longer survival, and antimicrobial resistance (Sutherland, <xref ref-type="bibr" rid="B311">2001</xref>; Donlan, <xref ref-type="bibr" rid="B72">2002</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Scanning electron microscopy (SEM) (A&#x02013;C)</bold>. Transmission electron microscopy (TEM) <bold>(D&#x02013;F)</bold> of an <italic>A. baumannii</italic> biofilm-forming strain in liquid medium. Black arrow specifies appendage structures (pili or fimbriae), and white arrow the thick exopolysaccharide layer. All electron microscopy images are derived from the work by Espinal et al. (unpublished data)</p></caption>
<graphic xlink:href="fmicb-03-00148-g001.tif"/>
</fig>
</sec>
<sec>
<title>Surface polysaccharides</title>
<p>Surface polysaccharide, such as capsule, is considered an important virulence trait in Gram-negative bacteria, but its role in the pathogenesis of <italic>A. baumannii</italic> is non-existent. Russo et al. (<xref ref-type="bibr" rid="B286">2010</xref>) obtained mutants from the <italic>A. baumannii</italic> strain AB307-0294 and identified two genes: <italic>ptk</italic>, that was predicted to be required for capsule polymerization and encodes a putative protein tyrosine kinase (PTK), and <italic>epsA</italic>, required for assembly and encoding a putative polysaccharide export outer membrane protein (EpsA). These genes are required for a capsule-positive phenotype and describe the participation of capsule in the pathogenesis of <italic>A. baumannii</italic>. This study demonstrated that the K1 capsule from the <italic>A. baumannii</italic> strain AB307-0294 was necessary for optimal growth in human ascitic fluid and survival in human serum as well as in a rat tissue infection model. The active protection of the capsule allows bacterial resistance to the bactericidal activity of the complement.</p>
<p>On the other hand, the potential of PtK and EpsA as drug targets was observed when the loss of PTK or EpsA resulted in a complete and durable killing of AB307-0294 <italic>in vivo</italic>.</p>
<p>Other important extracellular polysaccharide is the poly-&#x003B2;-(1-6)-<italic>N</italic>-acetyl glucosamine (PNAG) described as a major component of biofilms in <italic>Staphylococcus epidermidis</italic> and <italic>S. aureus</italic> (Kropec et al., <xref ref-type="bibr" rid="B153">2005</xref>). In <italic>A. baumannii</italic> clinical isolates the <italic>pgaABCD</italic> locus, encoding proteins for the synthesis of PNAG, has been proved critical for biofilm development (Choi et al., <xref ref-type="bibr" rid="B42">2009</xref>). Besides the role in surface and cell-to-cell adherence, PNAG has been described as a virulence factor that also protects bacteria against innate host defenses. Although PNAG is not essential for biofilm formation under static conditions, it is required for maintaining the integrity of <italic>A. baumannii</italic> biofilms in dynamic and stressful environments. Indeed, PNAG has shown a role in the pathogenesis of <italic>A. baumannii</italic> and is a candidate vaccine against this pathogen (Choi et al., <xref ref-type="bibr" rid="B42">2009</xref>; Cerqueira and Peleg, <xref ref-type="bibr" rid="B37">2011</xref>).</p>
<p>LPS structures containing long O-specific sugar chains (smooth or S-type LPS) have been associated with virulence, and previous studies have shown that nosocomial isolates of <italic>A. baumannii</italic> produce rough R- and smooth S-type LPS. The differences in the ability of LPS from different isolates of <italic>A. baumannii</italic> to elicit mitogenic activity could be caused by variations in the fatty acid content of lipid A and in the O-antigens. LPS and lipid A from <italic>Acinetobacter</italic> have exhibited lethal toxicity in mice, pyrogenicity in rabbits, as well as complement inactivation <italic>in vitro</italic> (Garc&#x000ED;a et al., <xref ref-type="bibr" rid="B99">1999</xref>). Pantophlet et al. (<xref ref-type="bibr" rid="B231">1998</xref>) suggested an important role for the LPS from nosocomial strains of <italic>A. baumannii</italic> as a virulence factor <italic>in vivo</italic> and that synthesis of endotoxin could be an important factor responsible for the severity of disease observed during sepsis by this microorganism.</p>
<p>Although little is known of the endotoxic potential of <italic>A. baumannii</italic> LPS with respect to human cells and its ability to stimulate inflammatory signaling via human toll-like receptors (TLRs), Erridge et al. (<xref ref-type="bibr" rid="B80">2007</xref>) investigated the biological activity of these endotoxins in human monocytic THP-1 cells and in TLR-deficient HEK-293 cells transfected with human TLR2 and TLR4 constructs. The results of this study showed that endotoxins derived from clinical isolates of <italic>A. baumannii</italic> and one <italic>Acinetobacter</italic> genomic species 9 are potent stimulators of inflammatory signaling in human monocyte cells and the responses to these bacteria are dependent on TLR2 and TLR4.</p>
<p>These results, however, are in apparent conflict with a recently published study by de Breij et al. (<xref ref-type="bibr" rid="B61">2010</xref>) that investigated the interplay among biofilm formation, adherence, and induction of an inflammatory response in human airway epithelial cells. De Breij and co-workers concluded that clinically relevant <italic>A. baumannii</italic> strains showing good adherence to human epithelial cells elicit a poor inflammatory response, allowing <italic>Acinetobacter</italic> strains to evade the host immune system and, therefore, explaining the exceptional survival and persistence capabilities of this microorganism.</p>
<p>These findings were in agreement with those reported in <italic>Haemophilus influenzae</italic> (Bresser et al., <xref ref-type="bibr" rid="B30">1997</xref>).</p>
</sec>
<sec>
<title>Outer membrane proteins</title>
<p>Outer membrane proteins (OMPs) of Gram-negative bacteria have been related to antibiotic resistance, adaptation, and pathogenesis in the host cells. Some OMPs of the OmpA family have been characterized in <italic>Acinetobacter</italic> strains, and represent one of the major OMP in the genus (Vallenet et al., <xref ref-type="bibr" rid="B324">2008</xref>).</p>
<p>Previous studies have determined that bacterial molecules secreted from <italic>A. baumannii</italic> are responsible for host cell death (Lee et al., <xref ref-type="bibr" rid="B160">2001</xref>). Among these molecules, OmpA from <italic>A. baumannii</italic> (AbOmpA) makes up a potential virulence factor with multiple important effects in pathogenesis and signal processing (Perez et al., <xref ref-type="bibr" rid="B239">2011</xref>). AbOmpA is the most abundant surface protein involved in the adherence to and invasion of epithelial cells and induces apoptosis in the early stages of <italic>A. baumannii</italic> infection (Gaddy et al., <xref ref-type="bibr" rid="B97">2009</xref>).</p>
<p><italic>Acinetobacter baumannii</italic> can induce cell death (Hep-2 cells) by means of cell surface death receptors and mitochondrial disintegration. Purified AbOmpA was identified in the mitochondria, where it induced the release of proapoptotic molecules such as cytochrome <italic>c</italic> and apoptosis-inducing factor (AIF), which mediates caspase-dependent and AIF-dependent apoptosis in epithelial cells and degrades chromosomal DNA (Choi et al., <xref ref-type="bibr" rid="B43">2005</xref>). Apoptosis of epithelial cells can lead to the internalization of bacteria through the disrupted mucosal lining and, therefore, the outcome of infections caused by this microorganism depends on apoptosis induction in the epithelial cells (Choi et al., <xref ref-type="bibr" rid="B43">2005</xref>).</p>
<p>AbOmpA is also implicated in resistance to complement and biofilm formation (Gaddy and Actis, <xref ref-type="bibr" rid="B96">2009</xref>; Kim et al., <xref ref-type="bibr" rid="B145">2009</xref>). Some <italic>A. baumannii</italic> strains are resistant to the killing activity of human serum by means of genetic components that increase <italic>Acinetobacter</italic> capabilities to cause bacteremia. The suggested serum-resistant mechanism involves the inhibition of host complement C3 protein cleavage and binding to the bacterial surface, which inhibit host phagocytic cell recognition and result in a serum-resistance phenotype (Kim et al., <xref ref-type="bibr" rid="B145">2009</xref>). In addition, the binding of complement regulators to OMPs also plays a role in complement activation. Kim et al. (<xref ref-type="bibr" rid="B145">2009</xref>) demonstrated that an alternative complement pathway was responsible for the killing of <italic>A. baumannii</italic> in normal human serum. <italic>In vitro</italic> assays have indicated that factor H, the main regulator of this pathway, bound to the surface of this microorganism treated with normal human sera, may contribute to the persistence and dissemination of <italic>Acinetobacter</italic> in the host. Comparisons between <italic>A. baumannii</italic> ATCC19606<sup>T</sup> and isogenic AbOmpA<sup>&#x02212;</sup> mutants have shown that mutant strains lose adherence and invasion capability in the host cells, demonstrating that AbOmpA participates in the evasion of the complement attack by interacting with factor H (Choi et al., <xref ref-type="bibr" rid="B44">2008</xref>). In this sense, AbOmpA is considered the main complement regulator-acquiring surface protein (Choi et al., <xref ref-type="bibr" rid="B44">2008</xref>) whereas secreted AbOmpA induces apoptosis in epithelial cells (Choi et al., <xref ref-type="bibr" rid="B43">2005</xref>). In view of these results, AbOmpA stands out as an important virulence factor in <italic>A. baumannii</italic> and could be used as a target in the development of antibiotics and vaccines against this microorganism (Kim et al., <xref ref-type="bibr" rid="B145">2009</xref>).</p>
</sec>
<sec>
<title>Outer membrane vesicles</title>
<p>In addition to OmpA, some Gram-negative bacterial species secrete outer membrane vesicles (OMVs) during bacterial growth. OMVs are spherical nanovesicles with a diameter between 20 and 200&#x02009;nm which are composed of lipopolysaccharides, OMPs, lipids, and DNA or RNA (Kwon et al., <xref ref-type="bibr" rid="B155">2009</xref>; Jin et al., <xref ref-type="bibr" rid="B137">2011</xref>). Secreted OMVs have been shown to participate in QS, the transport of virulence factors, the inhibition of phagosome-maturation in macrophages, biofilm formation, and gene transfer (McConnell et al., <xref ref-type="bibr" rid="B199">2011b</xref>; Rumbo et al., <xref ref-type="bibr" rid="B285">2011</xref>). The surface factors of OMVs mediate adherence to host cells as well as the internalization of vesicular components suggesting that OMVs function as a transport vehicle of effector molecules into host cells (Kwon et al., <xref ref-type="bibr" rid="B155">2009</xref>; Jin et al., <xref ref-type="bibr" rid="B137">2011</xref>). Kwon et al. demonstrated that <italic>A. baumannii</italic> secretes OMVs during <italic>in vitro</italic> growth in association with some virulence-associated proteins and immune modulators suggesting that OMVs play a role in the pathogenicity of <italic>A. baumannii</italic>. AbOmpA, mediating the adherence to and invasion of <italic>A. baumannii</italic> to epithelial cells (Choi et al., <xref ref-type="bibr" rid="B44">2008</xref>) was detected as a major protein component in the OMV fraction. Packaged in OMVs, AbOmpA induces cytotoxicity and host cell death. The results obtained in this study revealed that AbOmpA derived from OMVs was found in the cytoplasm of receiving cells, suggesting that OMVs can deliver virulence factors directly to host cells in the absence of bacteria.</p>
<p>Proteomic analysis of the OMVs from <italic>A. baumanii</italic> ATCC 19696<sup>T</sup> and the clinical isolate DU202 identified more than 110 proteins derived from the outer membrane, periplasmic space, inner membrane, cytosol, and other additional undetermined sites. OMVs contained putative serine and Zn-dependent proteases, phospholipases, bacterioferritin, catalase, and a ferrichrome&#x02013;iron receptor, as well as several proteins displaying secretion signals and pathogen-associated molecular patterns, such as LPS and lipoproteins (Kwon et al., <xref ref-type="bibr" rid="B155">2009</xref>; Jin et al., <xref ref-type="bibr" rid="B137">2011</xref>).</p>
<p>Since OMVs contain multiple antigenic proteins from the bacterial outer membrane, they could be used as vaccine antigens. Previous studies have shown that vaccination with OMVs resulted in the recovery of antibodies against multiple bacterial antigens displaying bactericidal activity and the ability to provide protection in animal models of infection (Schild et al., <xref ref-type="bibr" rid="B294">2008</xref>). McConnell et al. (<xref ref-type="bibr" rid="B199">2011b</xref>) evaluated the immune response elicited after immunization with <italic>A. baumannii</italic> OMVs and found that the serum recovered from vaccinated mice reacted against multiple proteins present in the OMVs as well as against many proteins from the bacterial outer membrane. The robust and protective response elicited by this serum suggests that OMVs might constitute a viable immunization approach to control the infection and mortality caused by <italic>A. baumannii</italic>.</p>
<p>Vesicles have also been shown to be involved in the transfer of genetic material among similar bacterial species (Klieve et al., <xref ref-type="bibr" rid="B147">2005</xref>). Rumbo et al. (<xref ref-type="bibr" rid="B285">2011</xref>) have demonstrated that OMVs vehiculate plasmids carrying carbapenem resistance genes such as the <italic>bla</italic><sub>OXA-24</sub> gene, which can be readily transferred between different strains of <italic>A. baumannii</italic>. In this respect, OMVs might be considered as important virulence factors not only because they participate in host&#x02013;pathogen interactions but also by allowing the spread of antibiotic resistance genes (such as those related to carbapenem resistance) to surrounding bacteria. The genetic material contained inside OMVs is protected from nucleases, thereby favoring the exchange of genetic material. These results might point toward a new mechanism for dissemination of resistance genes in addition to conjugation, transformation, and transduction processes.</p>
</sec>
<sec>
<title>Hydrolytic enzymes</title>
<p>Additional proteins proposed as virulence factors in <italic>A. baumannii</italic> also include Phospholipase D and Phospholipase C (Antunes et al., <xref ref-type="bibr" rid="B12">2011a</xref>).</p>
<p>Phospholipase D, which is important for human serum resistance, epithelial cell invasion, and pathogenesis in a murine model of pneumonia, also plays a role in the systemic dissemination of bacterial pathogens within infected animals and is considered the main virulence determinant in <italic>Corynebacterium pseudotuberculosis</italic> (McKean et al., <xref ref-type="bibr" rid="B200">2007</xref>). Jacobs et al. (<xref ref-type="bibr" rid="B132">2010</xref>) characterized a mutant <italic>A. baumannii</italic> strain harboring a transposon insertion within a putative phospholipase D (PLD) encoding-gene. In this study not only was phospholipase activity affected, but reduced <italic>A. baumannii</italic> epithelial cell invasion (<italic>in vitro</italic>) and serum proliferation were also reported. As a consequence, a decrease in bacteremia and colonization of visceral host organs was observed in a murine infection model. As suggested with AbOmpA, phospholipase D is an <italic>A. baumannii</italic> virulence factor that is required for wild-type levels of pathogenicity and is also a potential target for the therapeutic treatment of <italic>Acinetobacter</italic> infections (Jacobs et al., <xref ref-type="bibr" rid="B132">2010</xref>).</p>
<p>Phospholipase C has also been shown to enhance the toxicity of epithelial cells. Camarena et al. (<xref ref-type="bibr" rid="B33">2010</xref>) demonstrated that an insertional mutant carrying a kanamycin cassette in the coding region of <italic>plc1</italic> displayed a reduction in the cytotoxic effect caused by <italic>A. baumannii</italic> on epithelial cells, thereby indicating that phospholipase C is an important factor in cellular damage.</p>
</sec>
<sec>
<title>Ethanol-induced pathogenesis</title>
<p>In <italic>A. baumannii</italic>, ethanol is assimilated as a carbon source and enters the glyoxylate cycle which, in many pathogens, has been related to virulence. Smith et al. (<xref ref-type="bibr" rid="B302">2004</xref>) observed that ethanol promoted bacterial growth when <italic>A. baumannii</italic> was co-incubated with yeast and also demonstrated that low concentrations of ethanol stimulated <italic>Acinetobacter</italic> growth and contributed to endure salt stress. To understand the virulence of <italic>A. baumannii</italic> in the presence of ethanol, Camarena et al. (<xref ref-type="bibr" rid="B33">2010</xref>) characterized the transcriptional profile of this microorganism in the presence and absence of ethanol. They found 70 genes whose expression was affected by the presence of ethanol in the growth medium and suggested that virulence of <italic>A. baumannii</italic> in the presence of ethanol was due to increased metabolic capacity and the expression of some factors related to stress responses.</p>
<p>The genes that were induced by growth in the presence of ethanol during the exponential phase encoded proteins related to central metabolism or ethanol/acetate assimilation, such as ethanol dehydrogenase (AIS_2098) and aldehyde dehydrogenase (AIS_2102), genes encoding for <italic>pta</italic> (AIS_0481; phosphate acetyltransferase) and <italic>ack</italic>A (AIS_0482; acetate kinase), which are related to Acetyl-CoA synthesis.</p>
<p>Ethanol also induced genes involved in stress response and pathogenesis during exponential phase. Eleven genes encoded hypothetical proteins; five unique to <italic>A. baumannii</italic> ATCC 17978 and, among the remaining six, AIS_2195 was exclusive of the <italic>Acinetobacter</italic> genus and AIS_2509 was only present in <italic>A. baumannii</italic> ATCC 17978 and the non-pathogenic <italic>A. baylyi</italic> ADP1. AIS_2509 was shown to contribute to ethanol stress survival together with AIS_2510 (HSP70-like), which is mildly induced by ethanol.</p>
<p>Ethanol can also enhance the virulence of <italic>A. baumannii</italic> by inducing heat-shock proteins such as Hsp90, GroEL, and Lon. Furthermore, ethanol promotes the expression of <italic>plc1</italic> (AIS_0043) which encodes the <italic>A. baumannii</italic> phospholipase C.</p>
<p>Additional genes detected in stationary phase cultures grown in the presence of ethanol include AIS_2381, which is required for acinetobactin synthesis, and AIS_2566 and AIS_2578, encoding a protein involved in siderophore synthesis and a siderophore receptor, respectively, which are required for the iron-uptake systems. Camarena et al. (<xref ref-type="bibr" rid="B33">2010</xref>) also demonstrated that ethanol induces a stress response enhancing bacterial fitness to survive in the host.</p>
</sec>
<sec>
<title>Penicillin-binding proteins</title>
<p>Penicillin binding proteins (PBPs) are a family of enzymes that share a common evolutionary origin. These enzymes catalyze the synthesis of peptidoglycan, the primary component of the bacterial cell wall, and are also associated with cell morphogenesis and cell division complexes. The inhibition of PBPs causes instability in the cell wall, resulting in growth inhibition, or cell lysis (Cayo et al., <xref ref-type="bibr" rid="B35">2011</xref>). PBPs have been classified as either high- or low-molecular mass PBPs. High-molecular mass PBPs enable peptidoglycan polymerization and insertion into the preexisting cell wall, and low-molecular mass PBPs contribute to cell separation and peptidoglycan remodeling (Sauvage et al., <xref ref-type="bibr" rid="B293">2008</xref>). Although little is known about low-molecular mass PBPs, the putative low-molecular-mass penicillin-binding protein 7/8 (PBP-7/8) has been postulated to play a role in cell wall remodeling. PBP-7/8 is a hydrolase/endopeptidase. PBP-8 is an OmpT-mediated degradation product of PBP-7, and both PBPs stabilize and enhance soluble lytic transglycosylase 70 (<italic>in vitro</italic>). Although PBP-7/8 could be non-essential for normal elongation, it has been related to modulation of cell morphology and daughter cell separation. Russo et al. (<xref ref-type="bibr" rid="B287">2009</xref>) also demonstrated that a PBP-7/8-deficient mutant derivative of the wild <italic>A. baumannii</italic> AB307-0394 strain contributed to the pathogenesis of <italic>A. baumannii</italic> and participated in the growth and survival of <italic>A. baumannii</italic> in human ascites (<italic>in vitro</italic> and <italic>in vivo</italic>) in rat soft-tissue infection and pneumonia models. In addition, PBP-7/8 contributed either directly or indirectly to the serum resistance of AB307-0394.</p>
</sec>
<sec>
<title>Iron uptake</title>
<p>Iron constitutes an important resource that it is not readily available in the human host. It is found complexed with iron-binding molecules such as heme, lactoferrin, and transferrin. A common alternative to more conventional human host defenses against bacterial infections involves the reduction of free extracellular iron concentration by means of iron-binding proteins. However, bacteria are able to survive and multiply under iron-limiting conditions found both in natural and host environments by exploiting a number of strategies for high-affinity iron acquisition, including production of ferric iron chelators (siderophores) that are released outside cells, uptake of exogenous chelators, such as heme and heterologous siderophores, and acquisition of ferrous iron (Dorsey et al., <xref ref-type="bibr" rid="B74">2003a</xref>; Vallenet et al., <xref ref-type="bibr" rid="B324">2008</xref>; Antunes et al., <xref ref-type="bibr" rid="B12">2011a</xref>).</p>
</sec>
<sec>
<title>Siderophores</title>
<p>Siderophores are low-molecular-mass high-affinity iron chelating compounds classified according to their chemical structures (Dorsey et al., <xref ref-type="bibr" rid="B74">2003a</xref>), as in catechols, high-affinity iron chelating molecules containing catecholate groups which are part of the iron-binding site.</p>
<p>The <italic>A. baumannii</italic> 8399 isolate, recovered during a nosocomial outbreak, was shown to contain a high-affinity iron-uptake system which included a catechol siderophore capable of scavenging iron from the high-affinity iron-binding proteins present in the human host (Dorsey et al., <xref ref-type="bibr" rid="B75">2003b</xref>). The latter property was associated with the finding of <italic>dhb</italic> genes in the genome of <italic>A. baumannii</italic> 8399. Genetic complementation assays have proven that <italic>dhb</italic>A, <italic>dhb</italic>B, and <italic>dhb</italic>E genes encode active proteins that restore enterobactin biosynthesis and iron uptake when introduced in <italic>Escherichia coli</italic> mutants. These results demonstrated that <italic>A. baumannii</italic> 8399 harbors all the genetic determinants required for the biosynthesis of the catechol siderophore detected in iron-limited culture supernatants of this microorganism.</p>
<p><italic>Acinetobacter baumannii</italic> 8399 also contains genes encoding proteins that are highly related to iron-transport proteins: OM73, an iron-regulated OMP detected in iron-starved <italic>A. baumannii</italic> 8399 cells; the P45 protein, the expression of which is regulated by both iron and Fur and could have a possible role in the secretion of the catechol siderophore produced by <italic>A. baumannii</italic> 8399; and the P114 protein, which may also participate in siderophore secretion in conjunction with the P45 protein (Dorsey et al., <xref ref-type="bibr" rid="B75">2003b</xref>).</p>
<p>The mixed catechol-hydroxamate compound known as acinetobactin, (structurally similar to anguibactin and vibriobactin produced by <italic>Vibrio cholerae</italic>), was the first siderophore to be described in <italic>A. baumannii</italic>. Acinetobactin is produced by A. <italic>baumannii</italic> ATCC 19606<sup>T</sup> and some clinical isolates (Yamamoto et al., <xref ref-type="bibr" rid="B345">1994</xref>) but is absent in the non-clinical isolate SDF (Antunes et al., <xref ref-type="bibr" rid="B13">2011b</xref>).</p>
<p>A comparison between the complete genomes derived from AYE, SDF, and ACICU clinical strains has demonstrated that AYE and ACICU express independent siderophore-mediated iron acquisition systems together with acinetobactin and hemin iron-capturing systems. Iron acquisition in the SDF strain, however, depends on the expression of a hemin system rather than on the expression of biosynthesis and transport functions for a particular siderophore. Several associated ABC transporters probably involved in the translocation of heme/hemoglobin from the periplasm to the cytosol have also been detected in this strain (Zimbler et al., <xref ref-type="bibr" rid="B356">2009</xref>; Antunes et al., <xref ref-type="bibr" rid="B12">2011a</xref>).</p>
<p>Furthermore, some <italic>A. baumannii</italic>-producing acinetobactin strains utilize 30% iron-saturated transferrin and 15% iron-saturated lactoferrin as the sole sources of iron for growth by scavenging iron bound to these proteins. None of these strains use heme or hemoglobin as an iron source. Insertional analysis has demonstrated that inactivation of <italic>bau</italic>A and <italic>bas</italic>D, encoding for acinetobactin transport and biosynthesis functions, respectively, affects the ability of isogenic derivatives to grow under iron-limiting conditions (Mihara et al., <xref ref-type="bibr" rid="B203">2004</xref>; Zimbler et al., <xref ref-type="bibr" rid="B356">2009</xref>). These findings suggest that <italic>A. baumannii</italic> is a versatile pathogen with the ability to acquire iron and survive under iron-limiting conditions and highlights the role of acinetobactin-mediated iron acquisition mechanisms in the pathogenesis of <italic>A. baumannii</italic> infections (Mihara et al., <xref ref-type="bibr" rid="B203">2004</xref>; Zimbler et al., <xref ref-type="bibr" rid="B356">2009</xref>).</p>
<p>The ferric-siderophore complex is transported inside bacterial cells with the aid of specific outer-membrane receptors, periplasmic proteins, and inner-membrane-associated proteins, such as the iron-regulated outer membrane proteins system (IROMPs; Dorsey et al., <xref ref-type="bibr" rid="B75">2003b</xref>; Mihara et al., <xref ref-type="bibr" rid="B203">2004</xref>; Vallenet et al., <xref ref-type="bibr" rid="B324">2008</xref>). In Gram-negative bacteria, these receptors are localized on the outer membrane, where internalization of siderophores or heme is associated with dissipation of the proton gradient on the inner membrane and is mediated by the TonB protein complex in the periplasmic space. The TonBExbBD energy-transducing system is required for hemin utilization in many bacteria. Once internalized, the ferric-siderophore complexes are reduced to release iron by an enzyme with ferric reductase activity (Vallenet et al., <xref ref-type="bibr" rid="B324">2008</xref>; Zimbler et al., <xref ref-type="bibr" rid="B356">2009</xref>; Antunes et al., <xref ref-type="bibr" rid="B13">2011b</xref>).</p>
<p>In addition to the previously mentioned acinetobactin siderophore, Antunes et al. (<xref ref-type="bibr" rid="B13">2011b</xref>) have described two siderophore synthesis/transport gene clusters, which include genes for putative hydroxylase and acetyltransferase enzymes, suggestive of the synthesis of hydroxamate-type siderophores. One of these clusters was only present in the ATCC 17978, while the other was present in the ACICU, ATCC 17978, AYE, AB0057, AB307-294, and ATCC 19606<sup>T</sup> <italic>A. baumannii</italic> strains, but not in the non-human SDF isolate.</p>
<p>Another alternative mechanism for bacterial iron assimilation involves the direct uptake of iron by the Feo system, a homolog of the <italic>E. coli</italic> <italic>feo</italic>B. This system, found in ACICU, ATCC 17978, AYE, AB0057, AB307-294, ATCC 19606<sup>T</sup>, and SDF strains, consists of the cytosolic FeoA protein, the inner membrane Fe(II) permease FeoB, and the putative transcriptional repressor FeoC (Antunes et al., <xref ref-type="bibr" rid="B13">2011b</xref>). The expression of the proteins implied in iron acquisition systems, including siderophore biosynthetic enzymes, depends on the transcriptional regulation of the global iron-binding repressor protein Fur, for ferric uptake regulator (Mihara et al., <xref ref-type="bibr" rid="B203">2004</xref>; Vallenet et al., <xref ref-type="bibr" rid="B324">2008</xref>), which acts as a transcription repressor of genes involved in the siderophore/heme(globin) systems. A bioinformatic search for Fur-binding sites revealed that putative Fur boxes were present in the intergenic regions of the abovementioned gene clusters, demonstrating the participation of these clusters in iron capture.</p>
</sec>
<sec>
<title>Quorum sensing</title>
<p>Bacteria elaborate chemical signals excreted from the cells to perform intercellular communication and environmental adaptation. This ability of bacteria to monitor cell density before expressing a phenotype is known as &#x0201C;quorum sensing&#x0201D; (Whitehead et al., <xref ref-type="bibr" rid="B338">2001</xref>). QS is a widespread regulatory mechanism among Gram-negative bacteria and often takes place with the aid of acyl-homoserine lactone (AHL)-like signal molecules produced by the LuxI family of AHL synthases (Sarkar and Chakraborty, <xref ref-type="bibr" rid="B290">2008</xref>; Gonz&#x000E1;lez et al., <xref ref-type="bibr" rid="B108">2009</xref>). Modulation of the physiological processes controlled by acyl HSLs and, non-acyl HSL-mediated systems occurs in a cell density- and growth phase-dependent manner. AHLs-mediated QS has been linked with the production of virulence factors, motility, nodulation, plasmid transfer, antibiotic production, bioemulsan production, bioluminescence, and biofilm formation (Whitehead et al., <xref ref-type="bibr" rid="B338">2001</xref>; Vallenet et al., <xref ref-type="bibr" rid="B324">2008</xref>). These autoinducers bind to transcriptional regulatory proteins and activate or regulate gene expression in the organism (Bhargava et al., <xref ref-type="bibr" rid="B20">2010</xref>). In a previous study, Gonz&#x000E1;lez et al. (<xref ref-type="bibr" rid="B109">2001</xref>) detected QS signal molecules capable of activating AHL biosensors in <italic>A. baylyi</italic> ADP1 cultures and in culture supernatants of some clinical <italic>Acinetobacter</italic> strains. A common AHL system of Gram-negative bacteria is mediated by two proteins: LuxI proteins which interact with the LuxR protein. This complex binds to a specific promoter sequence known as <italic>lux-</italic>box, which regulates the expression of QS target genes. In <italic>Acinetobacter</italic>, the <italic>lux</italic>-box is found upstream from the putative ATG of <italic>aba</italic>I, representing a binding site for AbaR. AbaI protein belongs to the LuxI family of autoinducer synthases, producing <italic>N</italic>-(3-hydroxydodecanoyl)-<sc>l</sc>-HSL (3-hydroxy-C(12)-HSL) as the primary signal and performing the function of signal transduction and QS. The AbaR protein, which is an autoinducer receptor in <italic>A. baumannii</italic>, interacts with AHL and controls gene expression (Niu et al., <xref ref-type="bibr" rid="B223">2008</xref>).</p>
<p><italic>Acinetobacter</italic> quorum signals have been shown to vary in virulent and non-virulent strains, thus differentiation between them on the basis of QS is difficult. On the other hand, communication among bacteria with respect to cell density is related to maturation of biofilm. It was observed that mutations in <italic>abaI</italic> led to a reduction in biofilm production compared with the isogenic parental strain but the original phenotype could be restored when a exogenous <italic>Acinetobacter</italic> AHL was added to the mutant (Niu et al., <xref ref-type="bibr" rid="B223">2008</xref>; Bhargava et al., <xref ref-type="bibr" rid="B20">2010</xref>). Thus, QS signal molecules influence biofilm formation which represents an important virulence factor related to the survival and antibiotic resistance of <italic>A. baumannii</italic> (Gaddy and Actis, <xref ref-type="bibr" rid="B96">2009</xref>; Bhargava et al., <xref ref-type="bibr" rid="B20">2010</xref>). Kang and Park (<xref ref-type="bibr" rid="B140">2010a</xref>) evaluated the effect of QS signals on hexadecane biodegradation and biofilm formation in the <italic>Acinetobacter</italic> spp. strain DR1, and found phenotypic changes in the strain associated with three putative QS signals that strongly indicated their relation in biofilm formation. Particularly, C<sub>12</sub>-AHL, which was a major QS signal and controlled the biofilm formation in <italic>A. baumannii</italic> M2 previously described by Niu et al. (<xref ref-type="bibr" rid="B223">2008</xref>). The poor biodegradability of hydrocarbons was one of the significant changes observed when QS signals where eliminated, and consequently resulted in alterations of bacterial hydrophobicity, cellular motility by fimbriae or pili, biofilm formation, and other environmental factors (Clemmer et al., <xref ref-type="bibr" rid="B47">2011</xref>). Thus, in the DR1 strain, the QS system and putative AHLs directly regulated the biofilm formation and growth on hydrocarbons. In another study, Kang and Park (<xref ref-type="bibr" rid="B141">2010b</xref>) described a trade-off between antibiotic resistance and biological fitness (Kang and Park, <xref ref-type="bibr" rid="B141">2010b</xref>). The biological fitness of the <italic>Acinetobacter</italic> strain DR1 was influenced by the <italic>in situ</italic> acquisition of antibiotic resistance, probably attributable to the reduced ability to produce QS signals, lack of motility, and reduced substrate utilization.</p>
<p>As a concluding remark, it has been hypothesized that interference with bacterial virulence and/or cell-to-cell signaling pathways, such as interruption of QS signals, known as quorum quenching (QQ; Chan et al., <xref ref-type="bibr" rid="B38">2011</xref>), represents an important target for pathogenesis inhibition and development of novel therapeutics for the treatment of bacterial infections (Whitehead et al., <xref ref-type="bibr" rid="B338">2001</xref>; Bhargava et al., <xref ref-type="bibr" rid="B20">2010</xref>; Rasko and Sperandio, <xref ref-type="bibr" rid="B269">2010</xref>).</p>
</sec>
<sec>
<title>Putative alien islands</title>
<p>New insights into the pathogenesis of <italic>A. baumannii</italic> has demonstrated that mutagenesis and genomic sequencing can uncover and evaluate many virulence factors for a better understanding of the pathogenicity of this bacterium. Smith et al. (<xref ref-type="bibr" rid="B303">2007</xref>) performed a genomic analysis between <italic>A. baumannii</italic> and <italic>A. baylyi</italic> and found 55.74% homology at the protein level. One of the most interesting differences between both was the presence of 28 putative alien islands (pAs) in <italic>A. baumannii</italic> (Smith et al., <xref ref-type="bibr" rid="B303">2007</xref>). These islands were found to contain the majority of the drug resistance and virulence factors, many acquired from their environment, indicating their role in the pathogenicity of <italic>A. baumannii</italic>. Some of these islands contained genes associated with pathogenesis, encoding heavy metal resistance, iron uptake and metabolism, fimbrial genes, autoinducer processing, and cell envelope biogenesis. Other pAs contained hypothetical genes and mobile elements that remain uncharacterized. Thus, gene shuffling mutagenesis revealed that pAs might (Camarena et al., <xref ref-type="bibr" rid="B33">2010</xref>) play an important role in the pathogenesis of <italic>A. baumannii</italic>.</p>
</sec>
</sec>
<sec>
<title>Antimicrobial Resistance</title>
<p>While other human pathogens stand out due to their virulence and pathogenicity, <italic>A. baumannii</italic> is not known to be particularly virulent or to produce diffusible toxins or cytolysins, and only a few virulence factors have been described to date (Vallenet et al., <xref ref-type="bibr" rid="B324">2008</xref>). There is, however, one feature at which this microorganism excels, and that is antimicrobial resistance. Indeed, <italic>A. baumannii</italic> has an outstanding ability to accumulate different resistance mechanisms which, together with its innate resistance to desiccation, contribute to the survival and persistence of <italic>A. baumannii</italic> under selective environmental pressure, making this microorganism a phenomenal nosocomial pathogen.</p>
<p><italic>Acinetobacter baumannii</italic> has become resistant to almost all commonly used antimicrobial agents, including aminoglycosides, quinolones and broad-spectrum &#x003B2;-lactams, and multidrug or pan-drug-resistant strains are becoming a frequent problem in the clinical setting (Livermore et al., <xref ref-type="bibr" rid="B175">2008</xref>; Rossolini and Mantengoli, <xref ref-type="bibr" rid="B283">2008</xref>; Morgan et al., <xref ref-type="bibr" rid="B207">2009</xref>; Table <xref ref-type="table" rid="T1">1</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Antimicrobial resistance mechanisms in <italic>A. baumannii</italic></bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">Antimicrobial</th>
<th align="left">Resistance mechanism</th>
<th align="left">Class/family</th>
<th align="left">Protein</th>
<th align="left">Described in association with</th>
<th align="left">Selected reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">&#x003B2;-Lactams</td>
<td align="left">Chromosomal cephalosporinase</td>
<td align="left">Class C</td>
<td align="left">AmpC</td>
<td align="left">IS</td>
<td align="left">Hujer et al. (<xref ref-type="bibr" rid="B127">2005</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Carbapenem-hydrolyzing class D &#x003B2;-lactamases</td>
<td align="left">Class D</td>
<td align="left">OXA-51-like</td>
<td align="left">IS</td>
<td align="left">Turton et al. (<xref ref-type="bibr" rid="B320">2006</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">OXA-23-like</td>
<td align="left">IS, Tn, AbaR</td>
<td align="left">Corvec et al. (<xref ref-type="bibr" rid="B51">2007</xref>), Adams et al. (<xref ref-type="bibr" rid="B3">2008</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">OXA-24/40-like</td>
<td align="left">XerC/XerD</td>
<td align="left">Merino et al. (<xref ref-type="bibr" rid="B202">2010</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">OXA-58-like</td>
<td align="left">IS, Tn</td>
<td align="left">Poirel and Nordmann (<xref ref-type="bibr" rid="B255">2006b</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">OXA-143-like</td>
<td align="left"/>
<td align="left">Higgins et al. (<xref ref-type="bibr" rid="B120">2009</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Metallo-&#x003B2;-lactamases</td>
<td align="left">Class B</td>
<td align="left">IMP</td>
<td align="left">Integron</td>
<td align="left">Cornaglia et al. (<xref ref-type="bibr" rid="B50">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">VIM</td>
<td align="left">Integron</td>
<td align="left">Cornaglia et al. (<xref ref-type="bibr" rid="B50">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">SIM-1</td>
<td align="left">Integron</td>
<td align="left">Cornaglia et al. (<xref ref-type="bibr" rid="B50">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">NDM</td>
<td align="left">IS, Tn</td>
<td align="left">Espinal et al. (<xref ref-type="bibr" rid="B81">2011a</xref>), Pfeifer et al. (<xref ref-type="bibr" rid="B240">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Minor relevance &#x003B2;-lactamases</td>
<td align="left">Class A</td>
<td align="left">TEM</td>
<td align="left">AbaR</td>
<td align="left">Adams et al. (<xref ref-type="bibr" rid="B3">2008</xref>), Shakil and Khan (<xref ref-type="bibr" rid="B297">2010</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">SHV</td>
<td align="left"/>
<td align="left">Naas et al. (<xref ref-type="bibr" rid="B213">2007</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">SCO-1</td>
<td align="left"/>
<td align="left">Poirel et al. (<xref ref-type="bibr" rid="B245">2007</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">CARB</td>
<td align="left">IS, Tn, integron</td>
<td align="left">Potron et al. (<xref ref-type="bibr" rid="B259">2009</xref>), Ram&#x000ED;rez et al. (<xref ref-type="bibr" rid="B268">2010b</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">PER</td>
<td align="left">IS, Tn, integron</td>
<td align="left">Poirel et al. (<xref ref-type="bibr" rid="B243">2005a</xref>), Bonnin et al. (<xref ref-type="bibr" rid="B24">2011b</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">VEB</td>
<td align="left">IS, integron, AbaR</td>
<td align="left">Fournier et al. (<xref ref-type="bibr" rid="B94">2006</xref>), Poirel et al. (<xref ref-type="bibr" rid="B253">2009</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">CTX-M</td>
<td align="left">Tn</td>
<td align="left">Potron et al. (<xref ref-type="bibr" rid="B258">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">GES</td>
<td align="left">Integron</td>
<td align="left">Moubareck et al. (<xref ref-type="bibr" rid="B209">2009</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">KPC</td>
<td align="left"/>
<td align="left">Robledo et al. (<xref ref-type="bibr" rid="B275">2010</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">Class D</td>
<td align="left">OXA-2, 10, 20, 37</td>
<td align="left">Integron, AbaR</td>
<td align="left">Navia et al. (<xref ref-type="bibr" rid="B217">2002</xref>), Fournier et al. (<xref ref-type="bibr" rid="B94">2006</xref>), Adams et al. (<xref ref-type="bibr" rid="B3">2008</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Decreased permeability</td>
<td align="left"/>
<td align="left">CarO</td>
<td align="left">IS</td>
<td align="left">Ravasi et al. (<xref ref-type="bibr" rid="B270">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">47&#x02009;kDa OMP</td>
<td align="left"/>
<td align="left">Quale et al. (<xref ref-type="bibr" rid="B263">2003</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">44&#x02009;kDa OMP</td>
<td align="left"/>
<td align="left">Quale et al. (<xref ref-type="bibr" rid="B263">2003</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">37&#x02009;kDa OMP</td>
<td align="left"/>
<td align="left">Quale et al. (<xref ref-type="bibr" rid="B263">2003</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">33&#x02013;36&#x02009;kDa OMP</td>
<td align="left"/>
<td align="left">del Mar Tomas et al. (<xref ref-type="bibr" rid="B64">2005</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">22&#x02013;33&#x02009;kDa OMP</td>
<td align="left"/>
<td align="left">Bou et al. (<xref ref-type="bibr" rid="B26">2000a</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">HMP-AB</td>
<td align="left"/>
<td align="left">Gribun et al. (<xref ref-type="bibr" rid="B112">2003</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">43&#x02009;kDa OMP</td>
<td align="left"/>
<td align="left">Fern&#x000E1;ndez-Cuenca et al. (<xref ref-type="bibr" rid="B89">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Efflux pump</td>
<td align="left">RND</td>
<td align="left">AdeABC</td>
<td align="left">IS</td>
<td align="left">Magnet et al. (<xref ref-type="bibr" rid="B184">2001</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">AdeIJK</td>
<td align="left"/>
<td align="left">Damier-Piolle et al. (<xref ref-type="bibr" rid="B57">2008</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Modified penicillin-binding proteins</td>
<td align="left"/>
<td align="left">PBP</td>
<td align="left"/>
<td align="left">Cayo et al. (<xref ref-type="bibr" rid="B35">2011</xref>)</td>
</tr>
<tr>
<td align="left">Aminoglycosides</td>
<td align="left">Aminoglycoside-modifying enzymes</td>
<td align="left"/>
<td align="left">Acetyltransferases</td>
<td align="left">IS, Tn, Integron, AbaR</td>
<td align="left">Cho et al. (<xref ref-type="bibr" rid="B41">2009</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">Nucleotidyltransferases</td>
<td align="left"/>
<td align="left">Cho et al. (<xref ref-type="bibr" rid="B41">2009</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">Phosphotransferases</td>
<td align="left"/>
<td align="left">Cho et al. (<xref ref-type="bibr" rid="B41">2009</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Target binding site modification</td>
<td align="left"/>
<td align="left">16S rRNA methylases</td>
<td align="left">IS, Tn</td>
<td align="left">Doi et al. (<xref ref-type="bibr" rid="B70">2007</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Efflux</td>
<td align="left">RND</td>
<td align="left">AdeABC</td>
<td align="left">IS</td>
<td align="left">Magnet et al. (<xref ref-type="bibr" rid="B184">2001</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">MATE</td>
<td align="left">AbeM</td>
<td align="left"/>
<td align="left">Su et al. (<xref ref-type="bibr" rid="B310">2005</xref>)</td>
</tr>
<tr>
<td align="left">Quinolones</td>
<td align="left">Target site mutations</td>
<td align="left"/>
<td align="left">GyrA/ParC</td>
<td colspan="1" align="left"/>
<td align="left">Hamouda and Amyes (<xref ref-type="bibr" rid="B114">2004</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Efflux pump</td>
<td align="left">RND</td>
<td align="left">AdeABC</td>
<td align="left">IS</td>
<td align="left">Magnet et al. (<xref ref-type="bibr" rid="B184">2001</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">AdeIJK</td>
<td align="left"/>
<td align="left">Damier-Piolle et al. (<xref ref-type="bibr" rid="B57">2008</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">AdeFGH</td>
<td colspan="1" align="left"/>
<td align="left">Coyne et al. (<xref ref-type="bibr" rid="B54">2010b</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">MATE</td>
<td align="left">AbeM</td>
<td align="left"/>
<td align="left">Su et al. (<xref ref-type="bibr" rid="B310">2005</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">SMR</td>
<td align="left">AbeS</td>
<td align="left"/>
<td align="left">Srinivasan et al. (<xref ref-type="bibr" rid="B307">2009a</xref>)</td>
</tr>
<tr>
<td align="left">Chloramphenicol</td>
<td align="left">Efflux pump</td>
<td align="left">RND</td>
<td align="left">AdeABC</td>
<td align="left">IS</td>
<td align="left">Magnet et al. (<xref ref-type="bibr" rid="B184">2001</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">AdeIJK</td>
<td align="left"/>
<td align="left">Damier-Piolle et al. (<xref ref-type="bibr" rid="B57">2008</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">AdeFGH</td>
<td colspan="1" align="left"/>
<td align="left">Coyne et al. (<xref ref-type="bibr" rid="B54">2010b</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">MFS</td>
<td align="left">CmlA</td>
<td align="left">AbaR</td>
<td align="left">Fournier et al. (<xref ref-type="bibr" rid="B94">2006</xref>), Vila et al. (<xref ref-type="bibr" rid="B326">2007</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">CraA</td>
<td align="left"/>
<td align="left">Roca et al. (<xref ref-type="bibr" rid="B277">2009</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">MATE</td>
<td align="left">AbeM</td>
<td align="left"/>
<td align="left">Su et al., <xref ref-type="bibr" rid="B310">2005</xref></td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left">SMR</td>
<td align="left">AbeS</td>
<td align="left"/>
<td align="left">Srinivasan et al. (<xref ref-type="bibr" rid="B307">2009a</xref>)</td>
</tr>
<tr>
<td align="left">Tetracyclines</td>
<td align="left">Efflux pump</td>
<td align="left">MFS</td>
<td align="left">TetA</td>
<td align="left">IS, Tn, AbaR</td>
<td align="left">Ribera et al. (<xref ref-type="bibr" rid="B271">2003a</xref>), Fournier et al. (<xref ref-type="bibr" rid="B94">2006</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">TetB</td>
<td align="left"/>
<td align="left">Vila et al. (<xref ref-type="bibr" rid="B326">2007</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Ribosomal protection</td>
<td align="left"/>
<td align="left">TetM</td>
<td align="left"/>
<td align="left">Ribera et al. (<xref ref-type="bibr" rid="B272">2003b</xref>)</td>
</tr>
<tr>
<td align="left">Tigecycline</td>
<td align="left">Efflux pump</td>
<td align="left">RND</td>
<td align="left">AdeABC</td>
<td align="left">IS</td>
<td align="left">Magnet et al. (<xref ref-type="bibr" rid="B184">2001</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">AdeIJK</td>
<td align="left"/>
<td align="left">Damier-Piolle et al. (<xref ref-type="bibr" rid="B57">2008</xref>)</td>
</tr>
<tr>
<td align="left">Polymyxins</td>
<td align="left">Lipid A modification</td>
<td align="left"/>
<td align="left">PmrCAB</td>
<td align="left"/>
<td align="left">Arroyo et al. (<xref ref-type="bibr" rid="B14">2011</xref>), Beceiro et al. (<xref ref-type="bibr" rid="B16">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Loss of lipopolysaccharide</td>
<td align="left"/>
<td align="left">LpxABC</td>
<td align="left">IS</td>
<td align="left">Moffatt et al. (<xref ref-type="bibr" rid="B204">2011</xref>)</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Porin loss</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">Fern&#x000E1;ndez-Reyes et al. (<xref ref-type="bibr" rid="B91">2009</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>IS, Insertion sequence; Tn, transposon; AbaR, resistance island; RND, resistance&#x02013;nodulation&#x02013;cell division family; MFS, major facilitator superfamily; MATE, multidrug and toxic compound extrusion family; SMR, small multidrug resistance family</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Overall, antimicrobial resistance can be achieved by means of two main mechanisms: acquisition of novel genetic information through horizontal gene transfer and genetic modification of endogenous genes.</p>
<p>Acquisition of novel genetic determinants in <italic>A. baumannii</italic> takes place by the combined effect of mobile genetic elements (insertion sequences, IS and transposons), integrons, and transferable plasmids, while the genetic modification of endogenous genes implies either spontaneous mutations that modify drug targets or the insertion/deletion of mobile elements that alter the expression of endogenous resistance mechanisms or modify membrane permeability.</p>
<sec>
<title>&#x003B2;-lactams</title>
<p>The mechanisms involved in resistance to &#x003B2;-lactams in <italic>A. baumannii</italic> typically include: (i) <italic>enzymatic mechanisms</italic> or production of &#x003B2;-lactam hydrolyzing enzymes (&#x003B2;-lactamases) and (ii) <italic>non-enzymatic mechanisms</italic> that involve modification of membrane permeability by either the loss of or decrease in the expression of OMPs or an increased expression of efflux pumps as well as sequence variation of PBPs.</p>
</sec>
<sec>
<title>Enzymatic mechanisms</title>
<p>The main mechanism of resistance to &#x003B2;-lactam antibiotics in <italic>A. baumannii</italic> lies in the production of &#x003B2;-lactamases encoded either chromosomally or in plasmids. The common genome of <italic>A. baumannii</italic> possesses two intrinsic &#x003B2;-lactam hydrolyzing enzymes; a non-inducible cephalosporinase (AmpC; Bou and Martinez-Beltran, <xref ref-type="bibr" rid="B27">2000b</xref>) and a class D oxacillinase (OXA-51/69 variants; Brown et al., <xref ref-type="bibr" rid="B31">2005</xref>).</p>
<sec>
<title>Chromosomal cephalosporinases (AmpC)</title>
<p>AmpC enzymes are class C &#x003B2;-lactamases responsible for resistance to all penicillins and extended-spectrum cephalosporins, except cefepime, as well as to &#x003B2;-lactam-&#x003B2;-lactamase inhibitor combinations (Drawz et al., <xref ref-type="bibr" rid="B76">2010</xref>). Several allelic variants of the AmpC enzyme have been reported and a new designation for this family of cephalosporinases has been defined (<italic>Acinetobacter</italic>-derived cephalosporinases, or ADC). According to sequence similarities as well as preferred substrates, AmpCs found within <italic>Acinetobacter</italic> have been classified in up to 56 different ADC types, with more than 25 variants being found in <italic>A. baumannii</italic> (Hujer et al., <xref ref-type="bibr" rid="B127">2005</xref>; Zhao and Hu, <xref ref-type="bibr" rid="B354">2012</xref>). Being non-inducible, the basal expression levels of AmpC enzymes from <italic>A. baumannii</italic> do not significantly alter susceptibility to &#x003B2;-lactams, although the presence of an upstream IS element (known as IS<italic>AbaI</italic>) promotes increased expression of <italic>bla</italic><sub>ampC</sub> and resistance to expanded-spectrum cephalosporins but not to cefepime and carbapenems. Expression of <italic>bla</italic><sub>ampC</sub> is apparently driven by promoter sequences within the IS<italic>AbaI</italic> element (H&#x000E9;ritier et al., <xref ref-type="bibr" rid="B118">2006</xref>).</p>
</sec>
<sec>
<title>Oxacillinases</title>
<p>Ambler Class D enzymes, also known as oxacillinases (OXA; Ambler, <xref ref-type="bibr" rid="B9">1980</xref>), are distinguished by their ability to hydrolyze cloxacillin and oxacillin, and some also oxyimino-&#x003B2;-lactams, but not carbapenems and might be inhibited by clavulanic acid. The oxacillinase enzymes present in <italic>Acinetobacter</italic> spp., however, constitute an atypical subgroup of OXA enzymes since they present carbapenem-hydrolyzing activities (they hydrolyze imipenem and meropenem but not extended-spectrum cephalosporins and aztreonam) and, therefore, are also termed as carbapenem-hydrolyzing class D &#x003B2;-lactamases (CHDLs; Poirel and Nordmann, <xref ref-type="bibr" rid="B254">2006a</xref>) and have their own group (2df) in the updated functional classification of &#x003B2;-lactamases recently published by Bush and Jacoby (<xref ref-type="bibr" rid="B32">2010</xref>). In <italic>A. baumannii</italic>, five phylogenetic subgroups of class D &#x003B2;-lactamases have currently been identified: the naturally occurring OXA-51/69 and four clusters of acquired CHDLs (OXA-23, OXA-24/40, OXA-58, and OXA-143), each with a variety of enzymes that represent different sequence substitutions.</p>
<p>Similar to <italic>bla</italic><sub>ampC</sub>, basal expression of the naturally occurring OXA-51 oxacillinase in <italic>A. baumannii</italic> only allows for weak hydrolysis of &#x003B2;-lactamic substrates, mainly penicillins and carbapenems (they are not active against expanded-spectrum cephalosporins; H&#x000E9;ritier et al., <xref ref-type="bibr" rid="B116">2005a</xref>) unless IS<italic>AbaI</italic> or IS<italic>Aba9</italic> elements are located upstream from <italic>bla</italic><sub>OXA-51</sub>-like genes to increase their expression (Turton et al., <xref ref-type="bibr" rid="B320">2006</xref>; Figueiredo et al., <xref ref-type="bibr" rid="B93">2009</xref>). Over 68 different OXA-51 sequence variants are classified as Class D enzymes (Zhao and Hu, <xref ref-type="bibr" rid="B354">2012</xref>).</p>
<p>Originally named ARI-1, the acquired OXA-23 enzyme shares 56% identity at the protein level with OXA-51/69 and was initially identified in a plasmid from an <italic>A. baumannii</italic> isolate in Scotland, constituting the first oxacillinase with carbapenemase activity to be reported (Paton et al., <xref ref-type="bibr" rid="B235">1993</xref>). Since then, the <italic>bla</italic><sub>OXA-23</sub> gene has been identified all over the world, both in the chromosome or in plasmids, and it is apparently exclusive of the <italic>Acinetobacter</italic> genus, with a <italic>Proteus mirabilis</italic> isolate from France being the sole exception (Bonnet et al., <xref ref-type="bibr" rid="B22">2002</xref>). OXA-27, OXA-49, and OXA-73 are also included within this cluster (Afzal-Shah et al., <xref ref-type="bibr" rid="B7">2001</xref>; see also <uri xlink:href="http://www.lahey.org/studies/">http://www.lahey.org/studies/</uri>).</p>
<p>The second cluster of acquired class D enzymes is named after the OXA-24/40 enzyme (OXA-24 and OXA-40 were initially identified as different enzymes but re-sequencing has shown that they are indeed indistinguishable; see <uri xlink:href="http://www.lahey.org/studies/">http://www.lahey.org/studies/</uri>), which was originally isolated from the chromosome of a carbapenem-resistant <italic>A. baumannii</italic> isolate from Spain (Bou et al., <xref ref-type="bibr" rid="B28">2000c</xref>). This class also includes the OXA-25, OXA-26, and OXA-72 (Afzal-Shah et al., <xref ref-type="bibr" rid="B7">2001</xref>; Wang et al., <xref ref-type="bibr" rid="B334">2007</xref>) enzymes and shares roughly 63 and 60% amino acid identity with the OXA-51/69 and OXA-23 clusters, respectively. Although the OXA-26 enzyme has been identified in Belgium (Afzal-Shah et al., <xref ref-type="bibr" rid="B7">2001</xref>), the OXA-72 in isolates from Asia (Wang et al., <xref ref-type="bibr" rid="B334">2007</xref>; Lee et al., <xref ref-type="bibr" rid="B161">2009a</xref>; Lu et al., <xref ref-type="bibr" rid="B182">2009</xref>) and more recently also from Croatia (Goic-Barisic et al., <xref ref-type="bibr" rid="B107">2011</xref>), and the <italic>bla</italic><sub>OXA-40</sub> gene has also been found in the United States (Lolans et al., <xref ref-type="bibr" rid="B177">2006</xref>; Qi et al., <xref ref-type="bibr" rid="B262">2008</xref>), the <italic>bla</italic><sub>OXA-40</sub>-like genes seem to be highly prevalent in Spain and Portugal (Quinteira et al., <xref ref-type="bibr" rid="B265">2007</xref>; Ruiz et al., <xref ref-type="bibr" rid="B284">2007</xref>) and they can also be found either in the chromosome or be plasmid-borne.</p>
<p>The third cluster of acquired CHDLs is represented by OXA-58, identified in <italic>A. baumannii</italic> by Poirel et al. (<xref ref-type="bibr" rid="B244">2005b</xref>), sharing 59% amino acid identity with OXA-51/69 and less than 50% amino acid identity with OXA-23 and OXA-24/40. The <italic>bla</italic><sub>OXA-58</sub> gene has only been found in <italic>Acinetobacter</italic> spp. so far, and it has been detected in <italic>A. junii</italic> in Romania and Australia (Marqu&#x000E9; et al., <xref ref-type="bibr" rid="B190">2005</xref>; Peleg et al., <xref ref-type="bibr" rid="B237">2006</xref>), in <italic>A. pittii</italic> and <italic>Acinetobacter</italic> <italic>phenon</italic> 6/ct 13TU in Spain (Mart&#x000ED; et al., <xref ref-type="bibr" rid="B193">2008a</xref>,<xref ref-type="bibr" rid="B194">b</xref>), in <italic>A. nosocomialis</italic> in Taiwan (Lin et al., <xref ref-type="bibr" rid="B174">2010</xref>), and Wang et al. (<xref ref-type="bibr" rid="B334">2007</xref>) also reported the first identification of a <italic>bla</italic><sub>OXA-58</sub>-like gene in <italic>Acinetobacter</italic> genomic species 14TU in China.</p>
<p>The <italic>bla</italic><sub>OXA-58</sub> gene is usually plasmid-encoded, which most likely accounts for its wide distribution throughout the world, although it is especially prevalent in Italy and Greece (D&#x02019;Arezzo et al., <xref ref-type="bibr" rid="B59">2009</xref>; Papa et al., <xref ref-type="bibr" rid="B232">2009</xref>; Donnarumma et al., <xref ref-type="bibr" rid="B73">2010</xref>; Di Popolo et al., <xref ref-type="bibr" rid="B66">2011</xref>; Gogou et al., <xref ref-type="bibr" rid="B105">2011</xref>), where carbapenem-resistant <italic>A. baumannii</italic> strains producing OXA-58 have caused several outbreaks in intensive care and pediatric units (Poirel et al., <xref ref-type="bibr" rid="B251">2006</xref>; Pournaras et al., <xref ref-type="bibr" rid="B260">2006</xref>; Tsakris et al., <xref ref-type="bibr" rid="B318">2008</xref>). OXA-96 (Koh et al., <xref ref-type="bibr" rid="B149">2007b</xref>) and OXA-97 (Poirel et al., <xref ref-type="bibr" rid="B249">2008b</xref>) constitute point-mutation derivatives of OXA-58 included within the same cluster and with similar hydrolytic properties.</p>
<p>The fourth cluster of acquired CHDLs present in <italic>A. baumannii</italic> was identified more recently upon the isolation of a novel OXA-143 enzyme recovered from an <italic>A. baumannii</italic> clinical isolate in Brazil (Higgins et al., <xref ref-type="bibr" rid="B120">2009</xref>). At the protein level, this enzyme is 88, 63, and 52% identical to OXA-24/40, OXA-23, and OXA-58 respectively, but exhibits a similar substrate profile to that of other CHDLs from <italic>A. baumannii</italic>.</p>
<p>Overall, the level of carbapenem-hydrolysis by CHDLs is considerably low, with imipenem being the preferred substrate over meropenem, thereby raising a debate as to the exact contribution of these enzymes to carbapenem resistance (Queenan and Bush, <xref ref-type="bibr" rid="B264">2007</xref>). H&#x000E9;ritier et al. (<xref ref-type="bibr" rid="B117">2005b</xref>) addressed this issue by studying changes in susceptibility to carbapenems using either knockout mutants or transformation experiments with both natural and recombinant plasmids containing <italic>bla</italic><sub>OXA-23</sub>, <italic>bla</italic><sub>OXA-40</sub>, and <italic>bla</italic><sub>OXA-58</sub> in different hosts and genetic backgrounds. These experiments demonstrated that acquired CHDLs significantly contribute to the resistant phenotype, with OXA-40 and especially OXA-23 showing a significantly greater impact on resistance than OXA-58. In addition, they also noticed that CHDLs expressed from natural plasmids originated greater levels of carbapenem resistance than those expressed in recombinant vectors, pointing out the importance of IS elements to enhance the expression of acquired class D oxacillinases in <italic>A. baumannii</italic> (H&#x000E9;ritier et al., <xref ref-type="bibr" rid="B117">2005b</xref>). The role of mobile genetic elements in the expression and transfer of resistance determinants will be discussed further on.</p>
</sec>
<sec>
<title>Metallo-&#x003B2;-lactamases</title>
<p>Since their introduction back in 1985, carbapenems have probably been (and still are) the most important antimicrobial agents for the treatment of infections caused by multidrug-resistant <italic>A. baumannii</italic>. During the last decades, however, resistance to carbapenems is increasing worldwide (Gopalakrishnan and Sureshkumar, <xref ref-type="bibr" rid="B110">2010</xref>; Davies et al., <xref ref-type="bibr" rid="B60">2011</xref>; Gogou et al., <xref ref-type="bibr" rid="B105">2011</xref>; Lee et al., <xref ref-type="bibr" rid="B163">2011a</xref>) and carbapenem-resistant <italic>A. baumannii</italic> strains are commonly resistant to all other classes of antibiotics as well, showing intermediate susceptibility to rifampicin and only being susceptible to tigecycline and colistin, although resistance to both antimicrobials has also recently been reported (Al-Sweih et al., <xref ref-type="bibr" rid="B8">2011</xref>; Taneja et al., <xref ref-type="bibr" rid="B312">2011</xref>).</p>
<p>There is another class of acquired &#x003B2;-lactamases in <italic>A. baumannii</italic> which, together with Ambler class D enzymes, contributes to the carbapenem-resistant phenotype, the Ambler class B of metallo-&#x003B2;-lactamases or MBLs. This group of enzymes differs from other &#x003B2;-lactamases in its broad substrate profile (they are capable of hydrolyzing all &#x003B2;-lactams except the monobactam aztreonam), potential for horizontal transfer and the fact that they are zinc-dependent metalloproteins inhibited by EDTA but not by carbapenem or &#x003B2;-lactamase inhibitors such as clavulanic acid, tazobactam, and sulbactam (Bush and Jacoby, <xref ref-type="bibr" rid="B32">2010</xref>).</p>
<p>Although MBLs are not as much widespread as class D enzymes in <italic>A. baumannii</italic>, they display a significantly higher hydrolytic activity toward carbapenems (100- to 1,000-fold; Poirel and Nordmann, <xref ref-type="bibr" rid="B254">2006a</xref>). Of the several groups of MBLs described to date, only IMP, VIM, SIM, and the novel NDM have been found in <italic>A. baumannii</italic> and, with the exception of NDM, they are typically identified within class 1 integrons containing an array of resistance gene cassettes as well, usually including some aminoglycoside-resistance determinants (Riccio et al., <xref ref-type="bibr" rid="B273">2000</xref>; Houang et al., <xref ref-type="bibr" rid="B123">2003</xref>; Zarrilli et al., <xref ref-type="bibr" rid="B352">2004</xref>; Lee et al., <xref ref-type="bibr" rid="B166">2005</xref>; Tsakris et al., <xref ref-type="bibr" rid="B319">2006</xref>). The importance of integrons and their contribution to the MDR phenotype will be further expanded later in this review.</p>
<p>IMP metallo-&#x003B2;-lactamases (named for being active on imipenem) were first described in Japan from a <italic>Pseudomonas aeruginosa</italic> isolate in 1990 (Watanabe et al., <xref ref-type="bibr" rid="B336">1991</xref>). After that initial isolation, IMP enzymes have been reported worldwide in several Gram-negative bacteria, including <italic>A. baumannii</italic> (Queenan and Bush, <xref ref-type="bibr" rid="B264">2007</xref>). So far there are up to 33 different IMP variants (according to <uri xlink:href="http://www.lahey.org/studies/">http://www.lahey.org/studies/</uri>) but only 8 (IMP-1, -2, -4, -5, -6, -8, -11, and -19) have been identified in <italic>A. baumannii</italic>, mostly in Asia but also in Europe and parts of South America (Riccio et al., <xref ref-type="bibr" rid="B273">2000</xref>; Chu et al., <xref ref-type="bibr" rid="B45">2001</xref>; Da Silva et al., <xref ref-type="bibr" rid="B56">2002</xref>; Towner et al., <xref ref-type="bibr" rid="B317">2002</xref>; Gales et al., <xref ref-type="bibr" rid="B98">2003</xref>; Lee et al., <xref ref-type="bibr" rid="B165">2003</xref>, <xref ref-type="bibr" rid="B167">2008</xref>; Yamamoto et al., <xref ref-type="bibr" rid="B344">2011</xref>). Enzymes belonging to the IMP type have broad substrate specificity and are especially active against cephalosporins and carbapenems.</p>
<p>The first VIM enzyme (VIM-1) was initially described in 1999 from a <italic>P. aeruginosa</italic> isolate in the Italian location of Verona (hence, Veronese imipenemase; Lauretti et al., <xref ref-type="bibr" rid="B157">1999</xref>) but the first VIM enzyme (VIM-2) in <italic>A. baumannii</italic> was not described until a few years later (Yum et al., <xref ref-type="bibr" rid="B350">2002</xref>). VIM MBLs display &#x0003C;40% amino acid identity with IMP enzymes and share a similar substrate profile, albeit with a higher affinity toward carbapenems (Docquier et al., <xref ref-type="bibr" rid="B69">2003</xref>). During the past decade several VIM variants (VIM-1, -2, -3, -4, and -11) have been identified in <italic>A. baumannii</italic> isolates, mainly in European and Asian countries (Yum et al., <xref ref-type="bibr" rid="B350">2002</xref>; Lee et al., <xref ref-type="bibr" rid="B165">2003</xref>, <xref ref-type="bibr" rid="B167">2008</xref>; Tsakris et al., <xref ref-type="bibr" rid="B319">2006</xref>; Wroblewska et al., <xref ref-type="bibr" rid="B343">2007</xref>; Figueiredo et al., <xref ref-type="bibr" rid="B92">2008</xref>) but also in clinical isolates of the closely related <italic>A. nosocomialis</italic> and <italic>A. pittii</italic> (Espinal et al., <xref ref-type="bibr" rid="B82">2011b</xref>).</p>
<p>SIM-1 was originally found in <italic>A. baumannii</italic> in a tertiary care hospital in Seoul, Korea (hence, Seoul imipenemase), and so far this isolate contains the only <italic>bla</italic><sub>SIM-1</sub> gene reported in this microorganism (Lee et al., <xref ref-type="bibr" rid="B166">2005</xref>). SIM-1 exhibits 64&#x02013;69% amino acid identity with IMP enzymes and, similar to IMP and VIM, it is capable of hydrolyzing penicillins, narrow-, and expanded-spectrum cephalosporins as well as carbapenems.</p>
<p>More recently, a novel class B metallo-&#x003B2;-lactamase enzyme has been reported. This enzyme was first identified in <italic>Klebsiella pneumoniae</italic> and <italic>E. coli</italic> clinical isolates recovered in Sweden from a traveler returning from India and has, hence, been termed NDM-1 for New Delhi metallo-&#x003B2;-lactamase (Yong et al., <xref ref-type="bibr" rid="B348">2009</xref>). Similar to other MBL enzymes, NDM-1 confers resistance to all &#x003B2;-lactams except aztreonam. After its initial isolation, several reports have identified <italic>bla</italic><sub>NDM</sub> genes in Enterobacteriaceae worldwide due to their plasmidic localization that allows for rapid transfer and dissemination (Nordmann et al., <xref ref-type="bibr" rid="B225">2011</xref>, <xref ref-type="bibr" rid="B224">2012</xref>; Poirel et al., <xref ref-type="bibr" rid="B246">2011a</xref>). In 2010 the <italic>bla</italic><sub>NDM-1</sub> gene was first identified in an intensive care unit in India from an <italic>A. baumannii</italic> isolate that also contained the <italic>bla</italic><sub>OXA-23</sub> gene and <italic>armA</italic> (Karthikeyan et al., <xref ref-type="bibr" rid="B142">2010</xref>), a gene encoding a 16S rRNA methylase conferring resistance to aminoglycosides (Yamane et al., <xref ref-type="bibr" rid="B346">2005</xref>). The chromosomal or plasmidic location of this gene, however, was not clear. Kaase et al. (<xref ref-type="bibr" rid="B139">2011</xref>) identified the first NDM variant in an <italic>A. baumannii</italic> isolate from Egypt, NDM-2, which differed from NDM-1 by a single amino acid substitution but shared an identical spectrum of hydrolysis. Although not fully demonstrated, <italic>bla</italic><sub>NDM-2</sub> was thought to be chromosomally located. Several reports have subsequently described NDM enzymes in <italic>A. baumannii</italic> isolates from China, Germany, and Israel (Chen et al., <xref ref-type="bibr" rid="B40">2011</xref>; Espinal et al., <xref ref-type="bibr" rid="B81">2011a</xref>; Pfeifer et al., <xref ref-type="bibr" rid="B240">2011</xref>) but also in an <italic>Acinetobacter lwoffii</italic> isolate from China (Hu et al., <xref ref-type="bibr" rid="B124">2011</xref>). Interestingly, while the <italic>bla</italic><sub>NDM-1</sub> and <italic>bla</italic><sub>NDM-2</sub> from Germany (Pfeifer et al., <xref ref-type="bibr" rid="B240">2011</xref>) and Israel (Espinal et al., <xref ref-type="bibr" rid="B81">2011a</xref>), respectively, were found on the chromosome of <italic>A. baumannii</italic>, the <italic>bla</italic><sub>NDM-1</sub> from Chinese isolates were located on several plasmids ranging from 30 to 50&#x02009;kb in size (Chen et al., <xref ref-type="bibr" rid="B40">2011</xref>) and as was the <italic>bla</italic><sub>NDM-1</sub> gene found in <italic>A. lwoffii</italic> of Chinese origin.</p>
</sec>
<sec>
<title>Minor relevance &#x003B2;-lactamases</title>
<p>Additional &#x003B2;-lactamase enzymes belonging to the Ambler class A have also been described in <italic>A. baumannii</italic> but they are generally regarded of minor relevance since the prevalence of these enzymes as well as their specific contribution to the resistant phenotype is usually hindered by the presence of more prevalent mechanisms such as the intrinsic AmpC cephalosporinase or the naturally occurring OXA-51, among others (Poirel and Nordmann, <xref ref-type="bibr" rid="B254">2006a</xref>).</p>
<p>Narrow-spectrum serine &#x003B2;-lactamases such as TEM-1, SCO-1, CARB-2, -4, and -8 as well as OXA-20, OXA-21, and OXA-37 have all been detected in <italic>A. baumannii</italic> (Vila et al., <xref ref-type="bibr" rid="B327">1997a</xref>; Navia et al., <xref ref-type="bibr" rid="B217">2002</xref>; Mammeri et al., <xref ref-type="bibr" rid="B187">2003</xref>; Zarrilli et al., <xref ref-type="bibr" rid="B352">2004</xref>; Koh et al., <xref ref-type="bibr" rid="B149">2007b</xref>; Poirel et al., <xref ref-type="bibr" rid="B245">2007</xref>; Wang et al., <xref ref-type="bibr" rid="B334">2007</xref>; Ram&#x000ED;rez et al., <xref ref-type="bibr" rid="B268">2010b</xref>), but some other extended-spectrum &#x003B2;-lactamases and serine-carbapenemases are also present.</p>
<p>PER-1 was the first ESBL enzyme identified in <italic>A. baumannii</italic> (Vahaboglu et al., <xref ref-type="bibr" rid="B322">1997</xref>) but also PER-2 and -7 (Paster&#x000E1;n et al., <xref ref-type="bibr" rid="B234">2006</xref>; Bonnin et al., <xref ref-type="bibr" rid="B24">2011b</xref>), VEB-1 (Poirel et al., <xref ref-type="bibr" rid="B252">2003</xref>), TEM variants TEM-92, -116, and -150 (Naiemi et al., <xref ref-type="bibr" rid="B216">2005</xref>; Endimiani et al., <xref ref-type="bibr" rid="B79">2007</xref>; Shakil and Khan, <xref ref-type="bibr" rid="B297">2010</xref>), GES-11, -12, and -14 (Bogaerts et al., <xref ref-type="bibr" rid="B21">2010</xref>), the atypical expended-spectrum carbenicillinase CARB-10 (Potron et al., <xref ref-type="bibr" rid="B259">2009</xref>), capable of hydrolyzing fourth generation cephalosporins but not ceftazidime or cefotaxime, at least three different SHV-type ESBLs (SHV-2, -5, and -12; Naiemi et al., <xref ref-type="bibr" rid="B216">2005</xref>; Naas et al., <xref ref-type="bibr" rid="B213">2007</xref>) as well as three different types of the plasmid-mediated CTX-M enzymes (CTX-M-2, -15, -43; Nagano et al., <xref ref-type="bibr" rid="B215">2004</xref>; Celenza et al., <xref ref-type="bibr" rid="B36">2006</xref>; Shakil and Khan, <xref ref-type="bibr" rid="B297">2010</xref>) have been reported so far in this microorganism.</p>
<p>Interestingly, while PER and VEB are usually regarded as second-class &#x003B2;-lactamases in Enterobacteriaceae (Naas et al., <xref ref-type="bibr" rid="B214">2008</xref>), they are more commonly found in <italic>A. baumannii</italic> and seem to be emerging in certain geographic regions where they are responsible for nosocomial outbreaks (Vahaboglu et al., <xref ref-type="bibr" rid="B322">1997</xref>; Naas et al., <xref ref-type="bibr" rid="B211">2006a</xref>,<xref ref-type="bibr" rid="B212">b</xref>). On the other hand, CTX-M variants, especially CTX-M-15, are widely disseminated among Enterobacteriaceae worldwide (Canton and Coque, <xref ref-type="bibr" rid="B34">2006</xref>) but, until recently, were rare in <italic>A. baumannii</italic>. Recent reports seem to indicate an increase in <italic>A. baumannii</italic> strains bearing CTX-M variants within the Asia-Pacific region, most likely associated with transposon-mediated mobilization events (Nagano et al., <xref ref-type="bibr" rid="B215">2004</xref>; Shakil and Khan, <xref ref-type="bibr" rid="B297">2010</xref>; Potron et al., <xref ref-type="bibr" rid="B258">2011</xref>).</p>
<p>It is worth mentioning that 10 KPC enzymes, including a novel variant, KPC-10, have also recently been identified among isolates belonging to the <italic>A. calcoaceticus</italic>&#x02013;<italic>A. baumannii</italic> complex in Puerto Rico, although identification to the species level was not conclusive (Robledo et al., <xref ref-type="bibr" rid="B275">2010</xref>).</p>
</sec>
</sec>
<sec>
<title>Non-enzymatic mechanisms</title>
<sec>
<title>Membrane permeability</title>
<p>Resistance to &#x003B2;-lactams by means of non-enzymatic mechanisms includes any alteration in the permeability of bacterial membranes that either prevents the entry of antimicrobial agents or promotes their efflux. Very little is known about the OMPs of <italic>A. baumannii</italic>, but several studies have highlighted the relevance of such proteins in resistance to &#x003B2;-lactams. In 2002, Viale and co-workers demonstrated that the loss of a 29-kDa protein, named CarO, was associated with carbapenem resistance in <italic>A. baumannii</italic> in the absence of any known carbapenemase (Limansky et al., <xref ref-type="bibr" rid="B172">2002</xref>). The loss of CarO in several carbapenem-resistant <italic>A. baumannii</italic> isolates was due to the presence of distinct insertion elements that disrupted the <italic>carO</italic> gene (Mussi et al., <xref ref-type="bibr" rid="B210">2005</xref>). Structural studies on this protein, however, showed that although CarO presented some pore-forming properties, it did not contain any specific binding site for carbapenems and was rather a non-specific channel (Siroy et al., <xref ref-type="bibr" rid="B300">2005</xref>). Several other investigations have also identified a variety of OMP proteins mainly involved in carbapenem resistance upon OMP-loss or reduced expression, including a set of endemic carbapenem-resistant <italic>A. baumannii</italic> isolates from New York presenting reduced expression of 47-, 44-, and 37-kDa OMPs together with an increased expression of the class C cephalosporinase (Quale et al., <xref ref-type="bibr" rid="B263">2003</xref>); an <italic>A. baumannii</italic> isolate in Spain that had lost a 33- to 36-kDa OMP associated with carbapenem resistance (del Mar Tomas et al., <xref ref-type="bibr" rid="B64">2005</xref>); and, also similar to what has already been described in Enterobacteriaceae (Kitchel et al., <xref ref-type="bibr" rid="B146">2010</xref>; Pitart et al., <xref ref-type="bibr" rid="B242">2011</xref>), the combined effect of reduced expression of 22- and 33-kDa OMPs and an acquired carbapenemase enzyme (OXA-23; Bou et al., <xref ref-type="bibr" rid="B26">2000a</xref>).</p>
<p>Proteomic studies have also highlighted some OMPs that might have a relevant role in the resistant phenotype to &#x003B2;-lactams, such as the heat-modifiable HMP-AB, which constitutes the major OMP of <italic>A. baumannii</italic> and resembles the OmpA protein from Enterobacteriaceae (Gribun et al., <xref ref-type="bibr" rid="B112">2003</xref>), OmpW (Siroy et al., <xref ref-type="bibr" rid="B299">2006</xref>; Vila et al., <xref ref-type="bibr" rid="B326">2007</xref>), and a 43-kDa protein similar to OprD from <italic>P. aeruginosa</italic> (Dupont et al., <xref ref-type="bibr" rid="B77">2005</xref>).</p>
<p>More recently, Fern&#x000E1;ndez-Cuenca et al. investigated the virulence phenotype of a pan-drug-resistant <italic>A. baumannii</italic> clinical isolate and found an association between attenuated virulence and the decreased expression of genes encoding CarO and OprD-like porins. Attenuated virulence in this work was attributed to a higher biological cost when losing certain OMPs (Fern&#x000E1;ndez-Cuenca et al., <xref ref-type="bibr" rid="B89">2011</xref>).</p>
<p>The role of efflux proteins in the antibiotic susceptibility profile of <italic>A. baumannii</italic> will be discussed in more detail within the following pages, however, it should be mentioned that the contribution to &#x003B2;-lactam resistance of the three resistance&#x02013;nodulation&#x02013;cell division (RND) efflux pumps identified so far in <italic>A. baumannii</italic> (AdeABC, AdeIJK, and AdeFGH) has not been extensively studied. Disruption of either <italic>adeABC</italic> or <italic>adeIJK</italic> has been shown to cause 4- and 12-fold decreases in the MICs of cefotaxime and cefepime, respectively, with that of imipenem remaining unchanged. AdeFGH, on the other hand, does not seem to affect susceptibility to &#x003B2;-lactams (Magnet et al., <xref ref-type="bibr" rid="B184">2001</xref>; Damier-Piolle et al., <xref ref-type="bibr" rid="B57">2008</xref>; Coyne et al., <xref ref-type="bibr" rid="B54">2010b</xref>). Interestingly, Wong et al. (<xref ref-type="bibr" rid="B341">2009</xref>) showed that disruption of <italic>adeB</italic> in three <italic>A</italic>. <italic>baumannii</italic> strains significantly altered susceptibility to meropenem but not to imipenem and, more recently, Roca et al. (<xref ref-type="bibr" rid="B276">2011</xref>) characterized an AdeABC-type efflux pump in an isolate of the closely related <italic>A. nosocomialis</italic> which was able to extrude monobactams, third-generation cephalosporins, cefoxitin, and meropenem but, again, not imipenem.</p>
<p>Overall, &#x003B2;-lactam extrusion by means of efflux systems leads to small increases in the MIC, and high-level resistance can only be achieved in combination with additional resistance mechanisms (H&#x000E9;ritier et al., <xref ref-type="bibr" rid="B116">2005a</xref>).</p>
</sec>
<sec>
<title>Penicillin-binding proteins</title>
<p>Another non-enzymatic mechanism of resistance to &#x003B2;-lactams involves changes in the affinity or expression levels of PBPs. Several reports have identified differences in the expression patterns of PBPs between carbapenem-susceptible and carbapenem-resistant <italic>A. baumannii</italic> strains. In some of these strains, carbapenem resistance has been associated with the overexpression of PBP types with low affinity for carbapenem in the absence of any other known resistance mechanism (Gehrlein et al., <xref ref-type="bibr" rid="B101">1991</xref>; Urban et al., <xref ref-type="bibr" rid="B321">1995</xref>) but also with the reduced expression of PBP types together with the production of several &#x003B2;-lactamases or the loss of a 22.5-kDa OMP (Fern&#x000E1;ndez-Cuenca et al., <xref ref-type="bibr" rid="B88">2003</xref>; Cayo et al., <xref ref-type="bibr" rid="B35">2011</xref>). Overall, the contribution of PBP variants to carbapenem resistance is marginal unless associated with &#x003B2;-lactamases, overexpression of efflux pumps or decreased expression of OMPs, and the mechanisms leading to altered expression levels of these proteins have yet to be elucidated (Yun et al., <xref ref-type="bibr" rid="B351">2011</xref>).</p>
</sec>
</sec>
<sec>
<title>Aminoglycosides</title>
<p>Resistance to aminoglycosides in <italic>A. baumannii</italic> can be achieved by means of efflux proteins extruding these compounds (reviewed below) or by the expression of aminoglycoside-modifying enzymes (AMEs), specifically acetyltransferases, nucleotidyltransferases, and phosphotransferases (Cho et al., <xref ref-type="bibr" rid="B41">2009</xref>). Activity of AMEs results in the modification of hydroxyl or amino groups present within aminoglycosides that decrease their affinity for the target site (Smith and Baker, <xref ref-type="bibr" rid="B301">2002</xref>). AMEs can be located in either the bacterial chromosome or in plasmids and are usually associated with class 1 integrons and resistance islands where two or more aminoglycoside-resistance genes often occur in combination (Cho et al., <xref ref-type="bibr" rid="B41">2009</xref>). Nemec et al. showed that more than 95% out of 106 European multidrug-resistant <italic>A. baumannii</italic> isolates contained at least one aminoglycoside-resistance gene and 84% contained a combination of two to five different genes with more than 12 distinct combinations. Seventy-eight percent of the strains contained class 1 integrons as well, highlighting the major role of horizontal gene transfer in the dissemination of AMEs in <italic>A. baumannii</italic> (Nemec et al., <xref ref-type="bibr" rid="B218">2004</xref>).</p>
<p>More recently, 16S rRNA methylation mediated by <italic>armA</italic> has also been described in <italic>A. baumannii</italic>, conferring high-level resistance to all clinically relevant aminoglycosides, such as gentamicin, tobramycin, and amikacin (Doi and Arakawa, <xref ref-type="bibr" rid="B71">2007</xref>). <italic>armA</italic> has been found in China, Korea, and the United States (Lee et al., <xref ref-type="bibr" rid="B158">2006a</xref>; Doi et al., <xref ref-type="bibr" rid="B70">2007</xref>; Yu et al., <xref ref-type="bibr" rid="B349">2007</xref>), and it is also commonly found in combination with the <italic>bla</italic><sub>OXA-23</sub> gene (Kim et al., <xref ref-type="bibr" rid="B144">2008</xref>; Karthikeyan et al., <xref ref-type="bibr" rid="B142">2010</xref>).</p>
</sec>
<sec>
<title>Quinolones</title>
<p>The mechanisms of fluoroquinolone resistance in <italic>A. baumannii</italic> parallel those of other Gram-negative bacteria and are mainly achieved by point mutations originating amino acid substitutions within the quinolone-resistance determining regions (QRDR) of DNA gyrase and DNA topoisomerase IV (F&#x000E0;brega et al., <xref ref-type="bibr" rid="B86">2009</xref>). Mutations in both <italic>gyrA</italic> and <italic>parC</italic> have been described in <italic>A. baumannii</italic> with the most common substitutions being Ser83 to Leu83 for <italic>gyrA</italic> and Ser80 to Leu80 in <italic>parC</italic> (Vila et al., <xref ref-type="bibr" rid="B329">1995</xref>, <xref ref-type="bibr" rid="B328">1997b</xref>; Seward and Towner, <xref ref-type="bibr" rid="B295">1998</xref>; Spence and Towner, <xref ref-type="bibr" rid="B306">2003</xref>; Wisplinghoff et al., <xref ref-type="bibr" rid="B340">2003</xref>; Hamouda and Amyes, <xref ref-type="bibr" rid="B114">2004</xref>; Higgins et al., <xref ref-type="bibr" rid="B121">2004</xref>; Valentine et al., <xref ref-type="bibr" rid="B323">2008</xref>). It is worth mentioning that mutations in <italic>parC</italic> are always accompanied by a concurrent mutation in <italic>gyrA</italic>, probably suggesting that DNA gyrase is the preferred target for fluoroquinolones in <italic>A. baumannii</italic> (Vila et al., <xref ref-type="bibr" rid="B329">1995</xref>, <xref ref-type="bibr" rid="B328">1997b</xref>; Hamouda and Amyes, <xref ref-type="bibr" rid="B114">2004</xref>).</p>
<p>Several efflux pumps in <italic>A. baumannii</italic> are also involved in fluoroquinolone resistance and their specific contribution will be discussed later. Interestingly, plasmid-mediated fluoroquinolone resistance mechanisms such as <italic>qnr</italic>, <italic>aac(6&#x02032;)-Ib-cr</italic>, or <italic>qepA</italic> (F&#x000E0;brega et al., <xref ref-type="bibr" rid="B86">2009</xref>) have not yet been described in <italic>A. baumannii</italic> (Yin et al., <xref ref-type="bibr" rid="B347">2008</xref>; Srinivasan et al., <xref ref-type="bibr" rid="B308">2009b</xref>).</p>
</sec>
<sec>
<title>Polymyxins</title>
<p>To date, most multidrug <italic>A. baumannii</italic> strains still remain susceptible to polymyxins, prompting an increased use of these compounds despite previous concerns regarding toxicity issues (Falagas and Kasiakou, <xref ref-type="bibr" rid="B87">2005</xref>). Polymyxin E (Colistin), acts by modifying the negative charges of the outer membranes of Gram-negative bacteria, ultimately leading to the disruption of the bacterial membrane. There is very little information regarding the mechanisms of colistin resistance in <italic>A. baumannii</italic>, but it appears that colistin resistance might be multifactorial. By comparing the proteomes of colistin-susceptible versus colistin-resistant <italic>A. baumannii</italic> isolates Fern&#x000E1;ndez-Reyes et al. (<xref ref-type="bibr" rid="B91">2009</xref>) were able to identify the differential expression of 35 proteins, including OMPs, chaperons, protein biosynthesis factors, and metabolic enzymes. Other studies, however, have focused on modifications in the bacterial lipopolysaccharide. It has been shown that mutations causing an up-regulated expression of the <italic>pmrA</italic> and <italic>pmrB</italic> genes lead to colistin resistance in <italic>A. baumannii</italic> (Adams et al., <xref ref-type="bibr" rid="B4">2009</xref>). <italic>pmrA</italic> and <italic>pmrB</italic> constitute a two-component regulatory system that governs the expression of <italic>pmrC</italic>, encoding a phosphoethanolamine transferase enzyme involved in lipid A modification. Up-regulation of <italic>pmrA</italic> and <italic>pmrB</italic> also causes the overexpression of <italic>pmrC</italic> and the addition of phosphoethanolamine to the lipid A, which impairs the self-promoted uptake of colistin across the outer membrane (Arroyo et al., <xref ref-type="bibr" rid="B14">2011</xref>; Beceiro et al., <xref ref-type="bibr" rid="B16">2011</xref>).</p>
<p>On the other hand, Moffatt et al. (<xref ref-type="bibr" rid="B205">2010</xref>) demonstrated that colistin resistance could also be achieved by the complete loss of lipopolysaccharide production due to mutations affecting several genes involved in lipid A biosynthesis (<italic>lpxA</italic>, <italic>lpxC</italic>, or <italic>lpxD</italic>). Mutations in these genes ranged from single point mutations to large deletions or even the presence of an insertion element, IS<italic>Aba11</italic>, truncating either <italic>lpxA</italic> or <italic>lpxC</italic> (Moffatt et al., <xref ref-type="bibr" rid="B204">2011</xref>). Interestingly, Moffatt et al. observed that colistin-resistant mutants lacking LPS had a 32- to 256-fold increase in susceptibility to other classes of antibiotics. The authors attributed this observation to a direct consequence of LPS loss causing an increased permeability of the outer membrane.</p>
<p>Interestingly, some reports seem to indicate that colistin resistance in <italic>A. baumannii</italic> is associated with lower bacterial fitness <italic>in vivo</italic> as well as decreased virulence, suggesting that colistin usage for the treatment of <italic>A. baumannii</italic> infections might constitute a safe and effective strategy (L&#x000F3;pez-Rojas et al., <xref ref-type="bibr" rid="B180">2011b</xref>). Nevertheless, reduced bacterial fitness in colistin-resistant <italic>A. baumannii</italic> strains does not always occur as acquisition of compensatory mutations might contribute to maintain the virulence of resistant isolates (L&#x000F3;pez-Rojas et al., <xref ref-type="bibr" rid="B181">2011c</xref>; Rolain et al., <xref ref-type="bibr" rid="B281">2011</xref>).</p>
</sec>
<sec>
<title>Efflux</title>
<p>Antimicrobial efflux is yet another important mechanism of resistance in <italic>A. baumannii</italic>. In general, efflux constitutes a resistance mechanism that involves the extrusion of antimicrobial agents (as well as other compounds) from the inner side of bacterial membranes to the external environment by means of specific proteins typically named efflux pumps. Although only a few efflux systems have been described in this microorganism, their importance should not be taken lightly since most are capable of pumping out several antimicrobial agents and, therefore, contribute to the greatly feared multidrug-resistant phenotype of nosocomial <italic>A. baumannii</italic>.</p>
<p>Efflux pumps in bacteria are classified into up to five distinct families according to amino acid sequence similarities, energy source, number of components, number of transmembrane-spanning regions and types of substrates: (i) The adenosine triphosphate (ATP)-binding cassette (ABC) superfamily, (ii) the multidrug and toxic compound extrusion (MATE) family, (iii) the small multidrug resistance (SMR) family, (iv) the major facilitator superfamily (MFS), and (v) the RND family (Piddock, <xref ref-type="bibr" rid="B241">2006</xref>).</p>
<p>The RND family usually plays a predominant role in MDR in Gram-negative bacteria and species of <italic>Acinetobacter</italic> are not an exception (Li and Nikaido, <xref ref-type="bibr" rid="B170">2009</xref>). Members of this family consist of a tripartite system including a transporter protein embedded within the inner membrane, an OMP channel, and a membrane fusion protein linking the other two (Magnet et al., <xref ref-type="bibr" rid="B184">2001</xref>). The first RND pump to be identified in <italic>A. baumannii</italic> was named AdeABC, with AdeB constituting the multidrug transporter protein, AdeC being the OMP and AdeA the periplasmic linking protein (Magnet et al., <xref ref-type="bibr" rid="B184">2001</xref>). The <italic>adeABC</italic> genes are also preceded by two additional genes in inverted orientation, <italic>adeSR</italic>, which encode a two-component regulatory system apparently involved in controlling <italic>adeABC</italic> expression (Marchand et al., <xref ref-type="bibr" rid="B189">2004</xref>). Expression of AdeABC confers decreased susceptibility to a wide variety of antimicrobials such as kanamycin, gentamicin, tobramycin, netilmicin, amikacin, erythromycin, tetracycline, chloramphenicol, trimethoprim, sparfloxacin, ofloxacin, perfloxacin, norfloxacin, ethidium bromide and, more recently, tigecycline (Ruzin et al., <xref ref-type="bibr" rid="B289">2007</xref>) and meropenem (Koh et al., <xref ref-type="bibr" rid="B148">2007a</xref>). Not all <italic>A. baumannii</italic> isolates seem to carry this system, though: Huys et al. (<xref ref-type="bibr" rid="B128">2005a</xref>) detected the <italic>adeB</italic> gene in 49 out of 51 (96%) highly related <italic>A. baumannii</italic> strains, Chu et al. (<xref ref-type="bibr" rid="B46">2006</xref>) found <italic>adeB</italic> in 39 out of 56 (70%) <italic>A. baumannii</italic> isolates from Hong Kong, Nemec et al. (<xref ref-type="bibr" rid="B220">2007</xref>) in roughly 83% of 116 isolates tested and Courvalin and co-workers identified the <italic>adeB</italic> gene in 24 out of 27 <italic>A. baumannii</italic> strains (88%; Damier-Piolle et al., <xref ref-type="bibr" rid="B57">2008</xref>), altogether indicating that although AdeABC might not be intrinsic to <italic>A. baumannii</italic>, it is indeed highly widespread among clinical isolates. Interestingly, the <italic>adeSRABC</italic> genes have recently been identified in one isolate of the closely related <italic>A. nosocomialis</italic> together with two additional RND pumps not found in <italic>A. baumannii</italic> (Roca et al., <xref ref-type="bibr" rid="B276">2011</xref>). Very little is known about the resistance mechanisms in this particular microorganism but <italic>A. nosocomialis</italic> has appeared as a recent emergent pathogen with a great potential to cause disease and acquire a multidrug-resistant phenotype (Espinal et al., <xref ref-type="bibr" rid="B82">2011b</xref>). Hence, the presence of three major efflux systems in an emerging multidrug-resistant pathogen is alarming.</p>
<p>Some studies also seem to suggest a correlation between the presence of this efflux system and the resistant phenotype of <italic>A. baumannii</italic> clinical isolates, since AdeABC is commonly associated with class 1 integron genes in resistant strains but missing in highly susceptible isolates (Fournier et al., <xref ref-type="bibr" rid="B94">2006</xref>; Lin et al., <xref ref-type="bibr" rid="B173">2009</xref>).</p>
<p>The second RND efflux system (AdeIJK) described in <italic>A. baumannii</italic> was reported in the same clinical isolate that led to the identification of AdeABC (Damier-Piolle et al., <xref ref-type="bibr" rid="B57">2008</xref>). Overexpression of this pump either in <italic>E. coli</italic> or <italic>A. baumannii</italic> is apparently toxic, suggesting the presence of a tight regulation mechanism to maintain its expression levels low. No adjacent regulatory genes, however, have been found in the vicinity of <italic>adeIJK</italic>.</p>
<p>Inactivation of AdeIJK by allelic replacement showed decreased resistance to substrates similar to those of the AdeABC pump, and a double mutant (&#x00394;<italic>adeABC/</italic>&#x00394;<italic>adeIJK</italic>) displayed even lower MICs of chloramphenicol, tetracyclines, erythromycin, clindamycin, fluoroquinolones, and tigecycline than each of the single mutants, thus indicating both a cumulative effect of the pumps as well as overlapping substrate profiles, which is, nevertheless, interesting from a clinical point of view. However, opposed to AdeABC, AdeIJK did not seem capable of extruding ethidium bromide or azithromycin, despite the latter being a preferred substrate for AdeABC (Damier-Piolle et al., <xref ref-type="bibr" rid="B57">2008</xref>). Unfortunately, extrusion of aminoglycosides could not be tested in this system since the allelic replacement mutants incorporated either kanamycin or apramycin resistance cassettes.</p>
<p>AdeIJK has so far been detected in all the <italic>A. baumannii</italic> strains tested (Damier-Piolle et al., <xref ref-type="bibr" rid="B57">2008</xref>) and is therefore considered to have a more predominant role in the intrinsic low-level resistant phenotype of <italic>A. baumannii</italic>. The AdeIJK efflux transporter seems highly specific to <italic>A. baumannii</italic> and has not yet been described in other species of the <italic>Acinetobacter</italic> genus. It is worth mentioning, however, that <italic>adeIJK</italic> and <italic>adeXYZ</italic> (an RND efflux pump described in <italic>A. pittii</italic> and <italic>A. nosocomialis</italic>; Chu et al., <xref ref-type="bibr" rid="B46">2006</xref>; Roca et al., <xref ref-type="bibr" rid="B276">2011</xref>) are extremely alike, sharing 93% identity at the nucleotide level and 99% similarity at the protein level. Similarity percentages obtained when comparing already described <italic>adeJ</italic> sequences from different <italic>A. baumannii</italic> strains also provide similar figures which might suggest that they actually constitute the same efflux system that has been described twice in different genomic species and has been given different names.</p>
<p>Coyne et al. (<xref ref-type="bibr" rid="B53">2010a</xref>) reported a third RND-type efflux pump (AdeFGH) within a derivative mutant (&#x00394;<italic>adeABC/</italic>&#x00394;<italic>adeIJK</italic>) from the same <italic>A. baumannii</italic> strain in which AdeABC and AdeIJK had been characterized. Expression of AdeFGH was responsible for high-level resistance to chloramphenicol, clindamycin, fluoroquinolones, and trimethoprim as well as decreased susceptibility to tetracycline&#x02013;tigecycline and sulfonamides, but &#x003B2;-lactams, erythromycin, and rifampin remained unchanged (Coyne et al., <xref ref-type="bibr" rid="B54">2010b</xref>). Once again, substrate specificity toward aminoglycosides could not be assessed due to the presence of the respective kanamycin and apramycin resistance cassettes.</p>
<p>A small ORF encoding a putative LysR-type transcriptional regulator, named <italic>adeL</italic>, was also identified in inverted orientation upstream from <italic>adeFGH</italic> and mutations within the <italic>adeL</italic> gene have been associated with the overexpression of this efflux system (Coyne et al., <xref ref-type="bibr" rid="B54">2010b</xref>).</p>
<p>As for the presence of efflux pumps included within the remaining families of efflux transporters in <italic>A. baumannii</italic>, there is even less information than that available for the RND family.</p>
<p>Roca et al. (<xref ref-type="bibr" rid="B277">2009</xref>) identified the MFS efflux pump CraA, for chloramphenicol resistance <italic>Acinetobacter</italic>, in an <italic>A. baumannii</italic> clinical isolate from Spain. This protein was similar in sequence and secondary structure to the MdfA efflux pump from <italic>E. coli</italic> but differed in its substrate profile. CraA was shown to be highly specific for chloramphenicol and has, so far, been found in all the <italic>A. baumannii</italic> strains tested and might be responsible for the intrinsic resistance of <italic>A. baumannii</italic> to this antimicrobial agent.</p>
<p>More recently, Rajamohan et al. described a second MFS efflux pump, AmvA, mainly involved in the extrusion of dyes, disinfectants, and detergents and also erythromycin, although only causing a fourfold decrease in the MIC of this antibiotic. AmvA is also present in all <italic>A. baumannii</italic> strains studied so far (Rajamohan et al., <xref ref-type="bibr" rid="B266">2010</xref>).</p>
<p>The third type of MFS efflux pumps present in <italic>A. baumannii</italic> is made of the acquired tetracycline efflux systems (Tet) that are part of plasmids, transposons, or resistance islands (see below). TetA and TetB constitute the most prevalent Tet efflux pumps in <italic>A. baumannii</italic> with TetA conferring resistance to tetracycline and TetB to both tetracycline and minocycline (Vila et al., <xref ref-type="bibr" rid="B326">2007</xref>), although the <italic>tet(M)</italic> gene, involved in tetracycline ribosomal protection, has also been identified in one clinical isolate of <italic>A. baumannii</italic> (Ribera et al., <xref ref-type="bibr" rid="B272">2003b</xref>). <italic>tet(A)</italic>, together with the gene encoding its transcriptional regulator, <italic>tetR</italic>, is located in a Tn<italic>1721</italic>-like transposon that, in turn, might be part of a larger resistance island (Ribera et al., <xref ref-type="bibr" rid="B271">2003a</xref>; Fournier et al., <xref ref-type="bibr" rid="B94">2006</xref>). On the other hand, <italic>tet</italic>(B) is located in small plasmids ranging from 5- to 9-kDa (Srinivasan et al., <xref ref-type="bibr" rid="B308">2009b</xref>). Prevalence studies seemed to indicate that <italic>tet</italic>(B) is more commonly found in multidrug-resistant <italic>A. baumannii</italic> clinical isolates, with at least 50% of the strains containing this determinant (Guardabassi et al., <xref ref-type="bibr" rid="B113">2000</xref>; Huys et al., <xref ref-type="bibr" rid="B129">2005b</xref>; Mart&#x000ED; et al., <xref ref-type="bibr" rid="B192">2006</xref>; Mak et al., <xref ref-type="bibr" rid="B186">2009</xref>; Srinivasan et al., <xref ref-type="bibr" rid="B308">2009b</xref>).</p>
<p>The only efflux pump of the MATE family described so far in <italic>A. baumannii</italic>, AbeM, was identified in Su et al. (<xref ref-type="bibr" rid="B310">2005</xref>) and it was shown to extrude aminoglycosides, fluoroquinolones, chloramphenicol, trimethoprim, ethidium bromide and several dyes. Although AbeM has also been found in all <italic>A. baumannii</italic> strains studied to date, the role of this pump in antimicrobial resistance remains unclear since substrate-profiling studies carried out in <italic>E. coli</italic> did not fins any correlation between antibiotic resistance and overexpression of this pump.</p>
<p>AbeS is yet another efflux pump identified in <italic>A. baumannii</italic> that confers low-level resistance to several antimicrobial agents, including chloramphenicol, fluoroquinolones, erythromycin, and novobiocin, as well as resistance to dyes and detergents, but it is not present in all fully sequenced <italic>A. baumannii</italic> genomes. AbeS belongs to the SMR family and retains a certain degree of similarity with the EmrE system of <italic>E. coli</italic> (Srinivasan et al., <xref ref-type="bibr" rid="B307">2009a</xref>).</p>
</sec>
</sec>
<sec>
<title>Genome Plasticity</title>
<p>As already mentioned, probably one of the most intriguing characteristics of <italic>A. baumannii</italic> is its capacity to acquire, retain, and disseminate multiple resistance mechanisms which, combined with its ability to survive desiccation as well as most disinfectants, accounts for the prolonged survival of <italic>A. baumannii</italic> strains in the clinical setting and makes this microorganism almost impossible to eradicate.</p>
<p>Acquisition and dissemination of antimicrobial resistance determinants in <italic>A. baumannii</italic> are achieved by combining resistance genes with an array of mobile elements that mediate the exchange of genetic material and rearrange bacterial genomes, giving rise to multiple genetic combinations and providing an endless source of genetic adaptability.</p>
<p>Such an array includes IS, transposons, integrons, plasmids and, ultimately, resistance islands.</p>
<sec>
<title>Insertion sequences</title>
<p>Insertion sequences indeed have a predominant role in the acquisition of resistance within <italic>A. baumannii</italic>. They are generally defined as the smallest mobile DNA elements (&#x0003C;2.5&#x02009;kb), carrying only the genetic information required for their mobilization. In practical terms IS are constituted by a pair of short inverted-repeat sequences (IR) bracketing one or perhaps two ORFs encoding a transposase, the enzyme involved in the transposition or &#x0201C;jumping&#x0201D; of the IS element.</p>
<p>More than 30 different types of ISs have been reported in <italic>Acinetobacter</italic> spp. (Siguier et al., <xref ref-type="bibr" rid="B298">2006</xref>) being IS<italic>AbaI</italic> and IS<italic>Aba125</italic> the most prevalent ISs in this microorganism (Adams et al., <xref ref-type="bibr" rid="B2">2010</xref>). The genome of the <italic>A. baumannii</italic> AYE strain has been shown to contain up to 21 copies of IS<italic>AbaI</italic> (Vallenet et al., <xref ref-type="bibr" rid="B324">2008</xref>) but this IS has also been identified in additional <italic>A. baumannii</italic> isolates from around the world (Goic-Barisic et al., <xref ref-type="bibr" rid="B106">2009</xref>; Andriamanantena et al., <xref ref-type="bibr" rid="B11">2010</xref>; Culebras et al., <xref ref-type="bibr" rid="B55">2010</xref>; Higgins et al., <xref ref-type="bibr" rid="B119">2010</xref>; Koo et al., <xref ref-type="bibr" rid="B150">2010</xref>; Adams-Haduch et al., <xref ref-type="bibr" rid="B5">2011</xref>; Karunasagar et al., <xref ref-type="bibr" rid="B143">2011</xref>; Kusradze et al., <xref ref-type="bibr" rid="B154">2011</xref>; Nigro et al., <xref ref-type="bibr" rid="B222">2011b</xref>; Zhou et al., <xref ref-type="bibr" rid="B355">2011</xref>).</p>
<p>As a consequence of IS mobilization these genetic elements can contribute to resistance in three different ways:</p>
<list list-type="simple">
<list-item><label>(i)</label> <p>Insertion of an IS immediately upstream from a given ORF might provide additional promoters to enhance transcriptional levels of genes that are otherwise poorly expressed. In this respect, IS<italic>AbaI</italic> is commonly found upstream from <italic>bla</italic><sub>ampC</sub> and <italic>bla</italic><sub>OXA-51</sub>-like genes in <italic>A. baumannii</italic>, being responsible for ceftazidime and carbapenem resistance, respectively, in isolates lacking additional resistance mechanisms (H&#x000E9;ritier et al., <xref ref-type="bibr" rid="B118">2006</xref>; Turton et al., <xref ref-type="bibr" rid="B320">2006</xref>). In addition, IS<italic>AbaI</italic>, <italic>ISAba2</italic>, IS<italic>Aba3</italic>, IS<italic>Aba4</italic>, IS<italic>Aba10</italic>, IS<italic>Aba16</italic>, IS<italic>Aba125</italic>, IS<italic>Aba825</italic>, and IS<italic>18</italic> have also been found upstream from <italic>bla</italic><sub>OXA-23</sub> and <italic>bla</italic><sub>OXA-58</sub> (Poirel and Nordmann, <xref ref-type="bibr" rid="B255">2006b</xref>; Bertini et al., <xref ref-type="bibr" rid="B18">2007</xref>; Corvec et al., <xref ref-type="bibr" rid="B51">2007</xref>; Giannouli et al., <xref ref-type="bibr" rid="B104">2009</xref>; Lee et al., <xref ref-type="bibr" rid="B164">2011b</xref>; Ravasi et al., <xref ref-type="bibr" rid="B270">2011</xref>; Lopes et al., <xref ref-type="bibr" rid="B178">2012</xref>) and IS<italic>Aba9</italic> has been described upstream from both <italic>bla</italic><sub>OXA-51</sub> and the gene encoding CARB-10 (Figueiredo et al., <xref ref-type="bibr" rid="B93">2009</xref>; Potron et al., <xref ref-type="bibr" rid="B259">2009</xref>).</p>
<p>CHDLs however, are not the only &#x003B2;-lactamases whose expression is enhanced by the presence of upstream ISs, both <italic>bla</italic><sub>PER-1</sub> and <italic>bla</italic><sub>PER-2</sub> contain a novel IS element, IS<italic>Pa12</italic>, that has been shown to up-regulate their expression (Poirel et al., <xref ref-type="bibr" rid="B243">2005a</xref>; Paster&#x000E1;n et al., <xref ref-type="bibr" rid="B234">2006</xref>). Similarly, expression of <italic>bla</italic><sub>PER-7</sub> is also driven by a promoter sequence located within an upstream IS<italic>CR1</italic> element (Bonnin et al., <xref ref-type="bibr" rid="B24">2011b</xref>).</p></list-item>
<list-item><label>(ii)</label> <p>IS elements can also contribute to resistance by inserting within certain ORFs and disrupting their coding sequences. Insertional inactivation leading to resistance has been associated with the disruption of transcriptional regulators, such as the insertion of IS<italic>Aba1</italic> within the <italic>adeS</italic> gene leading to overexpression of the AdeABC efflux pump, but also with the disruption of genes involved in membrane permeability, such as IS<italic>Aba10</italic>, IS<italic>Aba10</italic>, IS<italic>Aba825</italic>, and IS<italic>Aba125</italic> insertion within the <italic>carO</italic> gene leading to carbapenem resistance (Lu et al., <xref ref-type="bibr" rid="B182">2009</xref>; Lee et al., <xref ref-type="bibr" rid="B164">2011b</xref>; Ravasi et al., <xref ref-type="bibr" rid="B270">2011</xref>) or the insertion of IS<italic>Aba11</italic> within the <italic>lpxA</italic> or <italic>lpxC</italic> genes causing loss of lipopolysaccharide production and colistin resistance (Moffatt et al., <xref ref-type="bibr" rid="B204">2011</xref>).</p></list-item>
<list-item><label>(iii)</label> <p>Without any doubt, however, the major contribution of ISs to the development of pan-resistant <italic>A. baumannii</italic> strains lies in their ability to mobilize gene cassettes, either within the bacterial chromosome or between the chromosome and plasmids, allowing for a rapid dissemination of such cassettes not only among different <italic>A. baumannii</italic> strains but also among isolates belonging to different taxonomic genera (Roberts et al., <xref ref-type="bibr" rid="B274">2008</xref>).</p></list-item>
</list>
<p>Insertion sequences-mediated mobilization might take place when two IS elements bracket a gene cassette, usually containing antimicrobial resistance genes, and the terminal IR from each IS cooperate to displace the intervening DNA sequence, thereby forming a compound transposon (Roberts et al., <xref ref-type="bibr" rid="B274">2008</xref>). Bear in mind that ISs involved in compound transposons can still provide promoter sequences for the transcriptional expression of the genes they carry.</p>
<p>A single IS can also mediate the mobilization of flanking DNA by a rare mechanism known as &#x0201C;one-ended&#x0201D; transposition that combines one <italic>authentic</italic> end together with a <italic>surrogate</italic> end displaying a certain degree of similarity and located nearby (Motsch et al., <xref ref-type="bibr" rid="B208">1985</xref>). In addition, ISs belonging to the IS<italic>91</italic> family (which includes IS<italic>CR1</italic> and IS<italic>CR2</italic>) are able to transpose by means of a rolling-circle replication mechanism (Toleman et al., <xref ref-type="bibr" rid="B314">2006</xref>) and mobilization of DNA elements adjacent to ISs can also be achieved due to homologous recombination between two ISs, although this mechanism feeds on the copy number of ISs.</p>
<p>In <italic>A. baumannii</italic>, mobilization of the <italic>bla</italic><sub>OXA-23</sub> gene is mediated either by two copies of IS<italic>Aba1</italic> in inverted or direct orientation and generating a compound transposon designated Tn<italic>2006</italic> or Tn<italic>2009</italic>, respectively (Corvec et al., <xref ref-type="bibr" rid="B51">2007</xref>; Adams et al., <xref ref-type="bibr" rid="B3">2008</xref>; Zhou et al., <xref ref-type="bibr" rid="B355">2011</xref>); by a single copy of IS<italic>Aba1</italic> forming a transposon-like structure named Tn<italic>2008</italic> (Adams-Haduch et al., <xref ref-type="bibr" rid="B6">2008</xref>); or by a similar structure comprising a single IS<italic>Aba4</italic> copy forming another transposon-like structure named Tn<italic>2007</italic> (Corvec et al., <xref ref-type="bibr" rid="B51">2007</xref>).</p>
<p>Of note, the chromosome of the non-pathogenic and environmental <italic>Acinetobacter radioresistens</italic> was recently identified as the original source of the acquired <italic>bla</italic><sub>OXA-23</sub> gene of <italic>A. baumannii</italic>, and other OXA-23 variants have also been found in other <italic>A. radioresistens</italic> isolates (Poirel et al., <xref ref-type="bibr" rid="B248">2008a</xref>), suggesting that the diversity of structures surrounding the <italic>bla</italic><sub>OXA-23</sub> gene might have arisen from independent transposition events from the chromosome of commensal <italic>A. radioresistens</italic> strains to transferable plasmids that have subsequently been mobilized into <italic>A. baumannii</italic>.</p>
<p>The plasmid-encoded <italic>bla</italic><sub>OXA-58</sub> gene is also commonly bracketed by distinct combinations of IS elements that usually contain IS<italic>Aba3</italic> downstream from <italic>bla</italic><sub>OXA-58</sub> and differ in the presence of ISs in the 5&#x02032; flanking end. Specifically, IS<italic>Aba3</italic> seems to be more prevalent, but IS<italic>Aba825</italic>, IS<italic>Aba1</italic>, IS<italic>Aba2</italic>, IS<italic>18</italic>, and IS<italic>26</italic> can also be present (Poirel and Nordmann, <xref ref-type="bibr" rid="B255">2006b</xref>; Bertini et al., <xref ref-type="bibr" rid="B18">2007</xref>; Giannouli et al., <xref ref-type="bibr" rid="B104">2009</xref>). The role of such upstream ISs in providing additional promoters has been clearly demonstrated, but their role in the genetic mobilization of <italic>bla</italic><sub>OXA-58</sub> is not yet clear. Apparently, each of these IS elements shows a distinct geographic distribution and since the <italic>bla</italic><sub>OXA-58</sub> is usually plasmid-borne they might have been acquired through horizontal gene transfer and homologous recombination (Poirel and Nordmann, <xref ref-type="bibr" rid="B255">2006b</xref>; Giannouli et al., <xref ref-type="bibr" rid="B104">2009</xref>). Of note, the <italic>bla</italic><sub>OXA-58</sub> gene flanked by two IS<italic>Aba3</italic> elements has also been identified in plasmids recovered from <italic>A. pittii</italic> isolates but, then again, this probably reflects the inter-genus transferability of these plasmids rather than transposon-mediated acquisition (Evans et al., <xref ref-type="bibr" rid="B85">2010</xref>; Huang et al., <xref ref-type="bibr" rid="B126">2010</xref>).</p>
<p>Additional resistance determinants thought to have been mobilized by means of IS-mediated transfer include the ESBLs <italic>bla</italic><sub>PER-1</sub>, bracketed by IS<italic>Pa12</italic> and IS<italic>Pa13</italic> and forming a compound transposon named Tn<italic>1213</italic> (Poirel et al., <xref ref-type="bibr" rid="B243">2005a</xref>), <italic>bla</italic><sub>PER-7</sub> and <italic>bla</italic><sub>VEB-1</sub> mobilized by the upstream IS<italic>CR1</italic> and IS<italic>CR2</italic>, respectively, by means of rolling-circle transposition (Poirel et al., <xref ref-type="bibr" rid="B253">2009</xref>; Bonnin et al., <xref ref-type="bibr" rid="B24">2011b</xref>), and also CARB-10, whose transfer is apparently due to a one-ended transposition event from an upstream IS<italic>Aba9</italic> (Potron et al., <xref ref-type="bibr" rid="B259">2009</xref>).</p>
<p>More recently, Potron et al. (<xref ref-type="bibr" rid="B258">2011</xref>) characterized a novel compound transposon in the chromosome of <italic>A. baumannii</italic> isolates from Haiti containing the <italic>bla</italic><sub>CTX-M-15</sub> gene flanked by IS<italic>Ecp1</italic> and a truncated IS<italic>26</italic>, reflecting a transfer event from Enterobacteriaceae.</p>
<p>Among MBLs, the <italic>bla</italic><sub>NDM</sub> sequences from Enterobacteriaceae have been shown to contain different ISs upstream from the <italic>bla</italic><sub>NDM-1</sub> gene, although the role of these ISs in the expression of NDM is not clear and they are most likely involved in the genetic mobilization of the resistance gene (Yong et al., <xref ref-type="bibr" rid="B348">2009</xref>; Poirel et al., <xref ref-type="bibr" rid="B250">2010</xref>; Ho et al., <xref ref-type="bibr" rid="B122">2011</xref>). Sequence analysis of some of these <italic>bla</italic><sub>NDM</sub> genes from Enterobacteriaceae identified a fragment of variable length containing the right-end repeat from the insertion sequence IS<italic>Aba125</italic> in-between the <italic>bla</italic><sub>NDM-1</sub> gene and the corresponding IS element as a remnant of IS<italic>Aba125</italic> insertion, and the IS element IS<italic>Ec33</italic> from <italic>E. coli</italic> strain 271 is bracketed by the sequence upstream from the IS<italic>Aba125</italic> right-end (Poirel et al., <xref ref-type="bibr" rid="B247">2011b</xref>; Sol&#x000E9; et al., <xref ref-type="bibr" rid="B305">2011</xref>). IS<italic>Aba125</italic> belongs to the IS<italic>30</italic> family and, until recently, had only been found in <italic>A. baumannii</italic>, either chromosomally or on a plasmid upstream from the <italic>bla</italic><sub>OXA-58</sub> gene (Mussi et al., <xref ref-type="bibr" rid="B210">2005</xref>; Evans et al., <xref ref-type="bibr" rid="B85">2010</xref>) but never linked to <italic>bla</italic><sub>NDM</sub> genes. Interestingly, Sol&#x000E9; et al. recently identified a complete IS<italic>Aba125</italic> copy upstream from a <italic>bla</italic><sub>NDM-1</sub> gene in <italic>E. coli</italic> and both Pfeifer et al. (<xref ref-type="bibr" rid="B240">2011</xref>) and Espinal et al. (<xref ref-type="bibr" rid="B81">2011a</xref>) have also found <italic>bla</italic><sub>NDM-1</sub> and <italic>bla</italic><sub>NDM-2</sub> sequences in <italic>A. baumannii</italic> bracketed between two copies of IS<italic>Aba125</italic>, thereby defining a novel transposon. In view of these results, it has been postulated that some of the <italic>bla</italic><sub>NDM</sub> sequences found in Enterobacteriaceae might have originated from <italic>Acinetobacter</italic> by means of IS<italic>Aba125</italic>-mediated mobilization (Sol&#x000E9; et al., <xref ref-type="bibr" rid="B305">2011</xref>). IS<italic>Aba125</italic> has also been found flanking the aminoglycoside-resistance gene <italic>aphA6</italic> and constituting the compound transposon Tn<italic>aphA6</italic> (Nigro et al., <xref ref-type="bibr" rid="B221">2011a</xref>).</p>
<p>Insertion sequences are also involved in the mobilization of the <italic>tet(A)</italic> and <italic>tetR</italic> genes, encoding the tetracycline efflux pump and its transcriptional regulator, respectively, and commonly found within a Tn<italic>1721</italic>-like transposon that might also be present in multiple copies within the bacterial chromosome (Ribera et al., <xref ref-type="bibr" rid="B271">2003a</xref>; Fournier et al., <xref ref-type="bibr" rid="B94">2006</xref>).</p>
<p>It is worth mentioning that conserved inverted repeats homologous to binding sites acting as targets for the XerC and XerD recombinases, usually involved in site-specific recombination mechanisms, have been described flanking <italic>bla</italic><sub>OXA-24/40</sub> genes in different plasmids recovered from <italic>A. baumannii</italic> isolates (D&#x02019;Andrea et al., <xref ref-type="bibr" rid="B58">2009</xref>; Merino et al., <xref ref-type="bibr" rid="B202">2010</xref>; Acosta et al., <xref ref-type="bibr" rid="B1">2011</xref>; Tian et al., <xref ref-type="bibr" rid="B313">2011</xref>). In view of these results, XerC/XerD recombinases have been postulated as a novel mechanism driving mobilization of the <italic>bla</italic><sub>OXA-24/40</sub> gene (Merino et al., <xref ref-type="bibr" rid="B202">2010</xref>).</p>
<p>Conjugative plasmids are also known to play a central role in the intra- and inter-species transfer of resistance determinants. However, although some resistance genes such as <italic>bla</italic><sub>OXA-58</sub> and <italic>bla</italic><sub>OXA-23</sub> are commonly plasmid-borne in <italic>Acinetobacter</italic> spp., a recent study of plasmid replicons in <italic>A. baumannii</italic> suggested that replicon types within this microorganism do not correspond to those circulating among Enterobacteriaceae, which might provide a plausible explanation for the observation that prevalent plasmid-encoded resistance mechanisms identified among Gram-negative bacteria (ESBLs, KPC, etc.) are rarely present in <italic>Acinetobacter</italic> spp. while this genus seems to contain its own type (CHDLs) of plasmid-borne carbapenemases (Bertini et al., <xref ref-type="bibr" rid="B19">2010</xref>).</p>
</sec>
<sec>
<title>Integrons</title>
<p>Integrons constitute another important vehicle for the spread and accumulation of resistance genes in <italic>A. baumannii</italic>, and several studies have demonstrated a positive correlation in <italic>A. baumannii</italic> between the carriage of integrons and the degree of MDR (Huang et al., <xref ref-type="bibr" rid="B125">2008</xref>; Lee et al., <xref ref-type="bibr" rid="B162">2009b</xref>). Integrons are genetic elements that mediate the integration of gene cassettes by a site-specific recombinational mechanism and direct their coordinated expression. All integrons bear three key elements: a specific recombination site (<italic>attI</italic>), a gene encoding an integrase (<italic>intI</italic>) and a common promoter region (P1&#x02013;P2) oriented toward the site of integration. The integrase recombinates discrete units of circular DNA known as gene cassettes (often carrying resistance genes) into the <italic>attI</italic> site allowing the coordinated expression of the genes in the cassette from the common promoter (Mazel, <xref ref-type="bibr" rid="B196">2006</xref>).</p>
<p>Although integrons are not mobile by themselves (but gene cassettes can readily be exchanged to other integrons), they can be spread to different chromosomal locations, plasmids or even other microorganisms by means of IS-mediated transposition or homologous recombination (Mazel, <xref ref-type="bibr" rid="B196">2006</xref>). There are several classes of integrons mainly classified according to the sequence of the encoded integrases, which show 40&#x02013;58% identity. Class 1 integrons displaying a wide variety of gene cassettes are commonly found in <italic>A. baumannii</italic>, and typically encode aminoglycoside-resistance genes as well as genes conferring resistance to antiseptics and sulfonamides (Nemec et al., <xref ref-type="bibr" rid="B218">2004</xref>; Zhao and Hu, <xref ref-type="bibr" rid="B353">2011</xref>). Other resistance determinants associated with class 1 integrons in <italic>A. baumannii</italic> include <italic>bla</italic><sub>IMP</sub>, <italic>bla</italic><sub>VIM</sub>, and <italic>bla</italic><sub>SIM</sub> MBL types (Lee et al., <xref ref-type="bibr" rid="B165">2003</xref>, <xref ref-type="bibr" rid="B166">2005</xref>, <xref ref-type="bibr" rid="B167">2008</xref>; Yamamoto et al., <xref ref-type="bibr" rid="B344">2011</xref>) as well as some Ambler class A &#x003B2;-lactamases such as CARB, GES, PER, VEB, and narrow-spectrum OXA-types (Vila et al., <xref ref-type="bibr" rid="B327">1997a</xref>; Navia et al., <xref ref-type="bibr" rid="B217">2002</xref>; Poirel et al., <xref ref-type="bibr" rid="B252">2003</xref>; Zarrilli et al., <xref ref-type="bibr" rid="B352">2004</xref>; Naas et al., <xref ref-type="bibr" rid="B211">2006a</xref>; Moubareck et al., <xref ref-type="bibr" rid="B209">2009</xref>; Potron et al., <xref ref-type="bibr" rid="B259">2009</xref>; Bonnin et al., <xref ref-type="bibr" rid="B23">2011a</xref>).</p>
<p>Class 2 integrons, which are embedded within the Tn7 transposon, display a narrower diversity of gene cassettes and those described in <italic>A. baumannii</italic> have been shown to contain several resistance determinants such as <italic>aadB</italic>, <italic>catB2</italic>, <italic>dfrA1</italic>, <italic>sat2</italic>, and <italic>aadA1</italic>, conferring resistance to aminoglycosides, chloramphenicol, trimethoprim, streptothricin, and streptomycin, respectively (Ram&#x000ED;rez et al., <xref ref-type="bibr" rid="B267">2010a</xref>). More recently, Ram&#x000ED;rez et al. reported an <italic>A. baumannii</italic> isolate carrying <italic>bla</italic><sub>CARB-4</sub> in a class 2 integron together with 6 additional resistance determinants comprising four families of antibiotics. This novel integron constitutes the longest class 2 integron described so far and also represents the only example of a &#x003B2;-lactamase gene encoded within such a class (Ram&#x000ED;rez et al., <xref ref-type="bibr" rid="B268">2010b</xref>).</p>
</sec>
<sec>
<title>Resistance islands</title>
<p>In addition to the huge diversity of resistance mechanisms displayed by <italic>A. baumannii</italic> isolates, this microorganism is also able to accumulate multiple resistance determinants in what has been termed as &#x0201C;resistance islands.&#x0201D; Resistance islands are specific regions of the genome that harbor large clusters of horizontally transferred genetic DNA including a great deal of antimicrobial resistance genes. Such regions provide a &#x0201C;safe haven&#x0201D; for mobile elements since insertion at this site is not likely to cause any damage to the host cell. They are often inserted at the same locus on the <italic>A. baumannii</italic> chromosome and are assembled by discrete genes or gene packages usually associated with mobile elements (IS and Tn), integrons, or both.</p>
<p>The first resistance island described in <italic>A. baumannii</italic> was found in the multidrug-resistant <italic>A. baumannii</italic> AYE strain and was hence termed AbaR1. AbaR1 comprised an 86&#x02009;kb region integrated within the <italic>comM</italic> gene and contained up to 45 antibiotic and heavy metal resistance genes. Interestingly, AbaR1 was flanked at both ends by 5&#x02009;bp perfect direct repeats (DR) and included two ORFs near the 3&#x02032; <italic>comM</italic> end annotated as putative transposition genes, thereby suggesting acquisition by means of a transposition event.</p>
<p>At the time of this review, more than 22 resistance islands have been described (Fournier et al., <xref ref-type="bibr" rid="B94">2006</xref>; Adams et al., <xref ref-type="bibr" rid="B3">2008</xref>, <xref ref-type="bibr" rid="B2">2010</xref>; Iacono et al., <xref ref-type="bibr" rid="B130">2008</xref>; Post and Hall, <xref ref-type="bibr" rid="B256">2009</xref>; Krizova and Nemec, <xref ref-type="bibr" rid="B152">2010</xref>; Post et al., <xref ref-type="bibr" rid="B257">2010</xref>; Rose, <xref ref-type="bibr" rid="B282">2010</xref>; Krizova et al., <xref ref-type="bibr" rid="B151">2011</xref>; Nigro et al., <xref ref-type="bibr" rid="B222">2011b</xref>; Zhou et al., <xref ref-type="bibr" rid="B355">2011</xref>) and, with only three exceptions (Adams et al., <xref ref-type="bibr" rid="B3">2008</xref>; Rose, <xref ref-type="bibr" rid="B282">2010</xref>), all have been found inserted within the <italic>comM</italic> gene (Table <xref ref-type="table" rid="T2">2</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p><bold>Resistance Islands in <italic>A. baumannii</italic></bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">AbaR-type</th>
<th align="left">Size (kb)</th>
<th align="left">Strain</th>
<th align="left">EC</th>
<th align="left"><italic>comM</italic> Insertion</th>
<th align="left">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">AbaR1</td>
<td align="left">86</td>
<td align="left">AYE</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Fournier et al. (<xref ref-type="bibr" rid="B94">2006</xref>)</td>
</tr>
<tr>
<td align="left">AbaR2</td>
<td align="left">17</td>
<td align="left">ACICU</td>
<td align="left">II</td>
<td align="left">&#x0002B;</td>
<td align="left">Iacono et al. (<xref ref-type="bibr" rid="B130">2008</xref>)</td>
</tr>
<tr>
<td align="left">AbaR3</td>
<td align="left">63</td>
<td align="left">AB0057</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Adams et al. (<xref ref-type="bibr" rid="B3">2008</xref>)</td>
</tr>
<tr>
<td align="left">AbaR4</td>
<td align="left">18</td>
<td align="left">AB0057</td>
<td align="left">I</td>
<td align="left">&#x02212;</td>
<td align="left">Adams et al. (<xref ref-type="bibr" rid="B3">2008</xref>)</td>
</tr>
<tr>
<td align="left">AbaR5</td>
<td align="left">56</td>
<td align="left">3208</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Post and Hall (<xref ref-type="bibr" rid="B256">2009</xref>)</td>
</tr>
<tr>
<td align="left">AbaR6</td>
<td align="left">27</td>
<td align="left">D2</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Post et al. (<xref ref-type="bibr" rid="B257">2010</xref>)</td>
</tr>
<tr>
<td align="left">AbaR7</td>
<td align="left">20</td>
<td align="left">A92</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Post et al. (<xref ref-type="bibr" rid="B257">2010</xref>)</td>
</tr>
<tr>
<td align="left">AbaR8</td>
<td align="left">29</td>
<td align="left">D13</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left"/>
</tr>
<tr>
<td align="left">AbaR9</td>
<td align="left">39</td>
<td align="left">AB056</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Adams et al. (<xref ref-type="bibr" rid="B2">2010</xref>)</td>
</tr>
<tr>
<td align="left">AbaR10</td>
<td align="left">30</td>
<td align="left">AB058</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Adams et al. (<xref ref-type="bibr" rid="B2">2010</xref>)</td>
</tr>
<tr>
<td align="left">AbaR11</td>
<td align="left">20</td>
<td align="left">NIPH470</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR12</td>
<td align="left">38</td>
<td align="left">LUH 6013</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR13</td>
<td align="left">45</td>
<td align="left">LUH6015</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR14</td>
<td align="left">21</td>
<td align="left">LUH5881</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR15</td>
<td align="left">55</td>
<td align="left">LUH6125</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR16</td>
<td align="left">39</td>
<td align="left">LUH7140</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR17</td>
<td align="left">58</td>
<td align="left">LUH8592</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR18</td>
<td align="left">52</td>
<td align="left">NIPH2713</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR19</td>
<td align="left">30</td>
<td align="left">NIPH2554</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Krizova et al. (<xref ref-type="bibr" rid="B151">2011</xref>)</td>
</tr>
<tr>
<td align="left">AbaR21</td>
<td align="left">64</td>
<td align="left">RUH875</td>
<td align="left">I</td>
<td align="left">&#x0002B;</td>
<td align="left">Nigro et al. (<xref ref-type="bibr" rid="B222">2011b</xref>)</td>
</tr>
<tr>
<td align="left">AbaR22</td>
<td align="left">39</td>
<td align="left">MDR-ZJ06</td>
<td align="left">II</td>
<td align="left">&#x0002B;</td>
<td align="left">Zhou et al. (<xref ref-type="bibr" rid="B355">2011</xref>)</td>
</tr>
<tr>
<td align="left">n.a.</td>
<td align="left">n.f.</td>
<td align="left">A473</td>
<td align="left">I</td>
<td align="left">&#x02212;</td>
<td align="left">Rose (<xref ref-type="bibr" rid="B282">2010</xref>)</td>
</tr>
<tr>
<td align="left">n.a.</td>
<td align="left">n.f.</td>
<td align="left">A473</td>
<td align="left">I</td>
<td align="left">&#x02212;</td>
<td align="left">Rose (<xref ref-type="bibr" rid="B282">2010</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>EC, European clone lineage; n.a., not assigned; n.f., not found</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Shaikh et al. (<xref ref-type="bibr" rid="B296">2009</xref>) studied a collection of 50 multidrug-resistant <italic>A. baumannii</italic> isolates and found that 82% contained a truncated <italic>comM</italic> gene. Deeper sequence analysis of 10 such isolates identified AbaR-like sequences in 8, thus confirming that the <italic>comM</italic> is likely a preferred integration site for this sort of genetic structures (Shaikh et al., <xref ref-type="bibr" rid="B296">2009</xref>).</p>
<p>In addition, all AbaR sequences identified in <italic>A. baumannii</italic> isolates belonging to the European Clone I (EC I) lineage seem to have a common genetic structure. They share a 16.3-kb backbone transposon, designated Tn<italic>6019</italic>, containing two ORFs annotated as putative transposition genes, an arsenate resistance operon (<italic>arsHBRC</italic>), a putative sulfate permease gene (<italic>sup</italic>), and a universal stress protein gene (<italic>uspA</italic>) that, in turn, is disrupted by a second compound transposon formed by two copies of a cadmium and zinc resistance transposon (Tn<italic>6018</italic>) bracketing a multiple antibiotic resistance region (MARR). The MARR region contains most of the variability found among all AbaRs, with only a few exceptions displaying additional differences within the left-hand copy of Tn<italic>6018</italic> and the Tn<italic>6019</italic> backbone region (Post et al., <xref ref-type="bibr" rid="B257">2010</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Schematic overview of the conserved AbaR structure found in <italic>A. baumannii</italic> isolates belonging to the European clone I lineage and that of AbaR22, isolated from strain MDR-ZJ06 belonging to the European clone II lineage (Zhou et al., <xref ref-type="bibr" rid="B355">2011</xref>)</bold>.</p></caption>
<graphic xlink:href="fmicb-03-00148-g002.tif"/>
</fig>
<p>Although AbaR1 is so far the largest resistance island described in <italic>A. baumannii</italic> (Fournier et al., <xref ref-type="bibr" rid="B94">2006</xref>), there is general agreement that AbaR5 to AbaR21 are all derivatives of AbaR3 that have originated as a result of either deletions mediated by one of the three IS<italic>26</italic> elements present within AbaR3, deletions caused by a single homologous recombination event or arisen due to integron shuffling (Krizova et al., <xref ref-type="bibr" rid="B151">2011</xref>; Nigro et al., <xref ref-type="bibr" rid="B222">2011b</xref>). AbaR1 displays the same general structure as AbaR3 but contains an additional 29&#x02009;kb region consisting of a very complex class 1 integron that might have been incorporated into AbaR3.</p>
<p>Interestingly, some AbaR-related structures found in <italic>A. baumannii</italic> isolates belonging to the EC II lineage present some noticeable differences compared to AbaRs from EC I. Several EC II isolates have been shown to contain a Tn<italic>6019</italic>-related transposon (termed Tn<italic>6021</italic>) as well as some genes present in AbaR1 but they also possess an intact <italic>uspA</italic> gene and, therefore, lack the Tn<italic>6018</italic> compound transposon and the MARR region (Post et al., <xref ref-type="bibr" rid="B257">2010</xref>; Zhou et al., <xref ref-type="bibr" rid="B355">2011</xref>; Bonnin et al., <xref ref-type="bibr" rid="B25">2012</xref>). These differences reinforce the delineation of <italic>A. baumannii</italic> isolates in different European clones since AbaRs structures seem to have appeared independently in each of these isolates (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
<p>Krizova et al. have recently suggested that the origin of AbaRs in strains of the EC I might lie in the antibiotic regimes administered in Europe during the 1970s and 1980s, since AbaRs seem to provide resistance to antimicrobials mostly used during that period, thereby facilitating the survival and spread of AbaRs-bearing strains. The subsequent modification of the treatment of choice might have then diminished the selective pressure on such determinants and accounted for the truncated AbaR3-derivatives in the current population of <italic>A. baumannii</italic> clinical isolates (Krizova et al., <xref ref-type="bibr" rid="B151">2011</xref>).</p>
<p>The combination of IS, Tn, integrons, conjugative plasmids, and resistance islands accounts for the extreme genomic plasticity of <italic>A. baumannii</italic> and partly explains the successful emergence of this microorganism as a dreadful nosocomial human pathogen. Recent studies comparing the whole genome sequence of closely related <italic>A. baumannii</italic> isolates have demonstrated a unique genetic repertoire in terms of IS, plasmids, and AbaRs even in <italic>A. baumannii</italic> isolates belonging to the same sequence type (ST; Adams et al., <xref ref-type="bibr" rid="B2">2010</xref>; Di Nocera et al., <xref ref-type="bibr" rid="B65">2011</xref>; Snitkin et al., <xref ref-type="bibr" rid="B304">2011</xref>).</p>
</sec>
</sec>
<sec>
<title>Clinical Importance and Treatment Options</title>
<p><italic>Acinetobacter baumannii</italic> is currently considered one of the most important nosocomial pathogens. In a prevalence study of infections in intensive care units conducted among 75 countries of the 5 continents, this microorganism was found to be the fifth most common pathogen, although with a high variability among the different countries (Vincent et al., <xref ref-type="bibr" rid="B332">2009</xref>). Different surveillance studies have found this pathogen to be the fifth cause of pneumonia, after <italic>P. aeruginosa</italic>, in hospitalized patients, mainly in intensive care units (Jones, <xref ref-type="bibr" rid="B138">2010</xref>). In addition, these microorganisms are also frequently reported to cause other nosocomial infections such as bacteremia and urinary tract and surgical infections. In fact, <italic>A. baumannii</italic> was found to be third most frequent cause of nosocomial bloodstream infection in a large multicenter study with an estimation of 34% of all patients and 43% in patients in intensive care units (Wisplinghoff et al., <xref ref-type="bibr" rid="B339">2004</xref>).</p>
<p>With respect to the treatment of <italic>A. baumannii</italic> infections it is important to take into account the resistant profile involved to thereby consider the different treatment options available. As mentioned above, <italic>A. baumannii</italic> is currently resistant to multiple antibacterial agents, including carbapenems and, occasionally, colistin. Therefore, in many cases, optimal treatment for nosocomial infections caused by this microorganism is sometimes not available. A decade ago sulbactam, which has intrinsic activity against <italic>A. baumannii</italic> and shows <italic>in vivo</italic> efficacy in a murine model of pneumoniae, was used to treat infections caused by carbapenem-resistant clinical isolates (Rodr&#x000ED;guez-Hern&#x000E1;ndez et al., <xref ref-type="bibr" rid="B279">2001</xref>; Levin et al., <xref ref-type="bibr" rid="B168">2003</xref>). However, nowadays the percentage of resistance to sulbactam has reached such a high level that its use as antimicrobial agent against infections caused by <italic>A. baumannii</italic> has been invalidated</p>
<p>Rifampicin has demonstrated consistent results related to <italic>in vivo</italic> efficacy in experimental models of infection and in some open studies of human infections, especially when combined with colistin. These studies suggest that the possible use of rifampicin for the treatment of multidrug-resistant <italic>A. baumannii</italic> infections should be analyzed in well-designed clinical trials (Pach&#x000F3;n-Ib&#x000E1;&#x000F1;ez et al., <xref ref-type="bibr" rid="B230">2006</xref>; Pach&#x000F3;n-Ib&#x000E1;nez et al., <xref ref-type="bibr" rid="B229">2010</xref>). Bassetti et al. (<xref ref-type="bibr" rid="B15">2008</xref>) studied the use of colistin in combination with rifampin in critically ill patients with pneumonia (19 patients) and bacteremia (10 patients) caused by <italic>A. baumannii</italic> resistant to all antibiotics except colistin in medical and surgical intensive care units. Clinical and microbiological response was observed in 22 of 29 cases (76%), suggesting that the combination of colistin and rifampicin appears to be an effective and safe therapy for severe infections due to multidrug-resistant <italic>A. baumannii</italic>.</p>
<p>There is some heterogenicity concerning the clinical data to determine the utility of tigecycline in the treatment of nosocomial infections caused by <italic>A. baumannii</italic>. The possible development of resistance during treatment with tigecycline suggests that it should only be used in combined regimens with other antimicrobials. Two studies have reported the combination of tigecycline with other antimicrobial agents. Principe et al. (<xref ref-type="bibr" rid="B261">2009</xref>) found that tigecycline showed synergism with levofloxacin, amikacin, imipenem, and colistin, whereas antagonism was observed for the tigecycline/piperacillin&#x02013;tazobactam combination. Considering all antimicrobials in combination with tigecycline, checkerboard analysis showed 5.9% synergy, 85.7% indifference, and 8.3% antagonism. Tigecycline showed synergism with levofloxacin (four strains; 16.6%), amikacin (two strains; 8.3%), imipenem (two strains; 8.3%), and colistin (two strains; 8.3%). Synergism was detected only among tigecycline non-susceptible strains. Time-kill assays confirmed the synergistic interaction between tigecycline and levofloxacin, amikacin, imipenem, and colistin in five out of seven selected isolates. Ozbek and Senturk (<xref ref-type="bibr" rid="B228">2010</xref>) isolated six meropenem-resistant <italic>A. baumannii</italic> strains in which synergy of tigecycline/colistin and tigecycline/levofloxacin was observed using checkerboard analysis in just one strain each.</p>
<p>Other combinations have recently been described in the scientific literature. Liang et al. isolated 14 extensive drug-resistant <italic>A. baumannii</italic> strains from patients admitted to the intensive care units of a Chinese hospital. Most of the strains were resistant to all antimicrobials except colistin and minocycline, and the combinatory results by killing curves showed a synergistic effect between colistin/meropenem, colistin/rifampicin meropenem/minocycline and colistin/minocycline. It is worth mentioning that the combination of meropenem/minocycline could be a possible alternative when colistin is not available as in China (Liang et al., <xref ref-type="bibr" rid="B171">2011</xref>). In a recent study the combination of teicoplanin/colistin was investigated against multidrug-resistant <italic>A. baumannii</italic> isolates (resistant to third-generation cephalosporins, quinolones, and aminoglycosides), with checkerboard analysis showing synergy between the two antibiotics. Bactericidal activity was shown in the first 4&#x02009;h for both colistin alone and in combination with teicoplanin, however regrowth was observed when colistin was used alone (Wareham et al., <xref ref-type="bibr" rid="B335">2011</xref>). Although the mechanism of action of colistin is not completely known, it is thought to act in the bacterial membrane by disrupting it (Lam et al., <xref ref-type="bibr" rid="B156">1986</xref>). Therefore, the use of colistin in combination with antibiotics such as teicoplanin or vancomycin which are effective against Gram-positive microorganisms (Gordon et al., <xref ref-type="bibr" rid="B111">2010</xref>), likely helps glycopeptides to reach the target.</p>
<p>Of particular concern are infections caused by pan-drug-resistant <italic>A. baumannii</italic> isolates, which are steadily increasing in various regions worldwide. There is an urgent need for new therapeutic strategies since isolates resistant to all antibacterial agents, including colistin, have been reported (Park et al., <xref ref-type="bibr" rid="B233">2009</xref>) and this scenario will likely progress in association with the increased use of this antibiotic.</p>
</sec>
<sec>
<title>Future Potential Therapeutic Alternatives</title>
<p>The emergence of bacteria resistant to most of the antibiotics available has lead to the appearance of different terms concerning resistance. Only a short time ago, experts in the topic homogenized all these terms, in the case of <italic>A. baumannii</italic>, MDR may be referred when the strain is non-susceptible to &#x02265;1 antimicrobial agent in &#x02265;3 antimicrobial categories; an increase in resistance now refers to extensive drug resistance (XDR) when non-susceptible to &#x02265;1 antimicrobial agents in all but &#x02264;2 categories (i.e., bacterial isolates remain susceptible to only one or two categories), and pan-drug resistance (PDR) is considered when the microorganism is non-susceptible to all the antimicrobial agents in all antimicrobial categories (Magiorakos et al., <xref ref-type="bibr" rid="B183">2012</xref>).</p>
<p>In regard to future potential therapeutic alternatives, the perspectives are not good, at least within the next decade (Payne et al., <xref ref-type="bibr" rid="B236">2007</xref>). Nonetheless there are two main options for the design of new drugs to treat infections caused by PDR-resistant <italic>A. baumannii</italic>. The first is related to knowledge of the biochemical bases of resistance and has been used to design rational strategy to counteract resistance. This strategy can follow two approaches: (i) Modification of the basic structure of the antibacterial agent, circumventing antibacterial resistant mechanisms, and (ii) Development of compounds inhibiting the mechanisms of resistance for an antibacterial agent, whereby the concomitant administration of the antibacterial agent plus the inhibitor, as a co-drug, potentiates this activity (Li and Heide, <xref ref-type="bibr" rid="B169">2005</xref>). Some studies have used this strategy to develop drugs active against MDR <italic>A. baumannii</italic>. A derivative of ciprofloxacin (UB-8902) showed good activity against <italic>A. baumannii</italic> strains carrying a mutation in the <italic>gyrA</italic> gene, with a MIC<sub>50</sub> of 4&#x02009;mg/L (range &#x0003C;0.06&#x02013;8&#x02009;mg/L) in comparison with ciprofloxacin displaying a MIC<sub>50</sub> of 64&#x02009;mg/L (Vila et al., <xref ref-type="bibr" rid="B330">2006</xref>). Further <italic>in vivo</italic> studies using this new quinolone have also been performed in a murine pneumonia model, showing that UB-8902 presented bactericidal activity against <italic>A. baumannii</italic> strains resistant to ciprofloxacin. Moreover, this quinolone was effective at reducing mortality with a dose lower than the toxic dose in a model of peritoneal sepsis (L&#x000F3;pez-Rojas et al., <xref ref-type="bibr" rid="B179">2011a</xref>). BAL30072 is a new monocyclic &#x003B2;-lactam belonging to the sulbactam class of antibiotics active against MDR <italic>A. baumannii</italic>. BAL30072 possesses a dihydropyrimidinone siderophore in its side chain and has shown better activity than meropenem in five MDR <italic>A. baumannii</italic> strains, with increased activity when a combination of the two was used (Russo et al., <xref ref-type="bibr" rid="B288">2011</xref>).</p>
<p>The second option is to design a new compound involving antimicrobial peptides (AMPs) as the principal candidates. The use of AMPs as antibiotics has several advantages and disadvantages, the main disadvantage being the instability of the compound against proteases present in the blood and serum. Several methods may be used to overcome this issue although these may sometimes not be easy to apply due to a possible loss of the effectiveness of peptides upon changes in their structure. <sc>d</sc>-Amino acids, stable to proteases (Chen et al., <xref ref-type="bibr" rid="B39">2006</xref>; Friedman, <xref ref-type="bibr" rid="B95">2010</xref>) may be used as well as both methylation and fluorination of specific amino acids (Meng and Kumar, <xref ref-type="bibr" rid="B201">2007</xref>; Fern&#x000E1;ndez-Reyes et al., <xref ref-type="bibr" rid="B90">2010</xref>). Another option, albeit sometimes less effective in terms of activity due to the loss of one positive charge which is important for the interaction with membranes, is cyclation (Molhoek et al., <xref ref-type="bibr" rid="B206">2011</xref>). On the other hand, the advantages of AMPs are that they are a less specific target and, compared to antibiotics, acquisition of resistance is difficult (Marr et al., <xref ref-type="bibr" rid="B191">2006</xref>).</p>
<p>Braunstein et al. (<xref ref-type="bibr" rid="B29">2004</xref>) used a gentamicin-resistant <italic>A. baumannii</italic> strain to test an AMP containing 33% of <sc>d</sc>-amino acids that showed better activity (5.6&#x02013;11.2&#x02009;mg/L) and greater stability to hemolysis (0&#x02013;100% at 180&#x02009;mg/L) than the <sc>l</sc>-amino acid form. The same effect was seen by Jiang et al. in which a totally synthetic <sc>d</sc>-amino acid AMP was tested against 550 clinical isolates involving 74% of MDR strains. Although no resistance profile was reported in the article, the AMP showed good values for both MIC<sub>50</sub> and MIC<sub>90</sub> (Jiang et al., <xref ref-type="bibr" rid="B136">2011</xref>).</p>
<p>In another study using strains resistant to ciprofloxacin, the MIC<sub>50</sub> and MIC<sub>90</sub> values of pexiganan, an analog of magainin, were 2 and 8&#x02009;mg/L, respectively (Ge et al., <xref ref-type="bibr" rid="B100">1999</xref>). In another analog, but in this case a short version of the peptide of human lactoferrin, 11 residues from the N-terminal were studied. The <italic>A. baumannii</italic> strains used were resistant or intermediate to 16 and 19 out of 20 antimicrobial agents, including imipenem and meropenem. This peptide was tested <italic>in vivo</italic> and a reduction of 3&#x02013;4 log CFU/ml was observed in an experimental infection in mice. However at peptide concentration ranging from 49.5 to 98.9&#x02009;mg/L, this effect was not seen in the control. In addition the effect of this peptide was very rapid, achieving the minimal number of CFU in 5&#x02013;15&#x02009;min (Dijkshoorn et al., <xref ref-type="bibr" rid="B67">2004</xref>). Other peptides present in the human body such as &#x003B2;-defensin 3 have been tested against <italic>A. baumannii</italic>. This AMPs belongs to the cysteine-rich peptides, and a bactericidal effect was achieved <italic>in vitro</italic> after 1.5&#x02009;h using 4&#x02009;mg/L of the peptide against MDR <italic>A. baumannii</italic> (Maisetta et al., <xref ref-type="bibr" rid="B185">2006</xref>).</p>
<p>The origin of the peptides tested so far is different, some being totally synthetic, some isolated from humans or others from animals. In the case of animals, amphibians are a large source of peptides as in the case of the study published by Mangoni et al. (<xref ref-type="bibr" rid="B188">2008</xref>) in which most of the peptides were isolated from frogs and showed good MIC values against MDR <italic>A. baumannii</italic>. The same strategy was used in the report published by Conlon et al. (<xref ref-type="bibr" rid="B48">2009</xref>) however the MIC values were higher compared to the other peptides. Other peptides isolated from toad skin secretions were also tested against XDR strains obtaining values from 112.8 to 2.8&#x02009;mg/L (Conlon et al., <xref ref-type="bibr" rid="B49">2010</xref>). The A3-APO peptide is shown to be more effective and less toxic against <italic>A. baumannii</italic> than colistin, however this has only been observed <italic>in vivo</italic> and the effect could not be shown <italic>in vitro</italic>, suggesting that this peptide may prevent inflammation at the site of the infection (Ostorhazi et al., <xref ref-type="bibr" rid="B227">2010</xref>, <xref ref-type="bibr" rid="B226">2011</xref>).</p>
<p>Different AMPs have been tested against <italic>A. baumannii</italic>, however the peptide constituted by the mixture of cecropin A and melittin (Andreu et al., <xref ref-type="bibr" rid="B10">1992</xref>) has been extensively studied. The first hybrid tested against MDR <italic>A. baumannii</italic> was cecropin A(1-8)melittin(1-18), or CA(1-8)M(1-18). This hybrid was tested under different experimental conditions, with all showing a lower MIC compared to polymixin B (Saugar et al., <xref ref-type="bibr" rid="B292">2002</xref>). The next hybrid tested was CA(1-7)M(2-9) and, compared to the original peptides cecropin A and melittin as well as to other antibiotics, the MIC of this hybrid peptide was 0.25&#x02013;8&#x02009;mg/L, being the lowest value compared to other hybrid peptides. In addition, this hybrid peptide also showed synergy with co-amoxiclav, ceftazidime, piperacillin, and imipenem (Giacometti et al., <xref ref-type="bibr" rid="B103">2003</xref>). Synergy of other AMPs and currently used antibiotics has also been studied by Giacometti et al. (<xref ref-type="bibr" rid="B102">2000</xref>), observing synergy of magainin II with co-amoxiclav, aztreonam, chloramphenicol, ceftazidime, piperacillin, and meropenem. CA(1-7)M(2-9) was also tested against PDR <italic>A. baumannii</italic> strains, Similar to other hybrids, CA(1-8)M(1-18), Oct-CA(1-7)M(2-9), and CA(1-7)M(5-9), the MIC values ranged from 2 to 8&#x02009;mg/L compared to 4 to 64&#x02009;mg/L for colistin. In addition, the hybrids showed bactericidal activity at 4&#x02009;&#x000D7;&#x02009;MIC (Rodr&#x000ED;guez-Hern&#x000E1;ndez et al., <xref ref-type="bibr" rid="B280">2006</xref>). Several commercial peptides have also been tested against colistin-resistant <italic>A. baumannii</italic> strains. Most did not show any activity, although indolicidin and particularly mastoparan showed MIC values of 2 and 1&#x02009;mg/L, respectively, compared to the colistin MIC of 256&#x02009;mg/L. Moreover, a bactericidal effect was found for mastoparan along all the killing curve for 8&#x02009;&#x000D7;&#x02009;MIC (Vila-Farr&#x000E9;s et al., <xref ref-type="bibr" rid="B331">2012</xref>).</p>
<p>Although AMPs and AMPs in combination with antibiotics are potential future therapeutic alternatives against PDR <italic>A. baumannii</italic> clinical isolates, another therapeutic alternative might involve the use of vaccines, specifically those administered through OMVs (McConnell et al., <xref ref-type="bibr" rid="B198">2011a</xref>,<xref ref-type="bibr" rid="B199">b</xref>).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Over the past few decades <italic>A. baumannii</italic> has emerged as one of the most successful nosocomial pathogens throughout the world. This is partly due to its intrinsic aptitude to persist in the hospital setting and acquire multiple resistance mechanisms, but also to its capacity to cause acute infections especially in severely ill patients. While we know a great deal about the mechanisms responsible for antimicrobial resistance in this microorganism we see ourselves unable to stop it. Pan-drug strains resistant even to colistin have already been reported and we are running out of options to deal with this novel menace. On the other hand, there is little knowledge regarding the mechanisms driving the pathogenesis of <italic>A. baumannii</italic> and there is much to learn on this issue. Novel therapeutic strategies are urgently needed and while research on novel antimicrobial agents does not seem very promising, the quest for novel drugs interfering with <italic>A. baumannii</italic> pathogenicity and not just bacterial growth opens up as a novel and challenging alternative.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>This work was supported by the Spanish Ministry of Health (FIS 08/00195), by grant 2009SGR1256 from the Generalitat de Catalunya and by Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III &#x02013; FEDER, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008). This work has also been supported by funding from the European Community (TROCAR contract HEALTH-F3-2008-223031 and AntiPathoGN contract HEALTH-F3-2008-223101).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acosta</surname> <given-names>J.</given-names></name> <name><surname>Merino</surname> <given-names>M.</given-names></name> <name><surname>Viedma</surname> <given-names>E.</given-names></name> <name><surname>Poza</surname> <given-names>M.</given-names></name> <name><surname>Sanz</surname> <given-names>F.</given-names></name> <name><surname>Otero</surname> <given-names>J. R.</given-names></name> <name><surname>Chaves</surname> <given-names>F.</given-names></name> <name><surname>Bou</surname> <given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Multidrug-resistant <italic>Acinetobacter baumannii</italic> Harboring OXA-24 carbapenemase, Spain</article-title>. <source>Emerging Infect. Dis.</source> <volume>17</volume>, <fpage>1064</fpage>&#x02013;<lpage>1067</lpage>.<pub-id pub-id-type="doi">10.3201/eid1706.091866</pub-id><pub-id pub-id-type="pmid">21749771</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>M. D.</given-names></name> <name><surname>Chan</surname> <given-names>E. R.</given-names></name> <name><surname>Molyneaux</surname> <given-names>N. D.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>3569</fpage>&#x02013;<lpage>3577</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00057-10</pub-id><pub-id pub-id-type="pmid">20530228</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>M. D.</given-names></name> <name><surname>Goglin</surname> <given-names>K.</given-names></name> <name><surname>Molyneaux</surname> <given-names>N.</given-names></name> <name><surname>Hujer</surname> <given-names>K. M.</given-names></name> <name><surname>Lavender</surname> <given-names>H.</given-names></name> <name><surname>Jamison</surname> <given-names>J. J.</given-names></name> <name><surname>MacDonald</surname> <given-names>I. J.</given-names></name> <name><surname>Martin</surname> <given-names>K. M.</given-names></name> <name><surname>Russo</surname> <given-names>T.</given-names></name> <name><surname>Campagnari</surname> <given-names>A. A.</given-names></name> <name><surname>Hujer</surname> <given-names>A. M.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name> <name><surname>Gill</surname> <given-names>S. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Comparative genome sequence analysis of multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Bacteriol.</source> <volume>190</volume>, <fpage>8053</fpage>&#x02013;<lpage>8064</lpage>.<pub-id pub-id-type="doi">10.1128/JB.01011-08</pub-id><pub-id pub-id-type="pmid">18931120</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>M. D.</given-names></name> <name><surname>Nickel</surname> <given-names>G. C.</given-names></name> <name><surname>Bajaksouzian</surname> <given-names>S.</given-names></name> <name><surname>Lavender</surname> <given-names>H.</given-names></name> <name><surname>Murthy</surname> <given-names>A. R.</given-names></name> <name><surname>Jacobs</surname> <given-names>M. R.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Resistance to colistin in <italic>Acinetobacter baumannii</italic> associated with mutations in the PmrAB two-component system</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>3628</fpage>&#x02013;<lpage>3634</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00284-09</pub-id><pub-id pub-id-type="pmid">19528270</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams-Haduch</surname> <given-names>J. M.</given-names></name> <name><surname>Onuoha</surname> <given-names>E. O.</given-names></name> <name><surname>Bogdanovich</surname> <given-names>T.</given-names></name> <name><surname>Tian</surname> <given-names>G. B.</given-names></name> <name><surname>Marschall</surname> <given-names>J.</given-names></name> <name><surname>Urban</surname> <given-names>C. M.</given-names></name> <name><surname>Spellberg</surname> <given-names>B. J.</given-names></name> <name><surname>Rhee</surname> <given-names>D.</given-names></name> <name><surname>Halstead</surname> <given-names>D. C.</given-names></name> <name><surname>Pasculle</surname> <given-names>A. W.</given-names></name> <name><surname>Doi</surname> <given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular epidemiology of carbapenem-non-susceptible <italic>Acinetobacter baumannii</italic> in the United States</article-title>. <source>J. Clin. Microbiol.</source> <volume>49</volume>, <fpage>3849</fpage>&#x02013;<lpage>3854</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.00619-11</pub-id><pub-id pub-id-type="pmid">21918019</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams-Haduch</surname> <given-names>J. M.</given-names></name> <name><surname>Paterson</surname> <given-names>D. L.</given-names></name> <name><surname>Sidjabat</surname> <given-names>H. E.</given-names></name> <name><surname>Pasculle</surname> <given-names>A. W.</given-names></name> <name><surname>Potoski</surname> <given-names>B. A.</given-names></name> <name><surname>Muto</surname> <given-names>C. A.</given-names></name> <name><surname>Harrison</surname> <given-names>L. H.</given-names></name> <name><surname>Doi</surname> <given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Genetic basis of multidrug resistance in <italic>Acinetobacter baumannii</italic> clinical isolates at a tertiary medical center in Pennsylvania</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>3837</fpage>&#x02013;<lpage>3843</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00570-08</pub-id><pub-id pub-id-type="pmid">18725452</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Afzal-Shah</surname> <given-names>M.</given-names></name> <name><surname>Woodford</surname> <given-names>N.</given-names></name> <name><surname>Livermore</surname> <given-names>D. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Characterization of OXA-25, OXA-26, and OXA-27, molecular class D &#x003B2;-lactamases associated with carbapenem resistance in clinical isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>45</volume>, <fpage>583</fpage>&#x02013;<lpage>588</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.45.2.583-588.2001</pub-id><pub-id pub-id-type="pmid">11158758</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Sweih</surname> <given-names>N. A.</given-names></name> <name><surname>Al-Hubail</surname> <given-names>M. A.</given-names></name> <name><surname>Rotimi</surname> <given-names>V. O.</given-names></name></person-group> (<year>2011</year>). <article-title>Emergence of tigecycline and colistin resistance in <italic>Acinetobacter</italic> species isolated from patients in Kuwait hospitals</article-title>. <source>J. Chemother.</source> <volume>23</volume>, <fpage>13</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">21482488</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ambler</surname> <given-names>R. P.</given-names></name></person-group> (<year>1980</year>). <article-title>The structure of &#x003B2;-lactamases</article-title>. <source>Philos. Trans. R. Soc. Lond. B. Biol. Sci.</source> <volume>289</volume>, <fpage>321</fpage>&#x02013;<lpage>331</lpage>.<pub-id pub-id-type="doi">10.1098/rstb.1980.0049</pub-id><pub-id pub-id-type="pmid">6109327</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreu</surname> <given-names>D.</given-names></name> <name><surname>Ubach</surname> <given-names>J.</given-names></name> <name><surname>Boman</surname> <given-names>A.</given-names></name> <name><surname>Wahlin</surname> <given-names>B.</given-names></name> <name><surname>Wade</surname> <given-names>D.</given-names></name> <name><surname>Merrifield</surname> <given-names>R. B.</given-names></name> <name><surname>Boman</surname> <given-names>H. G.</given-names></name></person-group> (<year>1992</year>). <article-title>Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity</article-title>. <source>FEBS Lett.</source> <volume>296</volume>, <fpage>190</fpage>&#x02013;<lpage>194</lpage>.<pub-id pub-id-type="doi">10.1016/0014-5793(92)80377-S</pub-id><pub-id pub-id-type="pmid">1733777</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andriamanantena</surname> <given-names>T. S.</given-names></name> <name><surname>Ratsima</surname> <given-names>E.</given-names></name> <name><surname>Rakotonirina</surname> <given-names>H. C.</given-names></name> <name><surname>Randrianirina</surname> <given-names>F.</given-names></name> <name><surname>Ramparany</surname> <given-names>L.</given-names></name> <name><surname>Carod</surname> <given-names>J. F.</given-names></name> <name><surname>Richard</surname> <given-names>V.</given-names></name> <name><surname>Talarmin</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Dissemination of multidrug resistant <italic>Acinetobacter baumannii</italic> in various hospitals of Antananarivo Madagascar</article-title>. <source>Ann. Clin. Microbiol. Antimicrob.</source> <volume>9</volume>, <fpage>17</fpage>.<pub-id pub-id-type="doi">10.1186/1476-0711-9-17</pub-id><pub-id pub-id-type="pmid">20591154</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antunes</surname> <given-names>L. C.</given-names></name> <name><surname>Imperi</surname> <given-names>F.</given-names></name> <name><surname>Carattoli</surname> <given-names>A.</given-names></name> <name><surname>Visca</surname> <given-names>P.</given-names></name></person-group> (<year>2011a</year>). <article-title>Deciphering the multifactorial nature of <italic>Acinetobacter baumannii</italic> pathogenicity</article-title>. <source>PLoS ONE</source> <volume>6</volume>, <fpage>e22674</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0022674.g003</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antunes</surname> <given-names>L. C.</given-names></name> <name><surname>Imperi</surname> <given-names>F.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name> <name><surname>Visca</surname> <given-names>P.</given-names></name></person-group> (<year>2011b</year>). <article-title>Genome-assisted identification of putative iron-utilization genes in <italic>Acinetobacter baumannii</italic> and their distribution among a genotypically diverse collection of clinical isolates</article-title>. <source>Res. Microbiol.</source> <volume>162</volume>, <fpage>279</fpage>&#x02013;<lpage>284</lpage>.<pub-id pub-id-type="doi">10.1016/j.resmic.2010.10.010</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arroyo</surname> <given-names>L. A.</given-names></name> <name><surname>Herrera</surname> <given-names>C. M.</given-names></name> <name><surname>Fern&#x000E1;ndez</surname> <given-names>L.</given-names></name> <name><surname>Hankins</surname> <given-names>J. V.</given-names></name> <name><surname>Trent</surname> <given-names>M. S.</given-names></name> <name><surname>Hancock</surname> <given-names>R. E.</given-names></name></person-group> (<year>2011</year>). <article-title>The pmrCAB operon mediates polymyxin resistance in <italic>Acinetobacter baumannii</italic> ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>3743</fpage>&#x02013;<lpage>3751</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00256-11</pub-id><pub-id pub-id-type="pmid">21646482</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bassetti</surname> <given-names>M.</given-names></name> <name><surname>Repetto</surname> <given-names>E.</given-names></name> <name><surname>Righi</surname> <given-names>E.</given-names></name> <name><surname>Boni</surname> <given-names>S.</given-names></name> <name><surname>Diverio</surname> <given-names>M.</given-names></name> <name><surname>Molinari</surname> <given-names>M. P.</given-names></name> <name><surname>Mussap</surname> <given-names>M.</given-names></name> <name><surname>Artioli</surname> <given-names>S.</given-names></name> <name><surname>Ansaldi</surname> <given-names>F.</given-names></name> <name><surname>Durando</surname> <given-names>P.</given-names></name> <name><surname>Orengo</surname> <given-names>G.</given-names></name> <name><surname>Bobbio Pallavicini</surname> <given-names>F.</given-names></name> <name><surname>Viscoli</surname> <given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Colistin and rifampicin in the treatment of multidrug-resistant <italic>Acinetobacter baumannii</italic> infections</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>61</volume>, <fpage>417</fpage>&#x02013;<lpage>420</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkm509</pub-id><pub-id pub-id-type="pmid">18174197</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beceiro</surname> <given-names>A.</given-names></name> <name><surname>Llobet</surname> <given-names>E.</given-names></name> <name><surname>Aranda</surname> <given-names>J.</given-names></name> <name><surname>Bengoechea</surname> <given-names>J. A.</given-names></name> <name><surname>Doumith</surname> <given-names>M.</given-names></name> <name><surname>Hornsey</surname> <given-names>M.</given-names></name> <name><surname>Dhanji</surname> <given-names>H.</given-names></name> <name><surname>Chart</surname> <given-names>H.</given-names></name> <name><surname>Bou</surname> <given-names>G.</given-names></name> <name><surname>Livermore</surname> <given-names>D. M.</given-names></name> <name><surname>Woodford</surname> <given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>Phosphoethanolamine modification of lipid A in colistin-resistant variants of <italic>Acinetobacter baumannii</italic> mediated by the pmrAB two-component regulatory system</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>3370</fpage>&#x02013;<lpage>3379</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00079-11</pub-id><pub-id pub-id-type="pmid">21576434</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernards</surname> <given-names>A. T.</given-names></name> <name><surname>van der Toorn</surname> <given-names>J.</given-names></name> <name><surname>van Boven</surname> <given-names>C. P.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name></person-group> (<year>1996</year>). <article-title>Evaluation of the ability of a commercial system to identify <italic>Acinetobacter</italic> genomic species</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source> <volume>15</volume>, <fpage>303</fpage>&#x02013;<lpage>308</lpage>.<pub-id pub-id-type="doi">10.1007/BF01695662</pub-id><pub-id pub-id-type="pmid">8781881</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertini</surname> <given-names>A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Bernabeu</surname> <given-names>S.</given-names></name> <name><surname>Fortini</surname> <given-names>D.</given-names></name> <name><surname>Villa</surname> <given-names>L.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Carattoli</surname> <given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>2324</fpage>&#x02013;<lpage>2328</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01502-06</pub-id><pub-id pub-id-type="pmid">17438042</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertini</surname> <given-names>A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Mugnier</surname> <given-names>P. D.</given-names></name> <name><surname>Villa</surname> <given-names>L.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Carattoli</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Characterization and PCR-based replicon typing of resistance plasmids in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>4168</fpage>&#x02013;<lpage>4177</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00542-10</pub-id><pub-id pub-id-type="pmid">20660691</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhargava</surname> <given-names>N.</given-names></name> <name><surname>Sharma</surname> <given-names>P.</given-names></name> <name><surname>Capalash</surname> <given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Quorum sensing in <italic>Acinetobacter</italic>: an emerging pathogen</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>36</volume>, <fpage>349</fpage>&#x02013;<lpage>360</lpage>.<pub-id pub-id-type="doi">10.3109/1040841X.2010.512269</pub-id><pub-id pub-id-type="pmid">20846031</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bogaerts</surname> <given-names>P.</given-names></name> <name><surname>Naas</surname> <given-names>T.</given-names></name> <name><surname>El Garch</surname> <given-names>F.</given-names></name> <name><surname>Cuzon</surname> <given-names>G.</given-names></name> <name><surname>Deplano</surname> <given-names>A.</given-names></name> <name><surname>Delaire</surname> <given-names>T.</given-names></name> <name><surname>Huang</surname> <given-names>T. D.</given-names></name> <name><surname>Lissoir</surname> <given-names>B.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Glupczynski</surname> <given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>GES extended-spectrum &#x003B2;-lactamases in <italic>Acinetobacter baumannii</italic> isolates in Belgium</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>4872</fpage>&#x02013;<lpage>4878</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00871-10</pub-id><pub-id pub-id-type="pmid">20805394</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnet</surname> <given-names>R.</given-names></name> <name><surname>Marchandin</surname> <given-names>H.</given-names></name> <name><surname>Chanal</surname> <given-names>C.</given-names></name> <name><surname>Sirot</surname> <given-names>D.</given-names></name> <name><surname>Labia</surname> <given-names>R.</given-names></name> <name><surname>De Champs</surname> <given-names>C.</given-names></name> <name><surname>Jumas-Bilak</surname> <given-names>E.</given-names></name> <name><surname>Sirot</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Chromosome-encoded class D &#x003B2;-lactamase OXA-23 in <italic>Proteus mirabilis</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>46</volume>, <fpage>2004</fpage>&#x02013;<lpage>2006</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.46.10.3316-3319.2002</pub-id><pub-id pub-id-type="pmid">12019126</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnin</surname> <given-names>R. A.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Potron</surname> <given-names>A.</given-names></name> <name><surname>Lecuyer</surname> <given-names>H.</given-names></name> <name><surname>Zahar</surname> <given-names>J. R.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name></person-group> (<year>2011a</year>). <article-title>Carbapenem-hydrolyzing GES-type extended-spectrum &#x003B2;-lactamase in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>349</fpage>&#x02013;<lpage>354</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00773-10</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnin</surname> <given-names>R. A.</given-names></name> <name><surname>Potron</surname> <given-names>A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Lecuyer</surname> <given-names>H.</given-names></name> <name><surname>Neri</surname> <given-names>R.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2011b</year>). <article-title>PER-7, an extended-spectrum beta-lactamase with increased activity toward broad-spectrum cephalosporins in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>2424</fpage>&#x02013;<lpage>2427</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00773-10</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnin</surname> <given-names>R. A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>AbaR-type transposon structures in <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>67</volume>, <fpage>234</fpage>&#x02013;<lpage>236</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr413</pub-id><pub-id pub-id-type="pmid">21965430</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bou</surname> <given-names>G.</given-names></name> <name><surname>Cervero</surname> <given-names>G.</given-names></name> <name><surname>Dom&#x000ED;nguez</surname> <given-names>M. A.</given-names></name> <name><surname>Quereda</surname> <given-names>C.</given-names></name> <name><surname>Mart&#x000ED;nez-Beltran</surname> <given-names>J.</given-names></name></person-group> (<year>2000a</year>). <article-title>Characterization of a nosocomial outbreak caused by a multiresistant <italic>Acinetobacter baumannii</italic> strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in <italic>A. baumannii</italic> is not due solely to the presence of &#x003B2;-lactamases</article-title>. <source>J. Clin. Microbiol.</source> <volume>38</volume>, <fpage>3299</fpage>&#x02013;<lpage>3305</lpage>.</citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bou</surname> <given-names>G.</given-names></name> <name><surname>Martinez-Beltran</surname> <given-names>J.</given-names></name></person-group> (<year>2000b</year>). <article-title>Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC &#x003B2;-lactamase in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>44</volume>, <fpage>428</fpage>&#x02013;<lpage>432</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.44.2.428-432.2000</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bou</surname> <given-names>G.</given-names></name> <name><surname>Oliver</surname> <given-names>A.</given-names></name> <name><surname>Mart&#x000ED;nez-Beltran</surname> <given-names>J.</given-names></name></person-group> (<year>2000c</year>). <article-title>OXA-24, a novel class D &#x003B2;-lactamase with carbapenemase activity in an <italic>Acinetobacter baumannii</italic> clinical strain</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>44</volume>, <fpage>1556</fpage>&#x02013;<lpage>1561</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.44.2.428-432.2000</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braunstein</surname> <given-names>A.</given-names></name> <name><surname>Papo</surname> <given-names>N.</given-names></name> <name><surname>Shai</surname> <given-names>Y.</given-names></name></person-group> (<year>2004</year>). <article-title>In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>48</volume>, <fpage>3127</fpage>&#x02013;<lpage>3129</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.48.8.3127-3129.2004</pub-id><pub-id pub-id-type="pmid">15273131</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bresser</surname> <given-names>P.</given-names></name> <name><surname>van Alphen</surname> <given-names>L.</given-names></name> <name><surname>Habets</surname> <given-names>F. J.</given-names></name> <name><surname>Hart</surname> <given-names>A. A.</given-names></name> <name><surname>Dankert</surname> <given-names>J.</given-names></name> <name><surname>Jansen</surname> <given-names>H. M.</given-names></name> <name><surname>Lutter</surname> <given-names>R.</given-names></name></person-group> (<year>1997</year>). <article-title>Persisting <italic>Haemophilus influenzae</italic> strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains</article-title>. <source>Eur. Respir. J.</source> <volume>10</volume>, <fpage>2319</fpage>&#x02013;<lpage>2326</lpage>.<pub-id pub-id-type="doi">10.1183/09031936.97.10102319</pub-id><pub-id pub-id-type="pmid">9387960</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>S.</given-names></name> <name><surname>Young</surname> <given-names>H. K.</given-names></name> <name><surname>Amyes</surname> <given-names>S. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of <italic>Acinetobacter baumannii</italic> from Argentina</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>11</volume>, <fpage>15</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2005.01096.x</pub-id><pub-id pub-id-type="pmid">15649299</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bush</surname> <given-names>K.</given-names></name> <name><surname>Jacoby</surname> <given-names>G. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Updated functional classification of &#x003B2;-lactamases</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>969</fpage>&#x02013;<lpage>976</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01009-09</pub-id><pub-id pub-id-type="pmid">19995920</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camarena</surname> <given-names>L.</given-names></name> <name><surname>Bruno</surname> <given-names>V.</given-names></name> <name><surname>Euskirchen</surname> <given-names>G.</given-names></name> <name><surname>Poggio</surname> <given-names>S.</given-names></name> <name><surname>Snyder</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing</article-title>. <source>PLoS Pathog.</source> <volume>6</volume>, <fpage>e1000834</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000834.t001</pub-id><pub-id pub-id-type="pmid">20368969</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Canton</surname> <given-names>R.</given-names></name> <name><surname>Coque</surname> <given-names>T. M.</given-names></name></person-group> (<year>2006</year>). <article-title>The CTX-M &#x003B2;-lactamase pandemic</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>9</volume>, <fpage>466</fpage>&#x02013;<lpage>475</lpage>.<pub-id pub-id-type="doi">10.1016/j.mib.2006.08.011</pub-id><pub-id pub-id-type="pmid">16942899</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cayo</surname> <given-names>R.</given-names></name> <name><surname>Rodr&#x000ED;guez</surname> <given-names>M. C.</given-names></name> <name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Fern&#x000E1;ndez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Ocampo-Sosa</surname> <given-names>A. A.</given-names></name> <name><surname>Pascual</surname> <given-names>A.</given-names></name> <name><surname>Ayala</surname> <given-names>J. A.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name> <name><surname>Mart&#x000ED;nez-Mart&#x000ED;nez</surname> <given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Analysis of genes encoding for penicillin-binding proteins in clinical isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>5907</fpage>&#x02013;<lpage>5913</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00459-11</pub-id><pub-id pub-id-type="pmid">21947403</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Celenza</surname> <given-names>G.</given-names></name> <name><surname>Pellegrini</surname> <given-names>C.</given-names></name> <name><surname>Caccamo</surname> <given-names>M.</given-names></name> <name><surname>Segatore</surname> <given-names>B.</given-names></name> <name><surname>Amicosante</surname> <given-names>G.</given-names></name> <name><surname>Perilli</surname> <given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Spread of blaCTX-M-type and blaPER-2 &#x003B2;-lactamase genes in clinical isolates from Bolivian hospitals</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>57</volume>, <fpage>975</fpage>&#x02013;<lpage>978</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkl055</pub-id><pub-id pub-id-type="pmid">16510850</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerqueira</surname> <given-names>G. M.</given-names></name> <name><surname>Peleg</surname> <given-names>A. Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Insights into <italic>Acinetobacter baumannii</italic> pathogenicity</article-title>. <source>IUBMB Life</source> <volume>63</volume>, <fpage>1055</fpage>&#x02013;<lpage>1060</lpage>.<pub-id pub-id-type="doi">10.1002/iub.533</pub-id><pub-id pub-id-type="pmid">21989983</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname> <given-names>K. G.</given-names></name> <name><surname>Atkinson</surname> <given-names>S.</given-names></name> <name><surname>Mathee</surname> <given-names>K.</given-names></name> <name><surname>Sam</surname> <given-names>C. K.</given-names></name> <name><surname>Chhabra</surname> <given-names>S. R.</given-names></name> <name><surname>Camara</surname> <given-names>M.</given-names></name> <name><surname>Koh</surname> <given-names>C. L.</given-names></name> <name><surname>Williams</surname> <given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Characterization of N-acylhomoserine lactone-degrading bacteria associated with the <italic>Zingiber officinale</italic> (ginger) rhizosphere: co-existence of quorum quenching and quorum sensing in <italic>Acinetobacter</italic> and <italic>Burkholderia</italic></article-title>. <source>BMC Microbiol.</source> <volume>11</volume>, <fpage>51</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2180-11-51</pub-id><pub-id pub-id-type="pmid">21385437</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Vasil</surname> <given-names>A. I.</given-names></name> <name><surname>Rehaume</surname> <given-names>L.</given-names></name> <name><surname>Mant</surname> <given-names>C. T.</given-names></name> <name><surname>Burns</surname> <given-names>J. L.</given-names></name> <name><surname>Vasil</surname> <given-names>M. L.</given-names></name> <name><surname>Hancock</surname> <given-names>R. E.</given-names></name> <name><surname>Hodges</surname> <given-names>R. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides</article-title>. <source>Chem. Biol. Drug Des.</source> <volume>67</volume>, <fpage>162</fpage>&#x02013;<lpage>173</lpage>.<pub-id pub-id-type="doi">10.1111/j.1747-0285.2006.00349.x</pub-id><pub-id pub-id-type="pmid">16492164</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Zhou</surname> <given-names>Z.</given-names></name> <name><surname>Jiang</surname> <given-names>Y.</given-names></name> <name><surname>Yu</surname> <given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Emergence of NDM-1-producing <italic>Acinetobacter baumannii</italic> in China</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1255</fpage>&#x02013;<lpage>1259</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr319</pub-id><pub-id pub-id-type="pmid">21398294</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>Y. J.</given-names></name> <name><surname>Moon</surname> <given-names>D. C.</given-names></name> <name><surname>Jin</surname> <given-names>J. S.</given-names></name> <name><surname>Choi</surname> <given-names>C. H.</given-names></name> <name><surname>Lee</surname> <given-names>Y. C.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Genetic basis of resistance to aminoglycosides in <italic>Acinetobacter</italic> spp. and spread of armA in <italic>Acinetobacter baumannii</italic> sequence group 1 in Korean hospitals</article-title>. <source>Diagn. Microbiol. Infect. Dis.</source> <volume>64</volume>, <fpage>185</fpage>&#x02013;<lpage>190</lpage>.<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2009.02.010</pub-id><pub-id pub-id-type="pmid">19361944</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>A. H.</given-names></name> <name><surname>Slamti</surname> <given-names>L.</given-names></name> <name><surname>Avci</surname> <given-names>F. Y.</given-names></name> <name><surname>Pier</surname> <given-names>G. B.</given-names></name> <name><surname>Maira-Litran</surname> <given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>The pgaABCD locus of <italic>Acinetobacter baumannii</italic> encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation</article-title>. <source>J. Bacteriol.</source> <volume>191</volume>, <fpage>5953</fpage>&#x02013;<lpage>5963</lpage>.<pub-id pub-id-type="doi">10.1128/JB.00958-09</pub-id><pub-id pub-id-type="pmid">19633088</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>C. H.</given-names></name> <name><surname>Lee</surname> <given-names>E. Y.</given-names></name> <name><surname>Lee</surname> <given-names>Y. C.</given-names></name> <name><surname>Park</surname> <given-names>T. I.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Hyun</surname> <given-names>S. H.</given-names></name> <name><surname>Kim</surname> <given-names>S. A.</given-names></name> <name><surname>Lee</surname> <given-names>S. K.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Outer membrane protein 38 of <italic>Acinetobacter baumannii</italic> localizes to the mitochondria and induces apoptosis of epithelial cells</article-title>. <source>Cell. Microbiol.</source> <volume>7</volume>, <fpage>1127</fpage>&#x02013;<lpage>1138</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00538.x</pub-id><pub-id pub-id-type="pmid">16008580</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>C. H.</given-names></name> <name><surname>Lee</surname> <given-names>J. S.</given-names></name> <name><surname>Lee</surname> <given-names>Y. C.</given-names></name> <name><surname>Park</surname> <given-names>T. I.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>Acinetobacter baumannii</italic> invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells</article-title>. <source>BMC Microbiol.</source> <volume>8</volume>, <fpage>216</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2180-8-216</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>Y. W.</given-names></name> <name><surname>Afzal-Shah</surname> <given-names>M.</given-names></name> <name><surname>Houang</surname> <given-names>E. T.</given-names></name> <name><surname>Palepou</surname> <given-names>M. I.</given-names></name> <name><surname>Lyon</surname> <given-names>D. J.</given-names></name> <name><surname>Woodford</surname> <given-names>N.</given-names></name> <name><surname>Livermore</surname> <given-names>D. M.</given-names></name></person-group> (<year>2001</year>). <article-title>IMP-4, a novel metallo-&#x003B2;-lactamase from nosocomial <italic>Acinetobacter</italic> spp. collected in Hong Kong between 1994 and 1998</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>45</volume>, <fpage>710</fpage>&#x02013;<lpage>714</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.45.3.710-714.2001</pub-id><pub-id pub-id-type="pmid">11181348</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>Y. W.</given-names></name> <name><surname>Chau</surname> <given-names>S. L.</given-names></name> <name><surname>Houang</surname> <given-names>E. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Presence of active efflux systems AdeABC, AdeDE and AdeXYZ in different <italic>Acinetobacter</italic> genomic DNA groups</article-title>. <source>J. Med. Microbiol.</source> <volume>55</volume>, <fpage>477</fpage>&#x02013;<lpage>478</lpage>.<pub-id pub-id-type="doi">10.1099/jmm.0.46266-0</pub-id><pub-id pub-id-type="pmid">16534000</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clemmer</surname> <given-names>K. M.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name> <name><surname>Rather</surname> <given-names>P. N.</given-names></name></person-group> (<year>2011</year>). <article-title>Genetic analysis of surface motility in <italic>Acinetobacter baumannii</italic></article-title>. <source>Microbiology</source> <volume>157</volume>, <fpage>2534</fpage>&#x02013;<lpage>2544</lpage>.<pub-id pub-id-type="doi">10.1099/mic.0.049791-0</pub-id><pub-id pub-id-type="pmid">21700662</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname> <given-names>J. M.</given-names></name> <name><surname>Ahmed</surname> <given-names>E.</given-names></name> <name><surname>Condamine</surname> <given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Antimicrobial properties of brevinin-2-related peptide and its analogs: efficacy against multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Chem. Biol. Drug Des.</source> <volume>74</volume>, <fpage>488</fpage>&#x02013;<lpage>493</lpage>.<pub-id pub-id-type="doi">10.1111/j.1747-0285.2009.00882.x</pub-id><pub-id pub-id-type="pmid">19793185</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname> <given-names>J. M.</given-names></name> <name><surname>Ahmed</surname> <given-names>E.</given-names></name> <name><surname>Pal</surname> <given-names>T.</given-names></name> <name><surname>Sonnevend</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of <italic>Acinetobacter baumannii</italic></article-title>. <source>Peptides</source> <volume>31</volume>, <fpage>1806</fpage>&#x02013;<lpage>1810</lpage>.<pub-id pub-id-type="doi">10.1016/j.peptides.2010.06.032</pub-id><pub-id pub-id-type="pmid">20603168</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornaglia</surname> <given-names>G.</given-names></name> <name><surname>Giamarellou</surname> <given-names>H.</given-names></name> <name><surname>Rossolini</surname> <given-names>G. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Metallo-&#x003B2;-lactamases: a last frontier for &#x003B2;-lactams?</article-title> <source>Lancet Infect. Dis.</source> <volume>11</volume>, <fpage>381</fpage>&#x02013;<lpage>393</lpage>.<pub-id pub-id-type="doi">10.1016/S1473-3099(11)70056-1</pub-id><pub-id pub-id-type="pmid">21530894</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corvec</surname> <given-names>S.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Naas</surname> <given-names>T.</given-names></name> <name><surname>Drugeon</surname> <given-names>H.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>1530</fpage>&#x02013;<lpage>1533</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01132-06</pub-id><pub-id pub-id-type="pmid">17220422</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname> <given-names>J.</given-names></name></person-group> (<year>1995</year>). <article-title>Overview of microbial biofilsm</article-title>. <source>J. Ind. Microbiol.</source> <volume>15</volume>, <fpage>137</fpage>&#x02013;<lpage>140</lpage>.<pub-id pub-id-type="doi">10.1007/BF01569816</pub-id><pub-id pub-id-type="pmid">8519468</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coyne</surname> <given-names>S.</given-names></name> <name><surname>Guigon</surname> <given-names>G.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name> <name><surname>P&#x000E9;richon</surname> <given-names>B.</given-names></name></person-group> (<year>2010a</year>). <article-title>Screening and quantification of the expression of antibiotic resistance genes in <italic>Acinetobacter baumannii</italic> with a microarray</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>333</fpage>&#x02013;<lpage>340</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01037-09</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coyne</surname> <given-names>S.</given-names></name> <name><surname>Rosenfeld</surname> <given-names>N.</given-names></name> <name><surname>Lambert</surname> <given-names>T.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name> <name><surname>P&#x000E9;richon</surname> <given-names>B.</given-names></name></person-group> (<year>2010b</year>). <article-title>Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>4389</fpage>&#x02013;<lpage>4393</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01037-09</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Culebras</surname> <given-names>E.</given-names></name> <name><surname>Gonzalez-Romo</surname> <given-names>F.</given-names></name> <name><surname>Head</surname> <given-names>J.</given-names></name> <name><surname>Gomez</surname> <given-names>M.</given-names></name> <name><surname>Morales</surname> <given-names>G.</given-names></name> <name><surname>Picazo</surname> <given-names>J. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Outbreak of <italic>Acinetobacter baumannii</italic> producing OXA-66 in a Spanish hospital: epidemiology and study of patient movements</article-title>. <source>Microb. Drug Resist.</source> <volume>16</volume>, <fpage>309</fpage>&#x02013;<lpage>315</lpage>.<pub-id pub-id-type="doi">10.1089/mdr.2009.0113</pub-id><pub-id pub-id-type="pmid">20528099</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname> <given-names>G. J.</given-names></name> <name><surname>Correia</surname> <given-names>M.</given-names></name> <name><surname>Vital</surname> <given-names>C.</given-names></name> <name><surname>Ribeiro</surname> <given-names>G.</given-names></name> <name><surname>Sousa</surname> <given-names>J. C.</given-names></name> <name><surname>Leitao</surname> <given-names>R.</given-names></name> <name><surname>Peixe</surname> <given-names>L.</given-names></name> <name><surname>Duarte</surname> <given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecular characterization of blaIMP-5, a new integron-borne metallo-&#x003B2;-lactamase gene from an <italic>Acinetobacter baumannii</italic> nosocomial isolate in Portugal</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>215</volume>, <fpage>33</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.2002.tb11366.x</pub-id><pub-id pub-id-type="pmid">12393197</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damier-Piolle</surname> <given-names>L.</given-names></name> <name><surname>Magnet</surname> <given-names>S.</given-names></name> <name><surname>Br&#x000E9;mont</surname> <given-names>S.</given-names></name> <name><surname>Lambert</surname> <given-names>T.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>557</fpage>&#x02013;<lpage>562</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00732-07</pub-id><pub-id pub-id-type="pmid">18086852</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Andrea</surname> <given-names>M. M.</given-names></name> <name><surname>Giani</surname> <given-names>T.</given-names></name> <name><surname>D&#x02019;Arezzo</surname> <given-names>S.</given-names></name> <name><surname>Capone</surname> <given-names>A.</given-names></name> <name><surname>Petrosillo</surname> <given-names>N.</given-names></name> <name><surname>Visca</surname> <given-names>P.</given-names></name> <name><surname>Luzzaro</surname> <given-names>F.</given-names></name> <name><surname>Rossolini</surname> <given-names>G. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>3528</fpage>&#x02013;<lpage>3533</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00178-09</pub-id><pub-id pub-id-type="pmid">19487447</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Arezzo</surname> <given-names>S.</given-names></name> <name><surname>Capone</surname> <given-names>A.</given-names></name> <name><surname>Petrosillo</surname> <given-names>N.</given-names></name> <name><surname>Visca</surname> <given-names>P.</given-names></name> <name><surname>Ballardini</surname> <given-names>M.</given-names></name> <name><surname>Bartolini</surname> <given-names>S.</given-names></name> <name><surname>Bordi</surname> <given-names>E.</given-names></name> <name><surname>Di Stefano</surname> <given-names>A.</given-names></name> <name><surname>Galie</surname> <given-names>M.</given-names></name> <name><surname>Minniti</surname> <given-names>R.</given-names></name> <name><surname>Meledandri</surname> <given-names>M.</given-names></name> <name><surname>Pacciani</surname> <given-names>L.</given-names></name> <name><surname>Parisi</surname> <given-names>G.</given-names></name> <name><surname>Prignano</surname> <given-names>G.</given-names></name> <name><surname>Santini</surname> <given-names>C.</given-names></name> <name><surname>Valmarin</surname> <given-names>M.</given-names></name> <name><surname>Venditti</surname> <given-names>M.</given-names></name> <name><surname>Ziantoni</surname> <given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Epidemic multidrug-resistant <italic>Acinetobacter baumannii</italic> related to European Clonal Types I and II in Rome (Italy)</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>15</volume>, <fpage>347</fpage>&#x02013;<lpage>357</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2009.02668.x</pub-id><pub-id pub-id-type="pmid">19431222</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>T. A.</given-names></name> <name><surname>Marie Queenan</surname> <given-names>A.</given-names></name> <name><surname>Morrow</surname> <given-names>B. J.</given-names></name> <name><surname>Shang</surname> <given-names>W.</given-names></name> <name><surname>Amsler</surname> <given-names>K.</given-names></name> <name><surname>He</surname> <given-names>W.</given-names></name> <name><surname>Lynch</surname> <given-names>A. S.</given-names></name> <name><surname>Pillar</surname> <given-names>C.</given-names></name> <name><surname>Flamm</surname> <given-names>R. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>2298</fpage>&#x02013;<lpage>2307</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr290</pub-id><pub-id pub-id-type="pmid">21775338</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Breij</surname> <given-names>A.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Lagendijk</surname> <given-names>E.</given-names></name> <name><surname>van der Meer</surname> <given-names>J.</given-names></name> <name><surname>Koster</surname> <given-names>A.</given-names></name> <name><surname>Bloemberg</surname> <given-names>G.</given-names></name> <name><surname>Wolterbeek</surname> <given-names>R.</given-names></name> <name><surname>van den Broek</surname> <given-names>P.</given-names></name> <name><surname>Nibbering</surname> <given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Do biofilm formation and interactions with human cells explain the clinical success of <italic>Acinetobacter baumannii</italic>?</article-title> <source>PLoS ONE</source> <volume>5</volume>, <fpage>e10732</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0010732</pub-id><pub-id pub-id-type="pmid">20505779</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Breij</surname> <given-names>A.</given-names></name> <name><surname>Gaddy</surname> <given-names>J.</given-names></name> <name><surname>van der Meer</surname> <given-names>J.</given-names></name> <name><surname>Koning</surname> <given-names>R.</given-names></name> <name><surname>Koster</surname> <given-names>A.</given-names></name> <name><surname>van den Broek</surname> <given-names>P.</given-names></name> <name><surname>Actis</surname> <given-names>L.</given-names></name> <name><surname>Nibbering</surname> <given-names>P.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>CsuA/BABCDE-dependent pili are not involved in the adherence of <italic>Acinetobacter baumannii</italic> ATCC19606(T) to human airway epithelial cells and their inflammatory response</article-title>. <source>Res. Microbiol.</source> <volume>160</volume>, <fpage>213</fpage>&#x02013;<lpage>218</lpage>.<pub-id pub-id-type="doi">10.1016/j.resmic.2009.01.002</pub-id><pub-id pub-id-type="pmid">19530313</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De La Fuente</surname> <given-names>L.</given-names></name> <name><surname>Burr</surname> <given-names>T. J.</given-names></name> <name><surname>Hoch</surname> <given-names>H. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Mutations in type I and type IV pilus biosynthetic genes affect twitching motility rates in <italic>Xylella fastidiosa</italic></article-title>. <source>J. Bacteriol.</source> <volume>189</volume>, <fpage>7507</fpage>&#x02013;<lpage>7510</lpage>.<pub-id pub-id-type="doi">10.1128/JB.00934-07</pub-id><pub-id pub-id-type="pmid">17693510</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>del Mar Tomas</surname> <given-names>M.</given-names></name> <name><surname>Beceiro</surname> <given-names>A.</given-names></name> <name><surname>Perez</surname> <given-names>A.</given-names></name> <name><surname>Velasco</surname> <given-names>D.</given-names></name> <name><surname>Moure</surname> <given-names>R.</given-names></name> <name><surname>Villanueva</surname> <given-names>R.</given-names></name> <name><surname>Martinez-Beltran</surname> <given-names>J.</given-names></name> <name><surname>Bou</surname> <given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>5172</fpage>&#x02013;<lpage>5175</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.12.5172-5175.2005</pub-id><pub-id pub-id-type="pmid">16304197</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Nocera</surname> <given-names>P. P.</given-names></name> <name><surname>Rocco</surname> <given-names>F.</given-names></name> <name><surname>Giannouli</surname> <given-names>M.</given-names></name> <name><surname>Triassi</surname> <given-names>M.</given-names></name> <name><surname>Zarrilli</surname> <given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Genome organization of epidemic <italic>Acinetobacter baumannii</italic> strains</article-title>. <source>BMC Microbiol.</source> <volume>11</volume>, <fpage>224</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2180-11-224</pub-id><pub-id pub-id-type="pmid">21985032</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Popolo</surname> <given-names>A.</given-names></name> <name><surname>Giannouli</surname> <given-names>M.</given-names></name> <name><surname>Triassi</surname> <given-names>M.</given-names></name> <name><surname>Brisse</surname> <given-names>S.</given-names></name> <name><surname>Zarrilli</surname> <given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular epidemiological investigation of multidrug-resistant <italic>Acinetobacter baumannii</italic> strains in four Mediterranean countries with a multilocus sequence typing scheme</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>17</volume>, <fpage>197</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03254.x</pub-id><pub-id pub-id-type="pmid">20456455</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Brouwer</surname> <given-names>C. P.</given-names></name> <name><surname>Bogaards</surname> <given-names>S. J.</given-names></name> <name><surname>Nemec</surname> <given-names>A.</given-names></name> <name><surname>van den Broek</surname> <given-names>P. J.</given-names></name> <name><surname>Nibbering</surname> <given-names>P. H.</given-names></name></person-group> (<year>2004</year>). <article-title>The synthetic N-terminal peptide of human lactoferrin, hLF(1&#x02013;11), is highly effective against experimental infection caused by multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>48</volume>, <fpage>4919</fpage>&#x02013;<lpage>4921</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.48.12.4919-4921.2004</pub-id><pub-id pub-id-type="pmid">15561882</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Nemec</surname> <given-names>A.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>An increasing threat in hospitals: multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Nat. Rev. Microbiol.</source> <volume>5</volume>, <fpage>939</fpage>&#x02013;<lpage>951</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro1789</pub-id><pub-id pub-id-type="pmid">18007677</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Docquier</surname> <given-names>J. D.</given-names></name> <name><surname>Lamotte-Brasseur</surname> <given-names>J.</given-names></name> <name><surname>Galleni</surname> <given-names>M.</given-names></name> <name><surname>Amicosante</surname> <given-names>G.</given-names></name> <name><surname>Frere</surname> <given-names>J. M.</given-names></name> <name><surname>Rossolini</surname> <given-names>G. M.</given-names></name></person-group> (<year>2003</year>). <article-title>On functional and structural heterogeneity of VIM-type metallo-&#x003B2;-lactamases</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>51</volume>, <fpage>257</fpage>&#x02013;<lpage>266</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkg067</pub-id><pub-id pub-id-type="pmid">12562689</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doi</surname> <given-names>Y.</given-names></name> <name><surname>Adams</surname> <given-names>J. M.</given-names></name> <name><surname>Yamane</surname> <given-names>K.</given-names></name> <name><surname>Paterson</surname> <given-names>D. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Identification of 16S rRNA methylase-producing <italic>Acinetobacter baumannii</italic> clinical strains in North America</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>4209</fpage>&#x02013;<lpage>4210</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00560-07</pub-id><pub-id pub-id-type="pmid">17785513</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doi</surname> <given-names>Y.</given-names></name> <name><surname>Arakawa</surname> <given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides</article-title>. <source>Clin. Infect. Dis.</source> <volume>45</volume>, <fpage>88</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1086/521246</pub-id><pub-id pub-id-type="pmid">17554708</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donlan</surname> <given-names>R.</given-names></name></person-group> (<year>2002</year>). <article-title>Biofilms: microbial life on surfaces</article-title>. <source>Emerging Infect. Dis.</source> <volume>8</volume>, <fpage>881</fpage>&#x02013;<lpage>890</lpage>.<pub-id pub-id-type="doi">10.3201/eid0809.020063</pub-id><pub-id pub-id-type="pmid">12194761</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donnarumma</surname> <given-names>F.</given-names></name> <name><surname>Sergi</surname> <given-names>S.</given-names></name> <name><surname>Indorato</surname> <given-names>C.</given-names></name> <name><surname>Mastromei</surname> <given-names>G.</given-names></name> <name><surname>Monnanni</surname> <given-names>R.</given-names></name> <name><surname>Nicoletti</surname> <given-names>P.</given-names></name> <name><surname>Pecile</surname> <given-names>P.</given-names></name> <name><surname>Cecconi</surname> <given-names>D.</given-names></name> <name><surname>Mannino</surname> <given-names>R.</given-names></name> <name><surname>Bencini</surname> <given-names>S.</given-names></name> <name><surname>Fanci</surname> <given-names>R.</given-names></name> <name><surname>Bosi</surname> <given-names>A.</given-names></name> <name><surname>Casalone</surname> <given-names>E.</given-names></name></person-group> (<year>2010</year>). <article-title>Molecular characterization of <italic>Acinetobacter</italic> isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysis</article-title>. <source>J. Clin. Microbiol.</source> <volume>48</volume>, <fpage>1297</fpage>&#x02013;<lpage>1304</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.01916-09</pub-id><pub-id pub-id-type="pmid">20181903</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorsey</surname> <given-names>C. W.</given-names></name> <name><surname>Beglin</surname> <given-names>M. S.</given-names></name> <name><surname>Actis</surname> <given-names>L. A.</given-names></name></person-group> (<year>2003a</year>). <article-title>Detection and analysis of iron uptake components expressed by <italic>Acinetobacter baumannii</italic> clinical isolates</article-title>. <source>J. Clin. Microbiol.</source> <volume>41</volume>, <fpage>4188</fpage>&#x02013;<lpage>4193</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.41.9.4188-4193.2003</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorsey</surname> <given-names>C. W.</given-names></name> <name><surname>Tolmasky</surname> <given-names>M. E.</given-names></name> <name><surname>Crosa</surname> <given-names>J. H.</given-names></name> <name><surname>Actis</surname> <given-names>L. A.</given-names></name></person-group> (<year>2003b</year>). <article-title>Genetic organization of an <italic>Acinetobacter baumannii</italic> chromosomal region harbouring genes related to siderophore biosynthesis and transport</article-title>. <source>Microbiology</source> <volume>149</volume>, <fpage>1227</fpage>&#x02013;<lpage>1238</lpage>.<pub-id pub-id-type="doi">10.1099/mic.0.26204-0</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drawz</surname> <given-names>S. M.</given-names></name> <name><surname>Babic</surname> <given-names>M.</given-names></name> <name><surname>Bethel</surname> <given-names>C. R.</given-names></name> <name><surname>Taracila</surname> <given-names>M.</given-names></name> <name><surname>Distler</surname> <given-names>A. M.</given-names></name> <name><surname>Ori</surname> <given-names>C.</given-names></name> <name><surname>Caselli</surname> <given-names>E.</given-names></name> <name><surname>Prati</surname> <given-names>F.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Inhibition of the class C &#x003B2;-lactamase from <italic>Acinetobacter</italic> spp.: insights into effective inhibitor design</article-title>. <source>Biochemistry</source> <volume>49</volume>, <fpage>329</fpage>&#x02013;<lpage>340</lpage>.<pub-id pub-id-type="doi">10.1021/bi9015988</pub-id><pub-id pub-id-type="pmid">19925018</pub-id></citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname> <given-names>M.</given-names></name> <name><surname>Pages</surname> <given-names>J. M.</given-names></name> <name><surname>Lafitte</surname> <given-names>D.</given-names></name> <name><surname>Siroy</surname> <given-names>A.</given-names></name> <name><surname>Bollet</surname> <given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Identification of an OprD homologue in <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Proteome Res.</source> <volume>4</volume>, <fpage>2386</fpage>&#x02013;<lpage>2390</lpage>.<pub-id pub-id-type="doi">10.1021/pr050143q</pub-id><pub-id pub-id-type="pmid">16335991</pub-id></citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eijkelkamp</surname> <given-names>B. A.</given-names></name> <name><surname>Stroeher</surname> <given-names>U. H.</given-names></name> <name><surname>Hassan</surname> <given-names>K. A.</given-names></name> <name><surname>Papadimitrious</surname> <given-names>M. S.</given-names></name> <name><surname>Paulsen</surname> <given-names>I. T.</given-names></name> <name><surname>Brown</surname> <given-names>M. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Adherence and motility characteristics of clinical <italic>Acinetobacter baumannii</italic> isolates</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>323</volume>, <fpage>44</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.2011.02362.x</pub-id><pub-id pub-id-type="pmid">22092679</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Endimiani</surname> <given-names>A.</given-names></name> <name><surname>Luzzaro</surname> <given-names>F.</given-names></name> <name><surname>Migliavacca</surname> <given-names>R.</given-names></name> <name><surname>Mantengoli</surname> <given-names>E.</given-names></name> <name><surname>Hujer</surname> <given-names>A. M.</given-names></name> <name><surname>Hujer</surname> <given-names>K. M.</given-names></name> <name><surname>Pagani</surname> <given-names>L.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name> <name><surname>Rossolini</surname> <given-names>G. M.</given-names></name> <name><surname>Toniolo</surname> <given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Spread in an Italian hospital of a clonal <italic>Acinetobacter baumannii</italic> strain producing the TEM-92 extended-spectrum &#x003B2;-lactamase</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>2211</fpage>&#x02013;<lpage>2214</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01139-06</pub-id><pub-id pub-id-type="pmid">17404005</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erridge</surname> <given-names>C.</given-names></name> <name><surname>Moncayo-Nieto</surname> <given-names>O. L.</given-names></name> <name><surname>Morgan</surname> <given-names>R.</given-names></name> <name><surname>Young</surname> <given-names>M.</given-names></name> <name><surname>Poxton</surname> <given-names>I. R.</given-names></name></person-group> (<year>2007</year>). <article-title><italic>Acinetobacter baumannii</italic> lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling</article-title>. <source>J. Med. Microbiol.</source> <volume>56</volume>, <fpage>165</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="doi">10.1099/jmm.0.46823-0</pub-id><pub-id pub-id-type="pmid">17244795</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Fugazza</surname> <given-names>G.</given-names></name> <name><surname>Lopez</surname> <given-names>Y.</given-names></name> <name><surname>Kasma</surname> <given-names>M.</given-names></name> <name><surname>Lerman</surname> <given-names>Y.</given-names></name> <name><surname>Malhotra-Kumar</surname> <given-names>S.</given-names></name> <name><surname>Goosens</surname> <given-names>H.</given-names></name> <name><surname>Carmeli</surname> <given-names>Y.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2011a</year>). <article-title>Dissemination of the NDM-2-producing <italic>Acinetobacter baumannii</italic> clone in an Israeli Rehabilitation Center</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>5396</fpage>&#x02013;<lpage>5398</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00679-11</pub-id></citation></ref>
<ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Roca</surname> <given-names>I.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2011b</year>). <article-title>Clinical impact and molecular basis of antimicrobial resistance in non-<italic>baumannii</italic> <italic>Acinetobacter</italic></article-title>. <source>Future Microbiol.</source> <volume>6</volume>, <fpage>495</fpage>&#x02013;<lpage>511</lpage>.<pub-id pub-id-type="doi">10.2217/fmb.11.30</pub-id></citation></ref>
<ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name> <name><surname>Roca</surname> <given-names>I.</given-names></name></person-group> (<year>2011c</year>). <article-title>Rapid and accurate identification of genomic species from the <italic>Acinetobacter baumannii</italic> (Ab) group by MALDI-TOF MS</article-title>. <source>Clin. Microbiol. Infect.</source> (in press).<pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03696.x</pub-id></citation></ref>
<ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Mart&#x000ED;</surname> <given-names>S.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Effect of biofilm formation on the survival of <italic>Acinetobacter baumannii</italic> on dry surfaces</article-title>. <source>J. Hosp. Infect.</source> <volume>80</volume>, <fpage>56</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.jhin.2011.08.013</pub-id><pub-id pub-id-type="pmid">21975219</pub-id></citation></ref>
<ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>B. A.</given-names></name> <name><surname>Hamouda</surname> <given-names>A.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name> <name><surname>Amyes</surname> <given-names>S. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Novel genetic context of multiple blaOXA-58 genes in <italic>Acinetobacter</italic> genospecies 3</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>65</volume>, <fpage>1586</fpage>&#x02013;<lpage>1588</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkq180</pub-id><pub-id pub-id-type="pmid">20542900</pub-id></citation></ref>
<ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>F&#x000E0;brega</surname> <given-names>A.</given-names></name> <name><surname>Madurga</surname> <given-names>S.</given-names></name> <name><surname>Giralt</surname> <given-names>E.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Mechanism of action of and resistance to quinolones</article-title>. <source>Microb. Biotechnol.</source> <volume>2</volume>, <fpage>40</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1111/j.1751-7915.2008.00063.x</pub-id><pub-id pub-id-type="pmid">21261881</pub-id></citation></ref>
<ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falagas</surname> <given-names>M. E.</given-names></name> <name><surname>Kasiakou</surname> <given-names>S. K.</given-names></name></person-group> (<year>2005</year>). <article-title>Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections</article-title>. <source>Clin. Infect. Dis.</source> <volume>40</volume>, <fpage>1333</fpage>&#x02013;<lpage>1341</lpage>.<pub-id pub-id-type="doi">10.1086/429323</pub-id><pub-id pub-id-type="pmid">15825037</pub-id></citation></ref>
<ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000E1;ndez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Mart&#x000ED;nez-Mart&#x000ED;nez</surname> <given-names>L.</given-names></name> <name><surname>Conejo</surname> <given-names>M. C.</given-names></name> <name><surname>Ayala</surname> <given-names>J. A.</given-names></name> <name><surname>Perea</surname> <given-names>E. J.</given-names></name> <name><surname>Pascual</surname> <given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Relationship between &#x003B2;-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>51</volume>, <fpage>565</fpage>&#x02013;<lpage>574</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkg097</pub-id><pub-id pub-id-type="pmid">12615856</pub-id></citation></ref>
<ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000E1;ndez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Smani</surname> <given-names>Y.</given-names></name> <name><surname>G&#x000F3;mez-S&#x000E1;nchez</surname> <given-names>M. C.</given-names></name> <name><surname>Docobo-P&#x000E9;rez</surname> <given-names>F.</given-names></name> <name><surname>Caballero-Moyano</surname> <given-names>F. J.</given-names></name> <name><surname>Dom&#x000ED;nguez-Herrera</surname> <given-names>J.</given-names></name> <name><surname>Pascual</surname> <given-names>A.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Attenuated virulence of a slow-growing pandrug-resistant <italic>Acinetobacter baumannii</italic> is associated with decreased expression of genes encoding the porins CarO and OprD-like</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>38</volume>, <fpage>548</fpage>&#x02013;<lpage>549</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2011.08.002</pub-id><pub-id pub-id-type="pmid">21940150</pub-id></citation></ref>
<ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000E1;ndez-Reyes</surname> <given-names>M.</given-names></name> <name><surname>D&#x000ED;az</surname> <given-names>D.</given-names></name> <name><surname>de la Torre</surname> <given-names>B. G.</given-names></name> <name><surname>Cabrales-Rico</surname> <given-names>A.</given-names></name> <name><surname>Vall&#x000E8;s-Miret</surname> <given-names>M.</given-names></name> <name><surname>Jim&#x000E9;nez-Barbero</surname> <given-names>J.</given-names></name> <name><surname>Andreu</surname> <given-names>D.</given-names></name> <name><surname>Rivas</surname> <given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Lysine N(epsilon)-trimethylation, a tool for improving the selectivity of antimicrobial peptides</article-title>. <source>J. Med. Chem.</source> <volume>53</volume>, <fpage>5587</fpage>&#x02013;<lpage>5596</lpage>.<pub-id pub-id-type="doi">10.1021/jm100261r</pub-id><pub-id pub-id-type="pmid">20617807</pub-id></citation></ref>
<ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000E1;ndez-Reyes</surname> <given-names>M.</given-names></name> <name><surname>Rodr&#x000ED;guez-Falc&#x000F3;n</surname> <given-names>M.</given-names></name> <name><surname>Chiva</surname> <given-names>C.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name> <name><surname>Andreu</surname> <given-names>D.</given-names></name> <name><surname>Rivas</surname> <given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>The cost of resistance to colistin in <italic>Acinetobacter baumannii</italic>: a proteomic perspective</article-title>. <source>Proteomics</source> <volume>9</volume>, <fpage>1632</fpage>&#x02013;<lpage>1645</lpage>.<pub-id pub-id-type="doi">10.1002/pmic.200800434</pub-id><pub-id pub-id-type="pmid">19253303</pub-id></citation></ref>
<ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname> <given-names>S.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Papa</surname> <given-names>A.</given-names></name> <name><surname>Koulourida</surname> <given-names>V.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>First identification of VIM-4 metallo-&#x003B2;-lactamase in <italic>Acinetobacter</italic> spp</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>14</volume>, <fpage>289</fpage>&#x02013;<lpage>290</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01942.x</pub-id><pub-id pub-id-type="pmid">18190570</pub-id></citation></ref>
<ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname> <given-names>S.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Papa</surname> <given-names>A.</given-names></name> <name><surname>Koulourida</surname> <given-names>V.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Overexpression of the naturally occurring blaOXA-51 gene in <italic>Acinetobacter baumannii</italic> mediated by novel insertion sequence ISAba9</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>4045</fpage>&#x02013;<lpage>4047</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01663-08</pub-id><pub-id pub-id-type="pmid">19564367</pub-id></citation></ref>
<ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fournier</surname> <given-names>P. E.</given-names></name> <name><surname>Vallenet</surname> <given-names>D.</given-names></name> <name><surname>Barbe</surname> <given-names>V.</given-names></name> <name><surname>Audic</surname> <given-names>S.</given-names></name> <name><surname>Ogata</surname> <given-names>H.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Richet</surname> <given-names>H.</given-names></name> <name><surname>Robert</surname> <given-names>C.</given-names></name> <name><surname>Mangenot</surname> <given-names>S.</given-names></name> <name><surname>Abergel</surname> <given-names>C.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Weissenbach</surname> <given-names>J.</given-names></name> <name><surname>Raoult</surname> <given-names>D.</given-names></name> <name><surname>Claverie</surname> <given-names>J. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Comparative genomics of multidrug resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>PLoS Genet.</source> <volume>2</volume>, <fpage>e7</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pgen.0020007</pub-id><pub-id pub-id-type="pmid">16415984</pub-id></citation></ref>
<ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Origin, microbiology, nutrition, and pharmacology of D-amino acids</article-title>. <source>Chem. Biodivers.</source> <volume>7</volume>, <fpage>1491</fpage>&#x02013;<lpage>1530</lpage>.<pub-id pub-id-type="doi">10.1002/cbdv.200900225</pub-id><pub-id pub-id-type="pmid">20564567</pub-id></citation></ref>
<ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaddy</surname> <given-names>J. A.</given-names></name> <name><surname>Actis</surname> <given-names>L. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Regulation of <italic>Acinetobacter baumannii</italic> biofilm formation</article-title>. <source>Future Microbiol.</source> <volume>4</volume>, <fpage>273</fpage>&#x02013;<lpage>278</lpage>.<pub-id pub-id-type="doi">10.2217/fmb.09.5</pub-id><pub-id pub-id-type="pmid">19327114</pub-id></citation></ref>
<ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaddy</surname> <given-names>J. A.</given-names></name> <name><surname>Tomaras</surname> <given-names>A. P.</given-names></name> <name><surname>Actis</surname> <given-names>L. A.</given-names></name></person-group> (<year>2009</year>). <article-title>The <italic>Acinetobacter baumannii</italic> 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells</article-title>. <source>Infect. Immun.</source> <volume>77</volume>, <fpage>3150</fpage>&#x02013;<lpage>3160</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00096-09</pub-id><pub-id pub-id-type="pmid">19470746</pub-id></citation></ref>
<ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gales</surname> <given-names>A. C.</given-names></name> <name><surname>Tognim</surname> <given-names>M. C.</given-names></name> <name><surname>Reis</surname> <given-names>A. O.</given-names></name> <name><surname>Jones</surname> <given-names>R. N.</given-names></name> <name><surname>Sader</surname> <given-names>H. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Emergence of an IMP-like metallo-enzyme in an <italic>Acinetobacter baumannii</italic> clinical strain from a Brazilian teaching hospital</article-title>. <source>Diagn. Microbiol. Infect. Dis.</source> <volume>45</volume>, <fpage>77</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1016/S0732-8893(02)00500-X</pub-id><pub-id pub-id-type="pmid">12573555</pub-id></citation></ref>
<ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ED;a</surname> <given-names>A.</given-names></name> <name><surname>Salgado</surname> <given-names>F.</given-names></name> <name><surname>Solar</surname> <given-names>H.</given-names></name> <name><surname>Gonz&#x000E1;lez</surname> <given-names>C. L.</given-names></name> <name><surname>Zemelman</surname> <given-names>R.</given-names></name> <name><surname>Onate</surname> <given-names>A.</given-names></name></person-group> (<year>1999</year>). <article-title>Some immunological properties of lipopolysaccharide from <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Med. Microbiol.</source> <volume>48</volume>, <fpage>479</fpage>&#x02013;<lpage>483</lpage>.<pub-id pub-id-type="doi">10.1099/00222615-48-5-479</pub-id><pub-id pub-id-type="pmid">10229545</pub-id></citation></ref>
<ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname> <given-names>Y.</given-names></name> <name><surname>MacDonald</surname> <given-names>D. L.</given-names></name> <name><surname>Holroyd</surname> <given-names>K. J.</given-names></name> <name><surname>Thornsberry</surname> <given-names>C.</given-names></name> <name><surname>Wexler</surname> <given-names>H.</given-names></name> <name><surname>Zasloff</surname> <given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>In vitro antibacterial properties of pexiganan, an analog of magainin</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>43</volume>, <fpage>782</fpage>&#x02013;<lpage>788</lpage>.<pub-id pub-id-type="pmid">10103181</pub-id></citation></ref>
<ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gehrlein</surname> <given-names>M.</given-names></name> <name><surname>Leying</surname> <given-names>H.</given-names></name> <name><surname>Cullmann</surname> <given-names>W.</given-names></name> <name><surname>Wendt</surname> <given-names>S.</given-names></name> <name><surname>Opferkuch</surname> <given-names>W.</given-names></name></person-group> (<year>1991</year>). <article-title>Imipenem resistance in <italic>Acinetobacter baumanii</italic> is due to altered penicillin-binding proteins</article-title>. <source>Chemotherapy</source> <volume>37</volume>, <fpage>405</fpage>&#x02013;<lpage>412</lpage>.<pub-id pub-id-type="doi">10.1159/000238887</pub-id><pub-id pub-id-type="pmid">1760939</pub-id></citation></ref>
<ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giacometti</surname> <given-names>A.</given-names></name> <name><surname>Cirioni</surname> <given-names>O.</given-names></name> <name><surname>Del Prete</surname> <given-names>M. S.</given-names></name> <name><surname>Barchiesi</surname> <given-names>F.</given-names></name> <name><surname>Paggi</surname> <given-names>A. M.</given-names></name> <name><surname>Petrelli</surname> <given-names>E.</given-names></name> <name><surname>Scalise</surname> <given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>46</volume>, <fpage>807</fpage>&#x02013;<lpage>810</lpage>.<pub-id pub-id-type="doi">10.1093/jac/46.5.751</pub-id><pub-id pub-id-type="pmid">11062203</pub-id></citation></ref>
<ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giacometti</surname> <given-names>A.</given-names></name> <name><surname>Cirioni</surname> <given-names>O.</given-names></name> <name><surname>Kamysz</surname> <given-names>W.</given-names></name> <name><surname>D&#x02019;Amato</surname> <given-names>G.</given-names></name> <name><surname>Silvestri</surname> <given-names>C.</given-names></name> <name><surname>Del Prete</surname> <given-names>M. S.</given-names></name> <name><surname>Lukasiak</surname> <given-names>J.</given-names></name> <name><surname>Scalise</surname> <given-names>G.</given-names></name></person-group> (<year>2003</year>). <article-title>Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>Peptides</source> <volume>24</volume>, <fpage>1315</fpage>&#x02013;<lpage>1318</lpage>.<pub-id pub-id-type="doi">10.1016/j.peptides.2003.08.003</pub-id><pub-id pub-id-type="pmid">14706545</pub-id></citation></ref>
<ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giannouli</surname> <given-names>M.</given-names></name> <name><surname>Tomasone</surname> <given-names>F.</given-names></name> <name><surname>Agodi</surname> <given-names>A.</given-names></name> <name><surname>Vahaboglu</surname> <given-names>H.</given-names></name> <name><surname>Daoud</surname> <given-names>Z.</given-names></name> <name><surname>Triassi</surname> <given-names>M.</given-names></name> <name><surname>Tsakris</surname> <given-names>A.</given-names></name> <name><surname>Zarrilli</surname> <given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular epidemiology of carbapenem-resistant <italic>Acinetobacter baumannii</italic> strains in intensive care units of multiple Mediterranean hospitals</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>63</volume>, <fpage>828</fpage>&#x02013;<lpage>830</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkp032</pub-id><pub-id pub-id-type="pmid">19223304</pub-id></citation></ref>
<ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gogou</surname> <given-names>V.</given-names></name> <name><surname>Pournaras</surname> <given-names>S.</given-names></name> <name><surname>Giannouli</surname> <given-names>M.</given-names></name> <name><surname>Voulgari</surname> <given-names>E.</given-names></name> <name><surname>Piperaki</surname> <given-names>E. T.</given-names></name> <name><surname>Zarrilli</surname> <given-names>R.</given-names></name> <name><surname>Tsakris</surname> <given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Evolution of multidrug-resistant <italic>Acinetobacter baumannii</italic> clonal lineages: a 10 year study in Greece (2000-09)</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>2767</fpage>&#x02013;<lpage>2772</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr390</pub-id><pub-id pub-id-type="pmid">21933784</pub-id></citation></ref>
<ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goic-Barisic</surname> <given-names>I.</given-names></name> <name><surname>Bedenic</surname> <given-names>B.</given-names></name> <name><surname>Tonkic</surname> <given-names>M.</given-names></name> <name><surname>Novak</surname> <given-names>A.</given-names></name> <name><surname>Katic</surname> <given-names>S.</given-names></name> <name><surname>Kalenic</surname> <given-names>S.</given-names></name> <name><surname>Punda-Polic</surname> <given-names>V.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of <italic>Acinetobacter baumannii</italic> from Croatia</article-title>. <source>J. Clin. Microbiol.</source> <volume>47</volume>, <fpage>3348</fpage>&#x02013;<lpage>3349</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.02394-08</pub-id><pub-id pub-id-type="pmid">19692565</pub-id></citation></ref>
<ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goic-Barisic</surname> <given-names>I.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name> <name><surname>Kovacic</surname> <given-names>A.</given-names></name> <name><surname>Sisko-Kraljevic</surname> <given-names>K.</given-names></name> <name><surname>Tonkic</surname> <given-names>M.</given-names></name> <name><surname>Novak</surname> <given-names>A.</given-names></name> <name><surname>Punda-Polic</surname> <given-names>V.</given-names></name></person-group> (<year>2011</year>). <article-title>Outbreak in Croatia caused by a new carbapenem-resistant clone of <italic>Acinetobacter baumannii</italic> producing OXA-72 carbapenemase</article-title>. <source>J. Hosp. Infect.</source> <volume>77</volume>, <fpage>368</fpage>&#x02013;<lpage>369</lpage>.<pub-id pub-id-type="doi">10.1016/j.jhin.2010.12.003</pub-id><pub-id pub-id-type="pmid">21316806</pub-id></citation></ref>
<ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000E1;lez</surname> <given-names>R. H.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Van den Barselaar</surname> <given-names>M.</given-names></name> <name><surname>Nudel</surname> <given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Quorum sensing signal profile of <italic>Acinetobacter</italic> strains from nosocomial and environmental sources</article-title>. <source>Rev. Argent. Microbiol.</source> <volume>41</volume>, <fpage>73</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">19623895</pub-id></citation></ref>
<ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000E1;lez</surname> <given-names>R. H.</given-names></name> <name><surname>Nusblat</surname> <given-names>A.</given-names></name> <name><surname>Nudel</surname> <given-names>B. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Detection and characterization of quorum sensing signal molecules in <italic>Acinetobacter</italic> strains</article-title>. <source>Microbiol. Res.</source> <volume>155</volume>, <fpage>271</fpage>&#x02013;<lpage>277</lpage>.<pub-id pub-id-type="doi">10.1016/S0944-5013(01)80004-5</pub-id><pub-id pub-id-type="pmid">11297357</pub-id></citation></ref>
<ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gopalakrishnan</surname> <given-names>R.</given-names></name> <name><surname>Sureshkumar</surname> <given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8 year period in a tertiary care hospital in relation to introduction of an infection control programme</article-title>. <source>J. Assoc. Physicians India</source> <volume>58</volume>(Suppl.), <fpage>25</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">21563610</pub-id></citation></ref>
<ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>N. C.</given-names></name> <name><surname>Png</surname> <given-names>K.</given-names></name> <name><surname>Wareham</surname> <given-names>D. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>5316</fpage>&#x02013;<lpage>5322</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00922-10</pub-id><pub-id pub-id-type="pmid">20876375</pub-id></citation></ref>
<ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gribun</surname> <given-names>A.</given-names></name> <name><surname>Nitzan</surname> <given-names>Y.</given-names></name> <name><surname>Pechatnikov</surname> <given-names>I.</given-names></name> <name><surname>Hershkovits</surname> <given-names>G.</given-names></name> <name><surname>Katcoff</surname> <given-names>D. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Molecular and structural characterization of the HMP-AB gene encoding a pore-forming protein from a clinical isolate of <italic>Acinetobacter baumannii</italic></article-title>. <source>Curr. Microbiol.</source> <volume>47</volume>, <fpage>434</fpage>&#x02013;<lpage>443</lpage>.<pub-id pub-id-type="doi">10.1007/s00284-003-4050-4</pub-id><pub-id pub-id-type="pmid">14669924</pub-id></citation></ref>
<ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guardabassi</surname> <given-names>L.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Collard</surname> <given-names>J. M.</given-names></name> <name><surname>Olsen</surname> <given-names>J. E.</given-names></name> <name><surname>Dalsgaard</surname> <given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic <italic>Acinetobacter</italic> strains</article-title>. <source>J. Med. Microbiol.</source> <volume>49</volume>, <fpage>929</fpage>&#x02013;<lpage>936</lpage>.<pub-id pub-id-type="pmid">11023190</pub-id></citation></ref>
<ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamouda</surname> <given-names>A.</given-names></name> <name><surname>Amyes</surname> <given-names>S. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Novel gyrA and parC point mutations in two strains of <italic>Acinetobacter baumannii</italic> resistant to ciprofloxacin</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>54</volume>, <fpage>695</fpage>&#x02013;<lpage>696</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkh368</pub-id><pub-id pub-id-type="pmid">15282231</pub-id></citation></ref>
<ref id="B115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henrichsen</surname> <given-names>J.</given-names></name> <name><surname>Blom</surname> <given-names>J.</given-names></name></person-group> (<year>1975</year>). <article-title>Correlation between twitching motility and possession of polar fimbriae in <italic>Acinetobacter calcoaceticus</italic></article-title>. <source>Acta Pathol. Microbiol. Scand. B</source> <volume>83</volume>, <fpage>103</fpage>&#x02013;<lpage>115</lpage>.<pub-id pub-id-type="pmid">1155109</pub-id></citation></ref>
<ref id="B116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x000E9;ritier</surname> <given-names>C.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Fournier</surname> <given-names>P. E.</given-names></name> <name><surname>Claverie</surname> <given-names>J. M.</given-names></name> <name><surname>Raoult</surname> <given-names>D.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2005a</year>). <article-title>Characterization of the naturally occurring oxacillinase of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>4174</fpage>&#x02013;<lpage>4179</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.10.4174-4179.2005</pub-id></citation></ref>
<ref id="B117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x000E9;ritier</surname> <given-names>C.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Lambert</surname> <given-names>T.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2005b</year>). <article-title>Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>3198</fpage>&#x02013;<lpage>3202</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.10.4174-4179.2005</pub-id></citation></ref>
<ref id="B118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x000E9;ritier</surname> <given-names>C.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Cephalosporinase over-expression resulting from insertion of ISAba1 in <italic>Acinetobacter baumannii</italic></article-title>. <source>Clin. Microbiol. Infect.</source> <volume>12</volume>, <fpage>123</fpage>&#x02013;<lpage>130</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2005.01320.x</pub-id><pub-id pub-id-type="pmid">16441449</pub-id></citation></ref>
<ref id="B119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname> <given-names>P. G.</given-names></name> <name><surname>Dammhayn</surname> <given-names>C.</given-names></name> <name><surname>Hackel</surname> <given-names>M.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Global spread of carbapenem-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>65</volume>, <fpage>233</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkp428</pub-id><pub-id pub-id-type="pmid">19996144</pub-id></citation></ref>
<ref id="B120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname> <given-names>P. G.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Lehmann</surname> <given-names>M.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>OXA-143, a novel carbapenem-hydrolyzing class D &#x003B2;-lactamase in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>5035</fpage>&#x02013;<lpage>5038</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00856-09</pub-id><pub-id pub-id-type="pmid">19770279</pub-id></citation></ref>
<ref id="B121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname> <given-names>P. G.</given-names></name> <name><surname>Wisplinghoff</surname> <given-names>H.</given-names></name> <name><surname>Stefanik</surname> <given-names>D.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name></person-group> (<year>2004</year>). <article-title>Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>54</volume>, <fpage>821</fpage>&#x02013;<lpage>823</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkh427</pub-id><pub-id pub-id-type="pmid">15355942</pub-id></citation></ref>
<ref id="B122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>P. L.</given-names></name> <name><surname>Lo</surname> <given-names>W. U.</given-names></name> <name><surname>Yeung</surname> <given-names>M. K.</given-names></name> <name><surname>Lin</surname> <given-names>C. H.</given-names></name> <name><surname>Chow</surname> <given-names>K. H.</given-names></name> <name><surname>Ang</surname> <given-names>I.</given-names></name> <name><surname>Tong</surname> <given-names>A. H.</given-names></name> <name><surname>Bao</surname> <given-names>J. Y.</given-names></name> <name><surname>Lok</surname> <given-names>S.</given-names></name> <name><surname>Lo</surname> <given-names>J. Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant <italic>Escherichia coli</italic> strain isolated in Hong Kong</article-title>. <source>PLoS ONE</source> <volume>6</volume>, <fpage>e17989</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0017989</pub-id><pub-id pub-id-type="pmid">21445317</pub-id></citation></ref>
<ref id="B123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Houang</surname> <given-names>E. T.</given-names></name> <name><surname>Chu</surname> <given-names>Y. W.</given-names></name> <name><surname>Lo</surname> <given-names>W. S.</given-names></name> <name><surname>Chu</surname> <given-names>K. Y.</given-names></name> <name><surname>Cheng</surname> <given-names>A. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-&#x003B2;-lactamase (<italic>bla</italic>IMP-4) gene cassettes in class 1 integrons in <italic>Acinetobacter</italic> strains isolated from blood cultures in 1997 to 2000</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>47</volume>, <fpage>1382</fpage>&#x02013;<lpage>1390</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.47.4.1472-1475.2003</pub-id><pub-id pub-id-type="pmid">12654674</pub-id></citation></ref>
<ref id="B124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Liang</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>L.</given-names></name> <name><surname>Peng</surname> <given-names>G.</given-names></name> <name><surname>Pan</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>X.</given-names></name> <name><surname>Zheng</surname> <given-names>B.</given-names></name> <name><surname>Gao</surname> <given-names>G. F.</given-names></name> <name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>Hu</surname> <given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Whole-genome sequence of a multidrug-resistant clinical isolate of <italic>Acinetobacter lwoffii</italic></article-title>. <source>J. Bacteriol.</source> <volume>193</volume>, <fpage>5549</fpage>&#x02013;<lpage>5550</lpage>.<pub-id pub-id-type="doi">10.1128/JB.00083-11</pub-id><pub-id pub-id-type="pmid">21742884</pub-id></citation></ref>
<ref id="B125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>L. Y.</given-names></name> <name><surname>Chen</surname> <given-names>T. L.</given-names></name> <name><surname>Lu</surname> <given-names>P. L.</given-names></name> <name><surname>Tsai</surname> <given-names>C. A.</given-names></name> <name><surname>Cho</surname> <given-names>W. L.</given-names></name> <name><surname>Chang</surname> <given-names>F. Y.</given-names></name> <name><surname>Fung</surname> <given-names>C. P.</given-names></name> <name><surname>Siu</surname> <given-names>L. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Dissemination of multidrug-resistant, class 1 integron-carrying <italic>Acinetobacter baumannii</italic> isolates in Taiwan</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>14</volume>, <fpage>1010</fpage>&#x02013;<lpage>1019</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2008.02115.x</pub-id><pub-id pub-id-type="pmid">19040472</pub-id></citation></ref>
<ref id="B126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>L. Y.</given-names></name> <name><surname>Lu</surname> <given-names>P. L.</given-names></name> <name><surname>Chen</surname> <given-names>T. L.</given-names></name> <name><surname>Chang</surname> <given-names>F. Y.</given-names></name> <name><surname>Fung</surname> <given-names>C. P.</given-names></name> <name><surname>Siu</surname> <given-names>L. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Molecular characterization of &#x003B2;-lactamase genes and their genetic structures in <italic>Acinetobacter</italic> genospecies 3 isolates in Taiwan</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>2699</fpage>&#x02013;<lpage>2703</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00482-10</pub-id><pub-id pub-id-type="pmid">20368407</pub-id></citation></ref>
<ref id="B127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hujer</surname> <given-names>K. M.</given-names></name> <name><surname>Hamza</surname> <given-names>N. S.</given-names></name> <name><surname>Hujer</surname> <given-names>A. M.</given-names></name> <name><surname>Perez</surname> <given-names>F.</given-names></name> <name><surname>Helfand</surname> <given-names>M. S.</given-names></name> <name><surname>Bethel</surname> <given-names>C. R.</given-names></name> <name><surname>Thomson</surname> <given-names>J. M.</given-names></name> <name><surname>Anderson</surname> <given-names>V. E.</given-names></name> <name><surname>Barlow</surname> <given-names>M.</given-names></name> <name><surname>Rice</surname> <given-names>L. B.</given-names></name> <name><surname>Tenover</surname> <given-names>F. C.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Identification of a new allelic variant of the <italic>Acinetobacter baumannii</italic> cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>2941</fpage>&#x02013;<lpage>2948</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.2.612-618.2005</pub-id><pub-id pub-id-type="pmid">15980372</pub-id></citation></ref>
<ref id="B128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huys</surname> <given-names>G.</given-names></name> <name><surname>Cnockaert</surname> <given-names>M.</given-names></name> <name><surname>Nemec</surname> <given-names>A.</given-names></name> <name><surname>Swings</surname> <given-names>J.</given-names></name></person-group> (<year>2005a</year>). <article-title>Sequence-based typing of adeB as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Clin. Microbiol.</source> <volume>43</volume>, <fpage>5327</fpage>&#x02013;<lpage>5331</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.43.10.5327-5331.2005</pub-id></citation></ref>
<ref id="B129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huys</surname> <given-names>G.</given-names></name> <name><surname>Cnockaert</surname> <given-names>M.</given-names></name> <name><surname>Vaneechoutte</surname> <given-names>M.</given-names></name> <name><surname>Woodford</surname> <given-names>N.</given-names></name> <name><surname>Nemec</surname> <given-names>A.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Swings</surname> <given-names>J.</given-names></name></person-group> (<year>2005b</year>). <article-title>Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant <italic>Acinetobacter baumannii</italic> strains from different European hospitals</article-title>. <source>Res. Microbiol.</source> <volume>156</volume>, <fpage>348</fpage>&#x02013;<lpage>355</lpage>.<pub-id pub-id-type="doi">10.1016/j.resmic.2004.10.008</pub-id></citation></ref>
<ref id="B130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iacono</surname> <given-names>M.</given-names></name> <name><surname>Villa</surname> <given-names>L.</given-names></name> <name><surname>Fortini</surname> <given-names>D.</given-names></name> <name><surname>Bordoni</surname> <given-names>R.</given-names></name> <name><surname>Imperi</surname> <given-names>F.</given-names></name> <name><surname>Bonnal</surname> <given-names>R. J. P.</given-names></name> <name><surname>Sicheritz-Ponten</surname> <given-names>T.</given-names></name> <name><surname>De Bellis</surname> <given-names>G.</given-names></name> <name><surname>Visca</surname> <given-names>P.</given-names></name> <name><surname>Cassone</surname> <given-names>A.</given-names></name> <name><surname>Carattoli</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Whole-genome pyrosequencing of an epidemic multidrug-resistant <italic>Acinetobacter baumannii</italic> strain belonging to the European clone II group</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>2616</fpage>&#x02013;<lpage>2625</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01643-07</pub-id><pub-id pub-id-type="pmid">18411315</pub-id></citation></ref>
<ref id="B131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Irie</surname> <given-names>Y.</given-names></name> <name><surname>Parsek</surname> <given-names>M. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Quorum sensing and microbial biofilms</article-title>. <source>Curr. Top. Microbiol. Immunol.</source> <volume>322</volume>, <fpage>67</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1007/978-3-540-75418-3_4</pub-id><pub-id pub-id-type="pmid">18453272</pub-id></citation></ref>
<ref id="B132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname> <given-names>A. C.</given-names></name> <name><surname>Hood</surname> <given-names>I.</given-names></name> <name><surname>Boyd</surname> <given-names>K. L.</given-names></name> <name><surname>Olson</surname> <given-names>P. D.</given-names></name> <name><surname>Morrison</surname> <given-names>J. M.</given-names></name> <name><surname>Carson</surname> <given-names>S.</given-names></name> <name><surname>Sayood</surname> <given-names>K.</given-names></name> <name><surname>Iwen</surname> <given-names>P. C.</given-names></name> <name><surname>Skaar</surname> <given-names>E. P.</given-names></name> <name><surname>Dunman</surname> <given-names>P. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Inactivation of phospholipase D diminishes <italic>Acinetobacter baumannii</italic> pathogenesis</article-title>. <source>Infect. Immun.</source> <volume>78</volume>, <fpage>1952</fpage>&#x02013;<lpage>1962</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00889-09</pub-id><pub-id pub-id-type="pmid">20194595</pub-id></citation></ref>
<ref id="B133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jarrell</surname> <given-names>K. F.</given-names></name> <name><surname>McBride</surname> <given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The surprisingly diverse ways that prokaryotes move</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>6</volume>, <fpage>466</fpage>&#x02013;<lpage>476</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro1900</pub-id><pub-id pub-id-type="pmid">18461074</pub-id></citation></ref>
<ref id="B134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jawad</surname> <given-names>A.</given-names></name> <name><surname>Heritage</surname> <given-names>J.</given-names></name> <name><surname>Snelling</surname> <given-names>A. M.</given-names></name> <name><surname>Gascoyne-Binzi</surname> <given-names>D. M.</given-names></name> <name><surname>Hawkey</surname> <given-names>P. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Influence of relative humidity and suspending menstrua on survival of <italic>Acinetobacter</italic> spp. on dry surfaces</article-title>. <source>J. Clin. Microbiol.</source> <volume>34</volume>, <fpage>2881</fpage>&#x02013;<lpage>2887</lpage>.<pub-id pub-id-type="pmid">8940416</pub-id></citation></ref>
<ref id="B135"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jawad</surname> <given-names>A.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name> <name><surname>Snelling</surname> <given-names>A.</given-names></name> <name><surname>Heritage</surname> <given-names>J.</given-names></name> <name><surname>Hawkey</surname> <given-names>P.</given-names></name></person-group> (<year>1998</year>). <article-title>Survival of <italic>Acinetobacter baumannii</italic> on dry surfaces: comparison of outbreak and sporadic isolates</article-title>. <source>J. Clin. Microbiol.</source> <volume>36</volume>, <fpage>1938</fpage>&#x02013;<lpage>1941</lpage>.<pub-id pub-id-type="pmid">9650940</pub-id></citation></ref>
<ref id="B136"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Z.</given-names></name> <name><surname>Vasil</surname> <given-names>A. I.</given-names></name> <name><surname>Gera</surname> <given-names>L.</given-names></name> <name><surname>Vasil</surname> <given-names>M. L.</given-names></name> <name><surname>Hodges</surname> <given-names>R. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Rational design of alpha-helical antimicrobial peptides to target Gram-negative pathogens, <italic>Acinetobacter baumannii</italic> and <italic>Pseudomonas aeruginosa</italic>: utilization of charge, &#x02018;specificity determinants,&#x02019; total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio</article-title>. <source>Chem. Biol. Drug Des.</source> <volume>77</volume>, <fpage>225</fpage>&#x02013;<lpage>240</lpage>.<pub-id pub-id-type="doi">10.1111/j.1747-0285.2011.01086.x</pub-id><pub-id pub-id-type="pmid">21219588</pub-id></citation></ref>
<ref id="B137"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>J. S.</given-names></name> <name><surname>Kwon</surname> <given-names>S. O.</given-names></name> <name><surname>Moon</surname> <given-names>D. C.</given-names></name> <name><surname>Gurung</surname> <given-names>M.</given-names></name> <name><surname>Lee</surname> <given-names>J. H.</given-names></name> <name><surname>Kim</surname> <given-names>S. I.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Acinetobacter baumannii</italic> secretes cytotoxic outer membrane protein A via outer membrane vesicles</article-title>. <source>PLoS ONE</source> <volume>6</volume>, <fpage>e17027</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0017027.g001</pub-id><pub-id pub-id-type="pmid">21386968</pub-id></citation></ref>
<ref id="B138"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>R. N.</given-names></name></person-group> (<year>2010</year>). <article-title>Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia</article-title>. <source>Clin. Infect. Dis.</source> <volume>51</volume>(<issue>Suppl. 1</issue>), <fpage>S81</fpage>&#x02013;<lpage>S87</lpage>.<pub-id pub-id-type="doi">10.1086/653053</pub-id><pub-id pub-id-type="pmid">20597676</pub-id></citation></ref>
<ref id="B139"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaase</surname> <given-names>M.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Wichelhaus</surname> <given-names>T. A.</given-names></name> <name><surname>Gatermann</surname> <given-names>S. G.</given-names></name> <name><surname>Bonnin</surname> <given-names>R. A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>NDM-2 carbapenemase in <italic>Acinetobacter baumannii</italic> from Egypt</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1260</fpage>&#x02013;<lpage>1262</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr135</pub-id><pub-id pub-id-type="pmid">21427107</pub-id></citation></ref>
<ref id="B140"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>Y. S.</given-names></name> <name><surname>Park</surname> <given-names>W.</given-names></name></person-group> (<year>2010a</year>). <article-title>Contribution of quorum-sensing system to hexadecane degradation and biofilm formation in <italic>Acinetobacter</italic> sp. strain DR1</article-title>. <source>J. Appl. Microbiol.</source> <volume>109</volume>, <fpage>1650</fpage>&#x02013;<lpage>1659</lpage>.</citation></ref>
<ref id="B141"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>Y. S.</given-names></name> <name><surname>Park</surname> <given-names>W.</given-names></name></person-group> (<year>2010b</year>). <article-title>Trade-off between antibiotic resistance and biological fitness in <italic>Acinetobacter</italic> sp. strain DR1</article-title>. <source>Environ. Microbiol.</source> <volume>12</volume>, <fpage>1304</fpage>&#x02013;<lpage>1318</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-2920.2010.02175.x</pub-id></citation></ref>
<ref id="B142"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karthikeyan</surname> <given-names>K.</given-names></name> <name><surname>Thirunarayan</surname> <given-names>M. A.</given-names></name> <name><surname>Krishnan</surname> <given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of <italic>Acinetobacter baumannii</italic> from India</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>65</volume>, <fpage>2253</fpage>&#x02013;<lpage>2254</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkq273</pub-id><pub-id pub-id-type="pmid">20650909</pub-id></citation></ref>
<ref id="B143"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karunasagar</surname> <given-names>A.</given-names></name> <name><surname>Maiti</surname> <given-names>B.</given-names></name> <name><surname>Shekar</surname> <given-names>M.</given-names></name> <name><surname>Shenoy</surname> <given-names>M. S.</given-names></name> <name><surname>Karunasagar</surname> <given-names>I.</given-names></name></person-group> (<year>2011</year>). <article-title>Prevalence of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of <italic>Acinetobacter</italic> spp. from Mangalore, India</article-title>. <source>Microbiol. Immunol.</source> <volume>55</volume>, <fpage>239</fpage>&#x02013;<lpage>246</lpage>.<pub-id pub-id-type="doi">10.1111/j.1348-0421.2011.00313.x</pub-id><pub-id pub-id-type="pmid">21244471</pub-id></citation></ref>
<ref id="B144"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J. W.</given-names></name> <name><surname>Heo</surname> <given-names>S. T.</given-names></name> <name><surname>Jin</surname> <given-names>J. S.</given-names></name> <name><surname>Choi</surname> <given-names>C. H.</given-names></name> <name><surname>Lee</surname> <given-names>Y. C.</given-names></name> <name><surname>Jeong</surname> <given-names>Y. G.</given-names></name> <name><surname>Kim</surname> <given-names>S. J.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Characterization of <italic>Acinetobacter baumannii</italic> carrying blaOXA-23, blaPER-1 and armA in a Korean hospital</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>14</volume>, <fpage>716</fpage>&#x02013;<lpage>718</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2008.02033.x</pub-id><pub-id pub-id-type="pmid">18558945</pub-id></citation></ref>
<ref id="B145"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S. W.</given-names></name> <name><surname>Choi</surname> <given-names>C. H.</given-names></name> <name><surname>Moon</surname> <given-names>D. C.</given-names></name> <name><surname>Jin</surname> <given-names>J. S.</given-names></name> <name><surname>Lee</surname> <given-names>J. H.</given-names></name> <name><surname>Shin</surname> <given-names>J. H.</given-names></name> <name><surname>Kim</surname> <given-names>J. M.</given-names></name> <name><surname>Lee</surname> <given-names>Y. C.</given-names></name> <name><surname>Seol</surname> <given-names>S. Y.</given-names></name> <name><surname>Cho</surname> <given-names>D. T.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Serum resistance of <italic>Acinetobacter baumannii</italic> through the binding of factor H to outer membrane proteins</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>301</volume>, <fpage>224</fpage>&#x02013;<lpage>231</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01820.x</pub-id><pub-id pub-id-type="pmid">19878322</pub-id></citation></ref>
<ref id="B146"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitchel</surname> <given-names>B.</given-names></name> <name><surname>Rasheed</surname> <given-names>J. K.</given-names></name> <name><surname>Endimiani</surname> <given-names>A.</given-names></name> <name><surname>Hujer</surname> <given-names>A. M.</given-names></name> <name><surname>Anderson</surname> <given-names>K. F.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name> <name><surname>Patel</surname> <given-names>J. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic factors associated with elevated carbapenem resistance in KPC-producing <italic>Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>4201</fpage>&#x02013;<lpage>4207</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00008-10</pub-id><pub-id pub-id-type="pmid">20660684</pub-id></citation></ref>
<ref id="B147"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klieve</surname> <given-names>A. V.</given-names></name> <name><surname>Yokoyama</surname> <given-names>M. T.</given-names></name> <name><surname>Forster</surname> <given-names>R. J.</given-names></name> <name><surname>Ouwerkerk</surname> <given-names>D.</given-names></name> <name><surname>Bain</surname> <given-names>P. A.</given-names></name> <name><surname>Mawhinney</surname> <given-names>E. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Naturally occurring DNA transfer system associated with membrane vesicles in cellulolytic <italic>Ruminococcus</italic> spp. of ruminal origin</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>71</volume>, <fpage>4248</fpage>&#x02013;<lpage>4253</lpage>.<pub-id pub-id-type="doi">10.1128/AEM.71.8.4248-4253.2005</pub-id><pub-id pub-id-type="pmid">16085810</pub-id></citation></ref>
<ref id="B148"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname> <given-names>T. H.</given-names></name> <name><surname>Sng</surname> <given-names>L. H.</given-names></name> <name><surname>Wang</surname> <given-names>G. C.</given-names></name> <name><surname>Hsu</surname> <given-names>L. Y.</given-names></name> <name><surname>Zhao</surname> <given-names>Y.</given-names></name></person-group> (<year>2007a</year>). <article-title>Carbapenemase and efflux pump genes in <italic>Acinetobacter calcoaceticus</italic>-<italic>Acinetobacter baumannii</italic> complex strains from Singapore</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>60</volume>, <fpage>1173</fpage>&#x02013;<lpage>1174</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkm140</pub-id></citation></ref>
<ref id="B149"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname> <given-names>T. H.</given-names></name> <name><surname>Sng</surname> <given-names>L. H.</given-names></name> <name><surname>Wang</surname> <given-names>G. C.</given-names></name> <name><surname>Hsu</surname> <given-names>L. Y.</given-names></name> <name><surname>Zhao</surname> <given-names>Y.</given-names></name></person-group> (<year>2007b</year>). <article-title>IMP-4 and OXA &#x003B2;-lactamases in <italic>Acinetobacter baumannii</italic> from Singapore</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>59</volume>, <fpage>627</fpage>&#x02013;<lpage>632</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkl544</pub-id></citation></ref>
<ref id="B150"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname> <given-names>S. H.</given-names></name> <name><surname>Kwon</surname> <given-names>K. C.</given-names></name> <name><surname>Cho</surname> <given-names>H. H.</given-names></name> <name><surname>Sung</surname> <given-names>J. Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic basis of multidrug-resistant <italic>Acinetobacter baumannii</italic> clinical isolates from three university hospitals in Chungcheong Province, Korea</article-title>. <source>Korean J. Lab. Med.</source> <volume>30</volume>, <fpage>498</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="doi">10.3343/kjlm.2010.30.5.498</pub-id><pub-id pub-id-type="pmid">20890082</pub-id></citation></ref>
<ref id="B151"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krizova</surname> <given-names>L.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Nemec</surname> <given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Diversity and evolution of AbaR genomic resistance islands in <italic>Acinetobacter baumannii</italic> strains of European clone I</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>3201</fpage>&#x02013;<lpage>3206</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00221-11</pub-id><pub-id pub-id-type="pmid">21537009</pub-id></citation></ref>
<ref id="B152"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krizova</surname> <given-names>L.</given-names></name> <name><surname>Nemec</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>A 63 kb genomic resistance island found in a multidrug-resistant <italic>Acinetobacter baumannii</italic> isolate of European clone I from 1977</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>65</volume>, <fpage>1915</fpage>&#x02013;<lpage>1918</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkq223</pub-id><pub-id pub-id-type="pmid">20558468</pub-id></citation></ref>
<ref id="B153"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kropec</surname> <given-names>A.</given-names></name> <name><surname>Maira-Litran</surname> <given-names>T.</given-names></name> <name><surname>Jefferson</surname> <given-names>K. K.</given-names></name> <name><surname>Grout</surname> <given-names>M.</given-names></name> <name><surname>Cramton</surname> <given-names>S. E.</given-names></name> <name><surname>Gotz</surname> <given-names>F.</given-names></name> <name><surname>Goldmann</surname> <given-names>D. A.</given-names></name> <name><surname>Pier</surname> <given-names>G. B.</given-names></name></person-group> (<year>2005</year>). <article-title>Poly-N-acetylglucosamine production in <italic>Staphylococcus aureus</italic> is essential for virulence in murine models of systemic infection</article-title>. <source>Infect. Immun.</source> <volume>73</volume>, <fpage>6868</fpage>&#x02013;<lpage>6876</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.73.10.6868-6876.2005</pub-id><pub-id pub-id-type="pmid">16177366</pub-id></citation></ref>
<ref id="B154"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kusradze</surname> <given-names>I.</given-names></name> <name><surname>Diene</surname> <given-names>S. M.</given-names></name> <name><surname>Goderdzishvili</surname> <given-names>M.</given-names></name> <name><surname>Rolain</surname> <given-names>J. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular detection of OXA carbapenemase genes in multidrug-resistant <italic>Acinetobacter baumannii</italic> isolates from Iraq and Georgia</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>38</volume>, <fpage>164</fpage>&#x02013;<lpage>168</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2011.03.021</pub-id><pub-id pub-id-type="pmid">21616644</pub-id></citation></ref>
<ref id="B155"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>S. O.</given-names></name> <name><surname>Gho</surname> <given-names>Y. S.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name> <name><surname>Kim</surname> <given-names>S. I.</given-names></name></person-group> (<year>2009</year>). <article-title>Proteome analysis of outer membrane vesicles from a clinical <italic>Acinetobacter baumannii</italic> isolate</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>297</volume>, <fpage>150</fpage>&#x02013;<lpage>156</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01669.x</pub-id><pub-id pub-id-type="pmid">19548894</pub-id></citation></ref>
<ref id="B156"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname> <given-names>C.</given-names></name> <name><surname>Hildebrandt</surname> <given-names>J.</given-names></name> <name><surname>Schutze</surname> <given-names>E.</given-names></name> <name><surname>Wenzel</surname> <given-names>A. F.</given-names></name></person-group> (<year>1986</year>). <article-title>Membrane-disorganizing property of polymyxin B nonapeptide</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>18</volume>, <fpage>9</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1093/jac/18.1.9</pub-id><pub-id pub-id-type="pmid">3019982</pub-id></citation></ref>
<ref id="B157"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauretti</surname> <given-names>L.</given-names></name> <name><surname>Riccio</surname> <given-names>M. L.</given-names></name> <name><surname>Mazzariol</surname> <given-names>A.</given-names></name> <name><surname>Cornaglia</surname> <given-names>G.</given-names></name> <name><surname>Amicosante</surname> <given-names>G.</given-names></name> <name><surname>Fontana</surname> <given-names>R.</given-names></name> <name><surname>Rossolini</surname> <given-names>G. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Cloning and characterization of blaVIM, a new integron-borne metallo-&#x003B2;-lactamase gene from a <italic>Pseudomonas aeruginosa</italic> clinical isolate</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>43</volume>, <fpage>1584</fpage>&#x02013;<lpage>1590</lpage>.<pub-id pub-id-type="pmid">10390207</pub-id></citation></ref>
<ref id="B158"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Yong</surname> <given-names>D.</given-names></name> <name><surname>Yum</surname> <given-names>J. H.</given-names></name> <name><surname>Roh</surname> <given-names>K. H.</given-names></name> <name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Yamane</surname> <given-names>K.</given-names></name> <name><surname>Arakawa</surname> <given-names>Y.</given-names></name> <name><surname>Chong</surname> <given-names>Y.</given-names></name></person-group> (<year>2006a</year>). <article-title>Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of <italic>Klebsiella pneumoniae</italic> and <italic>Acinetobacter baumannii</italic> in Korea</article-title>. <source>Diagn. Microbiol. Infect. Dis.</source> <volume>56</volume>, <fpage>305</fpage>&#x02013;<lpage>312</lpage>.<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2006.05.002</pub-id></citation></ref>
<ref id="B159"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J. C.</given-names></name> <name><surname>Koerten</surname> <given-names>H.</given-names></name> <name><surname>van den Broek</surname> <given-names>P.</given-names></name> <name><surname>Beekhuizen</surname> <given-names>H.</given-names></name> <name><surname>Wolterbeek</surname> <given-names>R.</given-names></name> <name><surname>van den Barselaar</surname> <given-names>M.</given-names></name> <name><surname>van der Reijden</surname> <given-names>T.</given-names></name> <name><surname>van der Meer</surname> <given-names>J.</given-names></name> <name><surname>van de Gevel</surname> <given-names>J.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name></person-group> (<year>2006b</year>). <article-title>Adherence of <italic>Acinetobacter baumannii</italic> strains to human bronchial epithelial cells</article-title>. <source>Res. Microbiol.</source> <volume>157</volume>, <fpage>360</fpage>&#x02013;<lpage>366</lpage>.<pub-id pub-id-type="doi">10.1016/j.resmic.2006.07.004</pub-id></citation></ref>
<ref id="B160"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J. C.</given-names></name> <name><surname>Oh</surname> <given-names>J. Y.</given-names></name> <name><surname>Kim</surname> <given-names>K. S.</given-names></name> <name><surname>Jeong</surname> <given-names>Y. W.</given-names></name> <name><surname>Park</surname> <given-names>J. C.</given-names></name> <name><surname>Cho</surname> <given-names>J. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Apoptotic cell death induced by <italic>Acinetobacter baumannii</italic> in epithelial cells through caspase-3 activation</article-title>. <source>APMIS</source> <volume>109</volume>, <fpage>679</fpage>&#x02013;<lpage>684</lpage>.<pub-id pub-id-type="doi">10.1034/j.1600-0463.2001.d01-107.x</pub-id><pub-id pub-id-type="pmid">11890571</pub-id></citation></ref>
<ref id="B161"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Kim</surname> <given-names>M. N.</given-names></name> <name><surname>Choi</surname> <given-names>T. Y.</given-names></name> <name><surname>Cho</surname> <given-names>S. E.</given-names></name> <name><surname>Lee</surname> <given-names>S.</given-names></name> <name><surname>Whang</surname> <given-names>D. H.</given-names></name> <name><surname>Yong</surname> <given-names>D.</given-names></name> <name><surname>Chong</surname> <given-names>Y.</given-names></name> <name><surname>Woodford</surname> <given-names>N.</given-names></name> <name><surname>Livermore</surname> <given-names>D. M.</given-names></name></person-group> (<year>2009a</year>). <article-title>Wide dissemination of OXA-type carbapenemases in clinical <italic>Acinetobacter</italic> spp. isolates from South Korea</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>33</volume>, <fpage>520</fpage>&#x02013;<lpage>524</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2008.09.017</pub-id></citation></ref>
<ref id="B162"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y. T.</given-names></name> <name><surname>Huang</surname> <given-names>L. Y.</given-names></name> <name><surname>Chen</surname> <given-names>T. L.</given-names></name> <name><surname>Siu</surname> <given-names>L. K.</given-names></name> <name><surname>Fung</surname> <given-names>C. P.</given-names></name> <name><surname>Cho</surname> <given-names>W. L.</given-names></name> <name><surname>Yu</surname> <given-names>K. W.</given-names></name> <name><surname>Liu</surname> <given-names>C. Y.</given-names></name></person-group> (<year>2009b</year>). <article-title>Gene cassette arrays, antibiotic susceptibilities, and clinical characteristics of <italic>Acinetobacter baumannii</italic> bacteremic strains harboring class 1 integrons</article-title>. <source>J. Microbiol. Immunol. Infect.</source> <volume>42</volume>, <fpage>210</fpage>&#x02013;<lpage>219</lpage>.</citation></ref>
<ref id="B163"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Kim</surname> <given-names>M. N.</given-names></name> <name><surname>Kim</surname> <given-names>J. S.</given-names></name> <name><surname>Hong</surname> <given-names>H. L.</given-names></name> <name><surname>Kang</surname> <given-names>J. O.</given-names></name> <name><surname>Shin</surname> <given-names>J. H.</given-names></name> <name><surname>Park</surname> <given-names>Y. J.</given-names></name> <name><surname>Yong</surname> <given-names>D.</given-names></name> <name><surname>Jeong</surname> <given-names>S. H.</given-names></name> <name><surname>Chong</surname> <given-names>Y.</given-names></name></person-group> (<year>2011a</year>). <article-title>Further Increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of <italic>Acinetobacter</italic> spp. and <italic>P. aeruginosa</italic> in Korea: KONSAR study 2009</article-title>. <source>Yonsei Med. J.</source> <volume>52</volume>, <fpage>793</fpage>&#x02013;<lpage>802</lpage>.<pub-id pub-id-type="doi">10.3349/ymj.2011.52.1.196</pub-id></citation></ref>
<ref id="B164"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>Y.</given-names></name> <name><surname>Kim</surname> <given-names>C. K.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Jeong</surname> <given-names>S. H.</given-names></name> <name><surname>Yong</surname> <given-names>D.</given-names></name> <name><surname>Lee</surname> <given-names>K.</given-names></name></person-group> (<year>2011b</year>). <article-title>A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the blaOXA-23 gene and disrupting the outer membrane protein gene carO in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>361</fpage>&#x02013;<lpage>363</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00271-11</pub-id></citation></ref>
<ref id="B165"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Lee</surname> <given-names>W. G.</given-names></name> <name><surname>Uh</surname> <given-names>Y.</given-names></name> <name><surname>Ha</surname> <given-names>G. Y.</given-names></name> <name><surname>Cho</surname> <given-names>J.</given-names></name> <name><surname>Chong</surname> <given-names>Y.</given-names></name></person-group> (<year>2003</year>). <article-title>VIM- and IMP-type metallo-&#x003B2;-lactamase-producing <italic>Pseudomonas</italic> spp. and <italic>Acinetobacter</italic> spp. in Korean hospitals</article-title>. <source>Emerging Infect. Dis.</source> <volume>9</volume>, <fpage>868</fpage>&#x02013;<lpage>871</lpage>.<pub-id pub-id-type="pmid">12890331</pub-id></citation></ref>
<ref id="B166"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Yum</surname> <given-names>J. H.</given-names></name> <name><surname>Yong</surname> <given-names>D.</given-names></name> <name><surname>Lee</surname> <given-names>H. M.</given-names></name> <name><surname>Kim</surname> <given-names>H. D.</given-names></name> <name><surname>Docquier</surname> <given-names>J. D.</given-names></name> <name><surname>Rossolini</surname> <given-names>G. M.</given-names></name> <name><surname>Chong</surname> <given-names>Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Novel acquired metallo-&#x003B2;-lactamase gene, blaSIM-1, in a class 1 integron from <italic>Acinetobacter baumannii</italic> clinical isolates from Korea</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>4485</fpage>&#x02013;<lpage>4491</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.4.1600-1603.2005</pub-id><pub-id pub-id-type="pmid">16251286</pub-id></citation></ref>
<ref id="B167"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>M. F.</given-names></name> <name><surname>Peng</surname> <given-names>C. F.</given-names></name> <name><surname>Hsu</surname> <given-names>H. J.</given-names></name> <name><surname>Chen</surname> <given-names>Y. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Molecular characterisation of the metallo-&#x003B2;-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>32</volume>, <fpage>475</fpage>&#x02013;<lpage>480</lpage>.<pub-id pub-id-type="doi">10.1016/S0924-8579(09)70002-0</pub-id><pub-id pub-id-type="pmid">18804966</pub-id></citation></ref>
<ref id="B168"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname> <given-names>A. S.</given-names></name> <name><surname>Levy</surname> <given-names>C. E.</given-names></name> <name><surname>Manrique</surname> <given-names>A. E.</given-names></name> <name><surname>Medeiros</surname> <given-names>E. A.</given-names></name> <name><surname>Costa</surname> <given-names>S. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Severe nosocomial infections with imipenem-resistant <italic>Acinetobacter baumannii</italic> treated with ampicillin/sulbactam</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>21</volume>, <fpage>58</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/S0924-8579(02)00276-5</pub-id><pub-id pub-id-type="pmid">12507838</pub-id></citation></ref>
<ref id="B169"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>S. M.</given-names></name> <name><surname>Heide</surname> <given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>New aminocoumarin antibiotics from genetically engineered <italic>Streptomyces</italic> strains</article-title>. <source>Curr. Med. Chem.</source> <volume>12</volume>, <fpage>419</fpage>&#x02013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">15720250</pub-id></citation></ref>
<ref id="B170"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X. Z.</given-names></name> <name><surname>Nikaido</surname> <given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Efflux-mediated drug resistance in bacteria: an update</article-title>. <source>Drugs</source> <volume>69</volume>, <fpage>1555</fpage>&#x02013;<lpage>1623</lpage>.<pub-id pub-id-type="doi">10.2165/11317030-000000000-00000</pub-id><pub-id pub-id-type="pmid">19678712</pub-id></citation></ref>
<ref id="B171"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>W.</given-names></name> <name><surname>Liu</surname> <given-names>X. F.</given-names></name> <name><surname>Huang</surname> <given-names>J.</given-names></name> <name><surname>Zhu</surname> <given-names>D. M.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Activities of colistin- and minocycline-based combinations against extensive drug resistant <italic>Acinetobacter baumannii</italic> isolates from intensive care unit patients</article-title>. <source>BMC Infect. Dis.</source> <volume>11</volume>, <fpage>109</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2334-11-109</pub-id><pub-id pub-id-type="pmid">21521536</pub-id></citation></ref>
<ref id="B172"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Limansky</surname> <given-names>A. S.</given-names></name> <name><surname>Mussi</surname> <given-names>M. A.</given-names></name> <name><surname>Viale</surname> <given-names>A. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Loss of a 29-kilodalton outer membrane protein in <italic>Acinetobacter baumannii</italic> is associated with imipenem resistance</article-title>. <source>J. Clin. Microbiol.</source> <volume>40</volume>, <fpage>4776</fpage>&#x02013;<lpage>4778</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.40.12.4776-4778.2002</pub-id><pub-id pub-id-type="pmid">12454194</pub-id></citation></ref>
<ref id="B173"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>L.</given-names></name> <name><surname>Ling</surname> <given-names>B. D.</given-names></name> <name><surname>Li</surname> <given-names>X. Z.</given-names></name></person-group> (<year>2009</year>). <article-title>Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of <italic>Acinetobacter baumannii</italic>-<italic>Acinetobacter calcoaceticus</italic> complex</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>33</volume>, <fpage>27</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/S0924-8579(09)70090-1</pub-id><pub-id pub-id-type="pmid">18790612</pub-id></citation></ref>
<ref id="B174"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y. C.</given-names></name> <name><surname>Hsia</surname> <given-names>K. C.</given-names></name> <name><surname>Chen</surname> <given-names>Y. C.</given-names></name> <name><surname>Sheng</surname> <given-names>W. H.</given-names></name> <name><surname>Chang</surname> <given-names>S. C.</given-names></name> <name><surname>Liao</surname> <given-names>M. H.</given-names></name> <name><surname>Li</surname> <given-names>S. Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic basis of multidrug resistance in <italic>Acinetobacter</italic> clinical isolates in Taiwan</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>2078</fpage>&#x02013;<lpage>2084</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00368-10</pub-id><pub-id pub-id-type="pmid">20194701</pub-id></citation></ref>
<ref id="B175"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livermore</surname> <given-names>D. M.</given-names></name> <name><surname>Hope</surname> <given-names>R.</given-names></name> <name><surname>Brick</surname> <given-names>G.</given-names></name> <name><surname>Lillie</surname> <given-names>M.</given-names></name> <name><surname>Reynolds</surname> <given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Non-susceptibility trends among <italic>Pseudomonas aeruginosa</italic> and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>62</volume>(<issue>Suppl. 2</issue>), <fpage>ii55</fpage>&#x02013;<lpage>ii63</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkn320</pub-id><pub-id pub-id-type="pmid">18819980</pub-id></citation></ref>
<ref id="B176"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loehfelm</surname> <given-names>T.</given-names></name> <name><surname>Luke</surname> <given-names>N.</given-names></name> <name><surname>Campagnari</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Identification and characterization of an <italic>Acinetobacter baumannii</italic> biofilm-associated protein</article-title>. <source>J. Bacteriol.</source> <volume>190</volume>, <fpage>1036</fpage>&#x02013;<lpage>1044</lpage>.<pub-id pub-id-type="doi">10.1128/JB.01416-07</pub-id><pub-id pub-id-type="pmid">18024522</pub-id></citation></ref>
<ref id="B177"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lolans</surname> <given-names>K.</given-names></name> <name><surname>Rice</surname> <given-names>T. W.</given-names></name> <name><surname>Munoz-Price</surname> <given-names>L. S.</given-names></name> <name><surname>Quinn</surname> <given-names>J. P.</given-names></name></person-group> (<year>2006</year>). <article-title>Multicity outbreak of carbapenem-resistant <italic>Acinetobacter baumannii</italic> isolates producing the carbapenemase OXA-40</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>50</volume>, <fpage>2941</fpage>&#x02013;<lpage>2945</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00116-06</pub-id><pub-id pub-id-type="pmid">16940085</pub-id></citation></ref>
<ref id="B178"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname> <given-names>B. S.</given-names></name> <name><surname>Evans</surname> <given-names>B. A.</given-names></name> <name><surname>Amyes</surname> <given-names>S. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Disruption of the blaOXA-51-like gene by ISAba16 and activation of the blaOXA-58 gene leading to carbapenem resistance in <italic>Acinetobacter baumannii</italic> Ab244</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>67</volume>, <fpage>59</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr415</pub-id><pub-id pub-id-type="pmid">21980071</pub-id></citation></ref>
<ref id="B179"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000F3;pez-Rojas</surname> <given-names>R.</given-names></name> <name><surname>Docobo-P&#x000E9;rez</surname> <given-names>F.</given-names></name> <name><surname>Pach&#x000F3;n-Ib&#x000E1;nez</surname> <given-names>M. E.</given-names></name> <name><surname>de la Torre</surname> <given-names>B. G.</given-names></name> <name><surname>Fern&#x000E1;ndez-Reyes</surname> <given-names>M.</given-names></name> <name><surname>March</surname> <given-names>C.</given-names></name> <name><surname>Bengoechea</surname> <given-names>J. A.</given-names></name> <name><surname>Andreu</surname> <given-names>D.</given-names></name> <name><surname>Rivas</surname> <given-names>L.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2011a</year>). <article-title>Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source> <volume>30</volume>, <fpage>1391</fpage>&#x02013;<lpage>1398</lpage>.<pub-id pub-id-type="doi">10.1007/s10096-011-1233-y</pub-id></citation></ref>
<ref id="B180"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000F3;pez-Rojas</surname> <given-names>R.</given-names></name> <name><surname>Dom&#x000ED;nguez-Herrera</surname> <given-names>J.</given-names></name> <name><surname>McConnell</surname> <given-names>M. J.</given-names></name> <name><surname>Docobo-Perez</surname> <given-names>F.</given-names></name> <name><surname>Smani</surname> <given-names>Y.</given-names></name> <name><surname>Fern&#x000E1;ndez-Reyes</surname> <given-names>M.</given-names></name> <name><surname>Rivas</surname> <given-names>L.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2011b</year>). <article-title>Impaired virulence and in vivo fitness of colistin-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Infect. Dis.</source> <volume>203</volume>, <fpage>545</fpage>&#x02013;<lpage>548</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiq086</pub-id></citation></ref>
<ref id="B181"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000F3;pez-Rojas</surname> <given-names>R.</given-names></name> <name><surname>Jim&#x000E9;nez-Mej&#x000ED;as</surname> <given-names>M. E.</given-names></name> <name><surname>Lepe</surname> <given-names>J. A.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2011c</year>). <article-title><italic>Acinetobacter baumannii</italic> resistant to colistin alters its antibiotic resistance profile: a case report from Spain</article-title>. <source>J. Infect. Dis.</source> <volume>204</volume>, <fpage>1147</fpage>&#x02013;<lpage>1148</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jir476</pub-id></citation></ref>
<ref id="B182"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>P. L.</given-names></name> <name><surname>Doumith</surname> <given-names>M.</given-names></name> <name><surname>Livermore</surname> <given-names>D. M.</given-names></name> <name><surname>Chen</surname> <given-names>T. P.</given-names></name> <name><surname>Woodford</surname> <given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Diversity of carbapenem resistance mechanisms in <italic>Acinetobacter baumannii</italic> from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>63</volume>, <fpage>641</fpage>&#x02013;<lpage>647</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkn553</pub-id><pub-id pub-id-type="pmid">19182237</pub-id></citation></ref>
<ref id="B183"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magiorakos</surname> <given-names>A. P.</given-names></name> <name><surname>Srinivasan</surname> <given-names>A.</given-names></name> <name><surname>Carey</surname> <given-names>R. B.</given-names></name> <name><surname>Carmeli</surname> <given-names>Y.</given-names></name> <name><surname>Falagas</surname> <given-names>M. E.</given-names></name> <name><surname>Giske</surname> <given-names>C. G.</given-names></name> <name><surname>Harbarth</surname> <given-names>S.</given-names></name> <name><surname>Hindler</surname> <given-names>J. F.</given-names></name> <name><surname>Kahlmeter</surname> <given-names>G.</given-names></name> <name><surname>Olsson-Liljequist</surname> <given-names>B.</given-names></name> <name><surname>Paterson</surname> <given-names>D. L.</given-names></name> <name><surname>Rice</surname> <given-names>L. B.</given-names></name> <name><surname>Stelling</surname> <given-names>J.</given-names></name> <name><surname>Struelens</surname> <given-names>M. J.</given-names></name> <name><surname>Vatopoulos</surname> <given-names>A.</given-names></name> <name><surname>Weber</surname> <given-names>J. T.</given-names></name> <name><surname>Monnet</surname> <given-names>D. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>18</volume>, <fpage>268</fpage>&#x02013;<lpage>281</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03570.x</pub-id><pub-id pub-id-type="pmid">21793988</pub-id></citation></ref>
<ref id="B184"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magnet</surname> <given-names>S.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name> <name><surname>Lambert</surname> <given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in <italic>Acinetobacter baumannii</italic> strain BM4454</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>45</volume>, <fpage>3375</fpage>&#x02013;<lpage>3380</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.45.12.3375-3380.2001</pub-id><pub-id pub-id-type="pmid">11709311</pub-id></citation></ref>
<ref id="B185"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maisetta</surname> <given-names>G.</given-names></name> <name><surname>Batoni</surname> <given-names>G.</given-names></name> <name><surname>Esin</surname> <given-names>S.</given-names></name> <name><surname>Florio</surname> <given-names>W.</given-names></name> <name><surname>Bottai</surname> <given-names>D.</given-names></name> <name><surname>Favilli</surname> <given-names>F.</given-names></name> <name><surname>Campa</surname> <given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>50</volume>, <fpage>806</fpage>&#x02013;<lpage>809</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.50.2.806-809.2006</pub-id><pub-id pub-id-type="pmid">16436752</pub-id></citation></ref>
<ref id="B186"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname> <given-names>J. K.</given-names></name> <name><surname>Kim</surname> <given-names>M. J.</given-names></name> <name><surname>Pham</surname> <given-names>J.</given-names></name> <name><surname>Tapsall</surname> <given-names>J.</given-names></name> <name><surname>White</surname> <given-names>P. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Antibiotic resistance determinants in nosocomial strains of multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>63</volume>, <fpage>47</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkn454</pub-id><pub-id pub-id-type="pmid">18988680</pub-id></citation></ref>
<ref id="B187"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mammeri</surname> <given-names>H.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Mangeney</surname> <given-names>N.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Chromosomal integration of a cephalosporinase gene from <italic>Acinetobacter baumannii</italic> into <italic>Oligella urethralis</italic> as a source of acquired resistance to &#x003B2;-lactams</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>47</volume>, <fpage>1536</fpage>&#x02013;<lpage>1542</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.47.12.3739-3742.2003</pub-id><pub-id pub-id-type="pmid">12709319</pub-id></citation></ref>
<ref id="B188"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mangoni</surname> <given-names>M. L.</given-names></name> <name><surname>Maisetta</surname> <given-names>G.</given-names></name> <name><surname>Di Luca</surname> <given-names>M.</given-names></name> <name><surname>Gaddi</surname> <given-names>L. M.</given-names></name> <name><surname>Esin</surname> <given-names>S.</given-names></name> <name><surname>Florio</surname> <given-names>W.</given-names></name> <name><surname>Brancatisano</surname> <given-names>F. L.</given-names></name> <name><surname>Barra</surname> <given-names>D.</given-names></name> <name><surname>Campa</surname> <given-names>M.</given-names></name> <name><surname>Batoni</surname> <given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>85</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00796-07</pub-id><pub-id pub-id-type="pmid">17954700</pub-id></citation></ref>
<ref id="B189"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchand</surname> <given-names>I.</given-names></name> <name><surname>Damier-Piolle</surname> <given-names>L.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name> <name><surname>Lambert</surname> <given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Expression of the RND-type efflux pump AdeABC in <italic>Acinetobacter baumannii</italic> is regulated by the AdeRS two-component system</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>48</volume>, <fpage>3298</fpage>&#x02013;<lpage>3304</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.48.9.3298-3304.2004</pub-id><pub-id pub-id-type="pmid">15328088</pub-id></citation></ref>
<ref id="B190"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marqu&#x000E9;</surname> <given-names>S.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>H&#x000E9;ritier</surname> <given-names>C.</given-names></name> <name><surname>Brisse</surname> <given-names>S.</given-names></name> <name><surname>Blasco</surname> <given-names>M. D.</given-names></name> <name><surname>Filip</surname> <given-names>R.</given-names></name> <name><surname>Coman</surname> <given-names>G.</given-names></name> <name><surname>Naas</surname> <given-names>T.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in <italic>Acinetobacter</italic> spp. in Europe</article-title>. <source>J. Clin. Microbiol.</source> <volume>43</volume>, <fpage>4885</fpage>&#x02013;<lpage>4888</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.43.9.4885-4888.2005</pub-id><pub-id pub-id-type="pmid">16145167</pub-id></citation></ref>
<ref id="B191"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marr</surname> <given-names>A. K.</given-names></name> <name><surname>Gooderham</surname> <given-names>W. J.</given-names></name> <name><surname>Hancock</surname> <given-names>R. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Antibacterial peptides for therapeutic use: obstacles and realistic outlook</article-title>. <source>Curr. Opin. Pharmacol.</source> <volume>6</volume>, <fpage>468</fpage>&#x02013;<lpage>472</lpage>.<pub-id pub-id-type="doi">10.1016/j.coph.2006.04.006</pub-id><pub-id pub-id-type="pmid">16890021</pub-id></citation></ref>
<ref id="B192"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ED;</surname> <given-names>S.</given-names></name> <name><surname>Fern&#x000E1;ndez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Pascual</surname> <given-names>A.</given-names></name> <name><surname>Ribera</surname> <given-names>A.</given-names></name> <name><surname>Rodr&#x000ED;guez-Ba&#x000F1;o</surname> <given-names>J.</given-names></name> <name><surname>Bou</surname> <given-names>G.</given-names></name> <name><surname>Miguel Cisneros</surname> <given-names>J.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name> <name><surname>Mart&#x000ED;nez-Mart&#x000ED;nez</surname> <given-names>L.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in <italic>Acinetobacter baumannii</italic> clinical isolates</article-title>. <source>Enferm. Infecc. Microbiol. Clin.</source> <volume>24</volume>, <fpage>77</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1157/13085012</pub-id><pub-id pub-id-type="pmid">16545313</pub-id></citation></ref>
<ref id="B193"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ED;</surname> <given-names>S.</given-names></name> <name><surname>S&#x000E1;nchez-C&#x000E9;spedes</surname> <given-names>J.</given-names></name> <name><surname>Blasco</surname> <given-names>M. D.</given-names></name> <name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Ruiz</surname> <given-names>M.</given-names></name> <name><surname>Alba</surname> <given-names>V.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2008a</year>). <article-title>Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an <italic>Acinetobacter phenon</italic> 6/ct13TU clinical isolate</article-title>. <source>Diagn. Microbiol. Infect. Dis.</source> <volume>61</volume>, <fpage>468</fpage>&#x02013;<lpage>470</lpage>.<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2008.03.014</pub-id></citation></ref>
<ref id="B194"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ED;</surname> <given-names>S.</given-names></name> <name><surname>S&#x000E1;nchez-C&#x000E9;spedes</surname> <given-names>J.</given-names></name> <name><surname>Blasco</surname> <given-names>M. D.</given-names></name> <name><surname>Ruiz</surname> <given-names>M.</given-names></name> <name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Alba</surname> <given-names>V.</given-names></name> <name><surname>Fern&#x000E1;ndez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Pascual</surname> <given-names>A.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2008b</year>). <article-title>Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an <italic>Acinetobacter</italic> genospecies 3 clinical isolate</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>2955</fpage>&#x02013;<lpage>2958</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00072-08</pub-id></citation></ref>
<ref id="B195"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattick</surname> <given-names>J. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Type IV pili and twitching motility</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>56</volume>, <fpage>289</fpage>&#x02013;<lpage>314</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.micro.56.012302.160938</pub-id><pub-id pub-id-type="pmid">12142488</pub-id></citation></ref>
<ref id="B196"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazel</surname> <given-names>D.</given-names></name></person-group> (<year>2006</year>). <article-title>Integrons: agents of bacterial evolution</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>4</volume>, <fpage>608</fpage>&#x02013;<lpage>620</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro1462</pub-id><pub-id pub-id-type="pmid">16845431</pub-id></citation></ref>
<ref id="B197"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname> <given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Shining a light on an opportunistic pathogen</article-title>. <source>J. Bacteriol.</source> <volume>192</volume>, <fpage>6325</fpage>&#x02013;<lpage>6326</lpage>.<pub-id pub-id-type="doi">10.1128/JB.01141-10</pub-id><pub-id pub-id-type="pmid">20952570</pub-id></citation></ref>
<ref id="B198"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McConnell</surname> <given-names>M. J.</given-names></name> <name><surname>Dom&#x000ED;nguez-Herrera</surname> <given-names>J.</given-names></name> <name><surname>Smani</surname> <given-names>Y.</given-names></name> <name><surname>L&#x000F3;pez-Rojas</surname> <given-names>R.</given-names></name> <name><surname>Docobo-P&#x000E9;rez</surname> <given-names>F.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2011a</year>). <article-title>Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Infect. Immun.</source> <volume>79</volume>, <fpage>518</fpage>&#x02013;<lpage>526</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00741-10</pub-id></citation></ref>
<ref id="B199"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McConnell</surname> <given-names>M. J.</given-names></name> <name><surname>Rumbo</surname> <given-names>C.</given-names></name> <name><surname>Bou</surname> <given-names>G.</given-names></name> <name><surname>Pachon</surname> <given-names>J.</given-names></name></person-group> (<year>2011b</year>). <article-title>Outer membrane vesicles as an acellular vaccine against <italic>Acinetobacter baumannii</italic></article-title>. <source>Vaccine</source> <volume>29</volume>, <fpage>5705</fpage>&#x02013;<lpage>5710</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2011.06.001</pub-id></citation></ref>
<ref id="B200"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKean</surname> <given-names>S. C.</given-names></name> <name><surname>Davies</surname> <given-names>J. K.</given-names></name> <name><surname>Moore</surname> <given-names>R. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Expression of phospholipase D, the major virulence factor of <italic>Corynebacterium pseudotuberculosis</italic>, is regulated by multiple environmental factors and plays a role in macrophage death</article-title>. <source>Microbiology</source> <volume>153</volume>, <fpage>2203</fpage>&#x02013;<lpage>2211</lpage>.<pub-id pub-id-type="doi">10.1099/mic.0.2007/005926-0</pub-id><pub-id pub-id-type="pmid">17600064</pub-id></citation></ref>
<ref id="B201"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>H.</given-names></name> <name><surname>Kumar</surname> <given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Antimicrobial activity and protease stability of peptides containing fluorinated amino acids</article-title>. <source>J. Am. Chem. Soc.</source> <volume>129</volume>, <fpage>15615</fpage>&#x02013;<lpage>15622</lpage>.<pub-id pub-id-type="doi">10.1021/ja075373f</pub-id><pub-id pub-id-type="pmid">18041836</pub-id></citation></ref>
<ref id="B202"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merino</surname> <given-names>M.</given-names></name> <name><surname>Acosta</surname> <given-names>J.</given-names></name> <name><surname>Poza</surname> <given-names>M.</given-names></name> <name><surname>Sanz</surname> <given-names>F.</given-names></name> <name><surname>Beceiro</surname> <given-names>A.</given-names></name> <name><surname>Chaves</surname> <given-names>F.</given-names></name> <name><surname>Bou</surname> <given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different <italic>Acinetobacter</italic> species isolated during a nosocomial outbreak</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>2724</fpage>&#x02013;<lpage>2727</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01674-09</pub-id><pub-id pub-id-type="pmid">20385865</pub-id></citation></ref>
<ref id="B203"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mihara</surname> <given-names>K.</given-names></name> <name><surname>Tanabe</surname> <given-names>T.</given-names></name> <name><surname>Yamakawa</surname> <given-names>Y.</given-names></name> <name><surname>Funahashi</surname> <given-names>T.</given-names></name> <name><surname>Nakao</surname> <given-names>H.</given-names></name> <name><surname>Narimatsu</surname> <given-names>S.</given-names></name> <name><surname>Yamamoto</surname> <given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by <italic>Acinetobacter baumannii</italic> ATCC 19606T</article-title>. <source>Microbiology</source> <volume>150</volume>, <fpage>2587</fpage>&#x02013;<lpage>2597</lpage>.<pub-id pub-id-type="doi">10.1099/mic.0.27141-0</pub-id><pub-id pub-id-type="pmid">15289555</pub-id></citation></ref>
<ref id="B204"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moffatt</surname> <given-names>J. H.</given-names></name> <name><surname>Harper</surname> <given-names>M.</given-names></name> <name><surname>Adler</surname> <given-names>B.</given-names></name> <name><surname>Nation</surname> <given-names>R. L.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Boyce</surname> <given-names>J. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>3022</fpage>&#x02013;<lpage>3024</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01732-10</pub-id><pub-id pub-id-type="pmid">21402838</pub-id></citation></ref>
<ref id="B205"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moffatt</surname> <given-names>J. H.</given-names></name> <name><surname>Harper</surname> <given-names>M.</given-names></name> <name><surname>Harrison</surname> <given-names>P.</given-names></name> <name><surname>Hale</surname> <given-names>J. D.</given-names></name> <name><surname>Vinogradov</surname> <given-names>E.</given-names></name> <name><surname>Seemann</surname> <given-names>T.</given-names></name> <name><surname>Henry</surname> <given-names>R.</given-names></name> <name><surname>Crane</surname> <given-names>B.</given-names></name> <name><surname>St Michael</surname> <given-names>F.</given-names></name> <name><surname>Cox</surname> <given-names>A. D.</given-names></name> <name><surname>Adler</surname> <given-names>B.</given-names></name> <name><surname>Nation</surname> <given-names>R. L.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Boyce</surname> <given-names>J. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Colistin resistance in <italic>Acinetobacter baumannii</italic> is mediated by complete loss of lipopolysaccharide production</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>4971</fpage>&#x02013;<lpage>4977</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00834-10</pub-id><pub-id pub-id-type="pmid">20855724</pub-id></citation></ref>
<ref id="B206"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molhoek</surname> <given-names>E. M.</given-names></name> <name><surname>van Dijk</surname> <given-names>A.</given-names></name> <name><surname>Veldhuizen</surname> <given-names>E. J.</given-names></name> <name><surname>Haagsman</surname> <given-names>H. P.</given-names></name> <name><surname>Bikker</surname> <given-names>F. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Improved proteolytic stability of chicken cathelicidin-2 derived peptides by d-amino acid substitutions and cyclization</article-title>. <source>Peptides</source> <volume>32</volume>, <fpage>875</fpage>&#x02013;<lpage>880</lpage>.<pub-id pub-id-type="doi">10.1016/j.peptides.2011.02.017</pub-id><pub-id pub-id-type="pmid">21376095</pub-id></citation></ref>
<ref id="B207"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname> <given-names>D. J.</given-names></name> <name><surname>Weisenberg</surname> <given-names>S. A.</given-names></name> <name><surname>Augenbraun</surname> <given-names>M. H.</given-names></name> <name><surname>Calfee</surname> <given-names>D. P.</given-names></name> <name><surname>Currie</surname> <given-names>B. P.</given-names></name> <name><surname>Furuya</surname> <given-names>E. Y.</given-names></name> <name><surname>Holzman</surname> <given-names>R.</given-names></name> <name><surname>Montecalvo</surname> <given-names>M. C.</given-names></name> <name><surname>Phillips</surname> <given-names>M.</given-names></name> <name><surname>Polsky</surname> <given-names>B.</given-names></name> <name><surname>Sepkowitz</surname> <given-names>K. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Multidrug-resistant <italic>Acinetobacter baumannii</italic> in New York City &#x02013; 10 years into the epidemic</article-title>. <source>Infect. Control Hosp. Epidemiol.</source> <volume>30</volume>, <fpage>196</fpage>&#x02013;<lpage>197</lpage>.<pub-id pub-id-type="doi">10.1086/593207</pub-id><pub-id pub-id-type="pmid">19146464</pub-id></citation></ref>
<ref id="B208"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Motsch</surname> <given-names>S.</given-names></name> <name><surname>Schmitt</surname> <given-names>R.</given-names></name> <name><surname>Avila</surname> <given-names>P.</given-names></name> <name><surname>de la Cruz</surname> <given-names>F.</given-names></name> <name><surname>Ward</surname> <given-names>E.</given-names></name> <name><surname>Grinsted</surname> <given-names>J.</given-names></name></person-group> (<year>1985</year>). <article-title>Junction sequences generated by &#x02018;one-ended transposition.&#x02019;</article-title> <source>Nucleic Acids Res.</source> <volume>13</volume>, <fpage>3335</fpage>&#x02013;<lpage>3342</lpage>.<pub-id pub-id-type="doi">10.1093/nar/13.9.3335</pub-id><pub-id pub-id-type="pmid">2987883</pub-id></citation></ref>
<ref id="B209"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moubareck</surname> <given-names>C.</given-names></name> <name><surname>Bremont</surname> <given-names>S.</given-names></name> <name><surname>Conroy</surname> <given-names>M. C.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name> <name><surname>Lambert</surname> <given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>GES-11, a novel integron-associated GES variant in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>3579</fpage>&#x02013;<lpage>3581</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00338-09</pub-id><pub-id pub-id-type="pmid">19451292</pub-id></citation></ref>
<ref id="B210"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mussi</surname> <given-names>M. A.</given-names></name> <name><surname>Limansky</surname> <given-names>A. S.</given-names></name> <name><surname>Viale</surname> <given-names>A. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of <italic>Acinetobacter baumannii</italic>: natural insertional inactivation of a gene encoding a member of a novel family of &#x003B2;-barrel outer membrane proteins</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>1432</fpage>&#x02013;<lpage>1440</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.4.1432-1440.2005</pub-id><pub-id pub-id-type="pmid">15793123</pub-id></citation></ref>
<ref id="B211"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naas</surname> <given-names>T.</given-names></name> <name><surname>Bogaerts</surname> <given-names>P.</given-names></name> <name><surname>Bauraing</surname> <given-names>C.</given-names></name> <name><surname>Degheldre</surname> <given-names>Y.</given-names></name> <name><surname>Glupczynski</surname> <given-names>Y.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2006a</year>). <article-title>Emergence of PER and VEB extended-spectrum &#x003B2;-lactamases in <italic>Acinetobacter baumannii</italic> in Belgium</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>58</volume>, <fpage>178</fpage>&#x02013;<lpage>182</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkl178</pub-id></citation></ref>
<ref id="B212"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naas</surname> <given-names>T.</given-names></name> <name><surname>Coignard</surname> <given-names>B.</given-names></name> <name><surname>Carbonne</surname> <given-names>A.</given-names></name> <name><surname>Blanckaert</surname> <given-names>K.</given-names></name> <name><surname>Bajolet</surname> <given-names>O.</given-names></name> <name><surname>Bernet</surname> <given-names>C.</given-names></name> <name><surname>Verdeil</surname> <given-names>X.</given-names></name> <name><surname>Astagneau</surname> <given-names>P.</given-names></name> <name><surname>Desenclos</surname> <given-names>J. C.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2006b</year>). <article-title>VEB-1 extended-spectrum &#x003B2;-lactamase-producing <italic>Acinetobacter baumannii</italic>, France</article-title>. <source>Emerging Infect. Dis.</source> <volume>12</volume>, <fpage>1214</fpage>&#x02013;<lpage>1222</lpage>.<pub-id pub-id-type="doi">10.3201/eid1708.051547</pub-id></citation></ref>
<ref id="B213"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naas</surname> <given-names>T.</given-names></name> <name><surname>Namdari</surname> <given-names>F.</given-names></name> <name><surname>Reglier-Poupet</surname> <given-names>H.</given-names></name> <name><surname>Poyart</surname> <given-names>C.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Panresistant extended-spectrum &#x003B2;-lactamase SHV-5-producing <italic>Acinetobacter baumannii</italic> from New York City</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>60</volume>, <fpage>1174</fpage>&#x02013;<lpage>1176</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkm366</pub-id><pub-id pub-id-type="pmid">17881631</pub-id></citation></ref>
<ref id="B214"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naas</surname> <given-names>T.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Minor extended-spectrum &#x003B2;-lactamases</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>14</volume>(<issue>Suppl. 1</issue>), <fpage>42</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01861.x</pub-id><pub-id pub-id-type="pmid">18154527</pub-id></citation></ref>
<ref id="B215"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname> <given-names>N.</given-names></name> <name><surname>Nagano</surname> <given-names>Y.</given-names></name> <name><surname>Cordevant</surname> <given-names>C.</given-names></name> <name><surname>Shibata</surname> <given-names>N.</given-names></name> <name><surname>Arakawa</surname> <given-names>Y.</given-names></name></person-group> (<year>2004</year>). <article-title>Nosocomial transmission of CTX-M-2 &#x003B2;-lactamase-producing <italic>Acinetobacter baumannii</italic> in a neurosurgery ward</article-title>. <source>J. Clin. Microbiol.</source> <volume>42</volume>, <fpage>3978</fpage>&#x02013;<lpage>3984</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.42.9.3978-3984.2004</pub-id><pub-id pub-id-type="pmid">15364979</pub-id></citation></ref>
<ref id="B216"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naiemi</surname> <given-names>N. A.</given-names></name> <name><surname>Duim</surname> <given-names>B.</given-names></name> <name><surname>Savelkoul</surname> <given-names>P. H.</given-names></name> <name><surname>Spanjaard</surname> <given-names>L.</given-names></name> <name><surname>de Jonge</surname> <given-names>E.</given-names></name> <name><surname>Bart</surname> <given-names>A.</given-names></name> <name><surname>Vandenbroucke-Grauls</surname> <given-names>C. M.</given-names></name> <name><surname>de Jong</surname> <given-names>M. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology</article-title>. <source>J. Clin. Microbiol.</source> <volume>43</volume>, <fpage>4862</fpage>&#x02013;<lpage>4864</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.43.9.4862-4864.2005</pub-id><pub-id pub-id-type="pmid">16145160</pub-id></citation></ref>
<ref id="B217"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Navia</surname> <given-names>M. M.</given-names></name> <name><surname>Ruiz</surname> <given-names>J.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Characterization of an integron carrying a new class D &#x003B2;-lactamase (OXA-37) in <italic>Acinetobacter baumannii</italic></article-title>. <source>Microb. Drug Resist.</source> <volume>8</volume>, <fpage>261</fpage>&#x02013;<lpage>265</lpage>.<pub-id pub-id-type="doi">10.1089/10766290260469516</pub-id><pub-id pub-id-type="pmid">12523622</pub-id></citation></ref>
<ref id="B218"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemec</surname> <given-names>A.</given-names></name> <name><surname>Dolzani</surname> <given-names>L.</given-names></name> <name><surname>Brisse</surname> <given-names>S.</given-names></name> <name><surname>van den Broek</surname> <given-names>P.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name></person-group> (<year>2004</year>). <article-title>Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European <italic>Acinetobacter baumannii</italic> clones</article-title>. <source>J. Med. Microbiol.</source> <volume>53</volume>, <fpage>1233</fpage>&#x02013;<lpage>1240</lpage>.<pub-id pub-id-type="doi">10.1099/jmm.0.45716-0</pub-id><pub-id pub-id-type="pmid">15585503</pub-id></citation></ref>
<ref id="B219"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemec</surname> <given-names>A.</given-names></name> <name><surname>Krizova</surname> <given-names>L.</given-names></name> <name><surname>Maixnerova</surname> <given-names>M.</given-names></name> <name><surname>van der Reijden</surname> <given-names>T. J.</given-names></name> <name><surname>Deschaght</surname> <given-names>P.</given-names></name> <name><surname>Passet</surname> <given-names>V.</given-names></name> <name><surname>Vaneechoutte</surname> <given-names>M.</given-names></name> <name><surname>Brisse</surname> <given-names>S.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Genotypic and phenotypic characterization of the <italic>Acinetobacter calcoaceticus</italic>-<italic>Acinetobacter baumannii</italic> complex with the proposal of <italic>Acinetobacter pittii</italic> sp. nov. (formerly <italic>Acinetobacter</italic> genomic species 3) and <italic>Acinetobacter nosocomialis</italic> sp. nov. (formerly <italic>Acinetobacter</italic> genomic species 13TU)</article-title>. <source>Res. Microbiol.</source> <volume>162</volume>, <fpage>393</fpage>&#x02013;<lpage>404</lpage>.<pub-id pub-id-type="doi">10.1016/j.resmic.2011.02.006</pub-id><pub-id pub-id-type="pmid">21320596</pub-id></citation></ref>
<ref id="B220"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemec</surname> <given-names>A.</given-names></name> <name><surname>Maixnerova</surname> <given-names>M.</given-names></name> <name><surname>van der Reijden</surname> <given-names>T. J.</given-names></name> <name><surname>van den Broek</surname> <given-names>P. J.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of <italic>Acinetobacter baumannii</italic> strains</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>60</volume>, <fpage>483</fpage>&#x02013;<lpage>489</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkm231</pub-id><pub-id pub-id-type="pmid">17595288</pub-id></citation></ref>
<ref id="B221"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nigro</surname> <given-names>S. J.</given-names></name> <name><surname>Post</surname> <given-names>V.</given-names></name> <name><surname>Hall</surname> <given-names>R. M.</given-names></name></person-group> (<year>2011a</year>). <article-title>Aminoglycoside resistance in multiply antibiotic-resistant <italic>Acinetobacter baumannii</italic> belonging to global clone 2 from Australian hospitals</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1504</fpage>&#x02013;<lpage>1509</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr230</pub-id></citation></ref>
<ref id="B222"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nigro</surname> <given-names>S. J.</given-names></name> <name><surname>Post</surname> <given-names>V.</given-names></name> <name><surname>Hall</surname> <given-names>R. M.</given-names></name></person-group> (<year>2011b</year>). <article-title>The multiresistant <italic>Acinetobacter baumannii</italic> European clone I type strain RUH875 (A297) carries a genomic antibiotic resistance island AbaR21, plasmid pRAY and a cluster containing ISAba1-sul2-CR2-strB-strA</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1928</fpage>&#x02013;<lpage>1930</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr230</pub-id></citation></ref>
<ref id="B223"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname> <given-names>C.</given-names></name> <name><surname>Clemmer</surname> <given-names>K. M.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name> <name><surname>Rather</surname> <given-names>P. N.</given-names></name></person-group> (<year>2008</year>). <article-title>Isolation and characterization of an autoinducer synthase from <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Bacteriol.</source> <volume>190</volume>, <fpage>3386</fpage>&#x02013;<lpage>3392</lpage>.<pub-id pub-id-type="doi">10.1128/JB.00967-08</pub-id><pub-id pub-id-type="pmid">18281398</pub-id></citation></ref>
<ref id="B224"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Couard</surname> <given-names>J. P.</given-names></name> <name><surname>Sansot</surname> <given-names>D.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Emergence of an autochthonous and community-acquired NDM-1-producing <italic>Klebsiella pneumoniae</italic> in Europe</article-title>. <source>Clin. Infect. Dis.</source> <volume>54</volume>, <fpage>150</fpage>&#x02013;<lpage>151</lpage>.<pub-id pub-id-type="doi">10.1093/cid/cir720</pub-id><pub-id pub-id-type="pmid">21960718</pub-id></citation></ref>
<ref id="B225"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Toleman</surname> <given-names>M. A.</given-names></name> <name><surname>Walsh</surname> <given-names>T. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Does broad-spectrum &#x003B2;-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?</article-title> <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>689</fpage>&#x02013;<lpage>692</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr056</pub-id><pub-id pub-id-type="pmid">21393184</pub-id></citation></ref>
<ref id="B226"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ostorhazi</surname> <given-names>E.</given-names></name> <name><surname>Holub</surname> <given-names>M. C.</given-names></name> <name><surname>Rozgonyi</surname> <given-names>F.</given-names></name> <name><surname>Harmos</surname> <given-names>F.</given-names></name> <name><surname>Cassone</surname> <given-names>M.</given-names></name> <name><surname>Wade</surname> <given-names>J. D.</given-names></name> <name><surname>Otvos</surname> <given-names>L.</given-names> <suffix>Jr.</suffix></name></person-group> (<year>2011</year>). <article-title>Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>37</volume>, <fpage>480</fpage>&#x02013;<lpage>484</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2011.01.003</pub-id><pub-id pub-id-type="pmid">21353493</pub-id></citation></ref>
<ref id="B227"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ostorhazi</surname> <given-names>E.</given-names></name> <name><surname>Rozgonyi</surname> <given-names>F.</given-names></name> <name><surname>Sztodola</surname> <given-names>A.</given-names></name> <name><surname>Harmos</surname> <given-names>F.</given-names></name> <name><surname>Kovalszky</surname> <given-names>I.</given-names></name> <name><surname>Szabo</surname> <given-names>D.</given-names></name> <name><surname>Knappe</surname> <given-names>D.</given-names></name> <name><surname>Hoffmann</surname> <given-names>R.</given-names></name> <name><surname>Cassone</surname> <given-names>M.</given-names></name> <name><surname>Wade</surname> <given-names>J. D.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name> <name><surname>Otvos</surname> <given-names>L.</given-names> <suffix>Jr.</suffix></name></person-group> (<year>2010</year>). <article-title>Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in <italic>Acinetobacter baumannii</italic> wound infections</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>65</volume>, <fpage>2416</fpage>&#x02013;<lpage>2422</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkq337</pub-id><pub-id pub-id-type="pmid">20810424</pub-id></citation></ref>
<ref id="B228"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozbek</surname> <given-names>B.</given-names></name> <name><surname>Senturk</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against <italic>Acinetobacter baumannii</italic></article-title>. <source>Chemotherapy</source> <volume>56</volume>, <fpage>466</fpage>&#x02013;<lpage>471</lpage>.<pub-id pub-id-type="doi">10.1159/000321015</pub-id><pub-id pub-id-type="pmid">21088399</pub-id></citation></ref>
<ref id="B229"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pach&#x000F3;n-Ib&#x000E1;nez</surname> <given-names>M. E.</given-names></name> <name><surname>Docobo-Per&#x000E9;z</surname> <given-names>F.</given-names></name> <name><surname>L&#x000F3;pez-Rojas</surname> <given-names>R.</given-names></name> <name><surname>Dom&#x000ED;nguez-Herrera</surname> <given-names>J.</given-names></name> <name><surname>Jim&#x000E9;nez-Mejias</surname> <given-names>M. E.</given-names></name> <name><surname>Garc&#x000ED;a-Curiel</surname> <given-names>A.</given-names></name> <name><surname>Pichardo</surname> <given-names>C.</given-names></name> <name><surname>Jim&#x000E9;nez</surname> <given-names>L.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>1165</fpage>&#x02013;<lpage>1172</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00367-09</pub-id><pub-id pub-id-type="pmid">20047914</pub-id></citation></ref>
<ref id="B230"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pach&#x000F3;n-Ib&#x000E1;&#x000F1;ez</surname> <given-names>M. E.</given-names></name> <name><surname>Fern&#x000E1;ndez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Docobo-P&#x000E9;rez</surname> <given-names>F.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name> <name><surname>Pascual</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Prevention of rifampicin resistance in <italic>Acinetobacter baumannii</italic> in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>58</volume>, <fpage>689</fpage>&#x02013;<lpage>692</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkl303</pub-id><pub-id pub-id-type="pmid">16870647</pub-id></citation></ref>
<ref id="B231"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pantophlet</surname> <given-names>R.</given-names></name> <name><surname>Brade</surname> <given-names>L.</given-names></name> <name><surname>Dijkshoorn</surname> <given-names>L.</given-names></name> <name><surname>Brade</surname> <given-names>H.</given-names></name></person-group> (<year>1998</year>). <article-title>Specificity of rabbit antisera against lipopolysaccharide of <italic>Acinetobacter</italic></article-title>. <source>J. Clin. Microbiol.</source> <volume>36</volume>, <fpage>1245</fpage>&#x02013;<lpage>1250</lpage>.<pub-id pub-id-type="pmid">9574685</pub-id></citation></ref>
<ref id="B232"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papa</surname> <given-names>A.</given-names></name> <name><surname>Koulourida</surname> <given-names>V.</given-names></name> <name><surname>Souliou</surname> <given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular epidemiology of carbapenem-resistant <italic>Acinetobacter baumannii</italic> in a newly established Greek hospital</article-title>. <source>Microb. Drug Resist.</source> <volume>15</volume>, <fpage>257</fpage>&#x02013;<lpage>260</lpage>.<pub-id pub-id-type="doi">10.1089/mdr.2009.0060</pub-id><pub-id pub-id-type="pmid">19857131</pub-id></citation></ref>
<ref id="B233"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>Y. K.</given-names></name> <name><surname>Jung</surname> <given-names>S. I.</given-names></name> <name><surname>Park</surname> <given-names>K. H.</given-names></name> <name><surname>Cheong</surname> <given-names>H. S.</given-names></name> <name><surname>Peck</surname> <given-names>K. R.</given-names></name> <name><surname>Song</surname> <given-names>J. H.</given-names></name> <name><surname>Ko</surname> <given-names>K. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Independent emergence of colistin-resistant <italic>Acinetobacter</italic> spp. isolates from Korea</article-title>. <source>Diagn. Microbiol. Infect. Dis.</source> <volume>64</volume>, <fpage>43</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2009.01.012</pub-id><pub-id pub-id-type="pmid">19362258</pub-id></citation></ref>
<ref id="B234"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paster&#x000E1;n</surname> <given-names>F.</given-names></name> <name><surname>Rapoport</surname> <given-names>M.</given-names></name> <name><surname>Petroni</surname> <given-names>A.</given-names></name> <name><surname>Faccone</surname> <given-names>D.</given-names></name> <name><surname>Corso</surname> <given-names>A.</given-names></name> <name><surname>Galas</surname> <given-names>M.</given-names></name> <name><surname>V&#x000E1;zquez</surname> <given-names>M.</given-names></name> <name><surname>Procopio</surname> <given-names>A.</given-names></name> <name><surname>Tokumoto</surname> <given-names>M.</given-names></name> <name><surname>Cagnoni</surname> <given-names>V.</given-names></name></person-group> (<year>2006</year>). <article-title>Emergence of PER-2 and VEB-1a in <italic>Acinetobacter baumannii</italic> strains in the Americas</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>50</volume>, <fpage>3222</fpage>&#x02013;<lpage>3224</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00284-06</pub-id><pub-id pub-id-type="pmid">16940137</pub-id></citation></ref>
<ref id="B235"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paton</surname> <given-names>R.</given-names></name> <name><surname>Miles</surname> <given-names>R. S.</given-names></name> <name><surname>Hood</surname> <given-names>J.</given-names></name> <name><surname>Amyes</surname> <given-names>S. G.</given-names></name> <name><surname>Miles</surname> <given-names>R. S.</given-names></name> <name><surname>Amyes</surname> <given-names>S. G.</given-names></name></person-group> (<year>1993</year>). <article-title>ARI 1: &#x003B2;-lactamase-mediated imipenem resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>2</volume>, <fpage>81</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/0924-8579(93)90046-8</pub-id><pub-id pub-id-type="pmid">18611526</pub-id></citation></ref>
<ref id="B236"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname> <given-names>D. J.</given-names></name> <name><surname>Gwynn</surname> <given-names>M. N.</given-names></name> <name><surname>Holmes</surname> <given-names>D. J.</given-names></name> <name><surname>Pompliano</surname> <given-names>D. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Drugs for bad bugs: confronting the challenges of antibacterial discovery</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>6</volume>, <fpage>29</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1038/nrd2201</pub-id><pub-id pub-id-type="pmid">17159923</pub-id></citation></ref>
<ref id="B237"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peleg</surname> <given-names>A. Y.</given-names></name> <name><surname>Franklin</surname> <given-names>C.</given-names></name> <name><surname>Walters</surname> <given-names>L. J.</given-names></name> <name><surname>Bell</surname> <given-names>J. M.</given-names></name> <name><surname>Spelman</surname> <given-names>D. W.</given-names></name></person-group> (<year>2006</year>). <article-title>OXA-58 and IMP-4 carbapenem-hydrolyzing &#x003B2;-lactamases in an <italic>Acinetobacter junii</italic> blood culture isolate from Australia</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>50</volume>, <fpage>399</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.50.1.399-400.2006</pub-id><pub-id pub-id-type="pmid">16377723</pub-id></citation></ref>
<ref id="B238"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peleg</surname> <given-names>A. Y.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name> <name><surname>Paterson</surname> <given-names>D. L.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>Acinetobacter baumannii</italic>: emergence of a successful pathogen</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>21</volume>, <fpage>538</fpage>&#x02013;<lpage>582</lpage>.<pub-id pub-id-type="doi">10.1128/CMR.00058-07</pub-id><pub-id pub-id-type="pmid">18625687</pub-id></citation></ref>
<ref id="B239"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname> <given-names>F.</given-names></name> <name><surname>Ponce-Terashima</surname> <given-names>R.</given-names></name> <name><surname>Adams</surname> <given-names>M. D.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Are we closing in on an &#x0201C;elusive enemy?&#x0201D; The current status of our battle with <italic>Acinetobacter baumannii</italic></article-title>. <source>Virulence</source> <volume>2</volume>, <fpage>86</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.4161/viru.2.2.15748</pub-id><pub-id pub-id-type="pmid">21499025</pub-id></citation></ref>
<ref id="B240"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pfeifer</surname> <given-names>Y.</given-names></name> <name><surname>Wilharm</surname> <given-names>G.</given-names></name> <name><surname>Zander</surname> <given-names>E.</given-names></name> <name><surname>Wichelhaus</surname> <given-names>T. A.</given-names></name> <name><surname>Gottig</surname> <given-names>S.</given-names></name> <name><surname>Hunfeld</surname> <given-names>K. P.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name> <name><surname>Witte</surname> <given-names>W.</given-names></name> <name><surname>Higgins</surname> <given-names>P. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular characterization of blaNDM-1 in an <italic>Acinetobacter baumannii</italic> strain isolated in Germany in 2007</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1998</fpage>&#x02013;<lpage>2001</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr256</pub-id><pub-id pub-id-type="pmid">21693460</pub-id></citation></ref>
<ref id="B241"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piddock</surname> <given-names>L. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>19</volume>, <fpage>382</fpage>&#x02013;<lpage>402</lpage>.<pub-id pub-id-type="doi">10.1128/CMR.19.2.382-402.2006</pub-id><pub-id pub-id-type="pmid">16614254</pub-id></citation></ref>
<ref id="B242"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pitart</surname> <given-names>C.</given-names></name> <name><surname>Sol&#x000E9;</surname> <given-names>M.</given-names></name> <name><surname>Roca</surname> <given-names>I.</given-names></name> <name><surname>F&#x000E0;brega</surname> <given-names>A.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name> <name><surname>Marco</surname> <given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 &#x003B2;-lactamase in <italic>Klebsiella pneumoniae</italic> in Spain</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>4398</fpage>&#x02013;<lpage>4401</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00329-11</pub-id><pub-id pub-id-type="pmid">21746954</pub-id></citation></ref>
<ref id="B243"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Cabanne</surname> <given-names>L.</given-names></name> <name><surname>Vahaboglu</surname> <given-names>H.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2005a</year>). <article-title>Genetic environment and expression of the extended-spectrum &#x003B2;-lactamase blaPER-1 gene in Gram-negative bacteria</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>1708</fpage>&#x02013;<lpage>1713</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.9.3743-3748.2005</pub-id></citation></ref>
<ref id="B244"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Marqu&#x000E9;</surname> <given-names>S.</given-names></name> <name><surname>H&#x000E9;ritier</surname> <given-names>C.</given-names></name> <name><surname>Segonds</surname> <given-names>C.</given-names></name> <name><surname>Chabanon</surname> <given-names>G.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2005b</year>). <article-title>OXA-58, a novel class D &#x003B2;-lactamase involved in resistance to carbapenems in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>202</fpage>&#x02013;<lpage>208</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.7.3091-3094.2005</pub-id></citation></ref>
<ref id="B245"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Corvec</surname> <given-names>S.</given-names></name> <name><surname>Rapoport</surname> <given-names>M.</given-names></name> <name><surname>Mugnier</surname> <given-names>P.</given-names></name> <name><surname>Petroni</surname> <given-names>A.</given-names></name> <name><surname>Pasteran</surname> <given-names>F.</given-names></name> <name><surname>Faccone</surname> <given-names>D.</given-names></name> <name><surname>Galas</surname> <given-names>M.</given-names></name> <name><surname>Drugeon</surname> <given-names>H.</given-names></name> <name><surname>Cattoir</surname> <given-names>V.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Identification of the novel narrow-spectrum &#x003B2;-lactamase SCO-1 in <italic>Acinetobacter</italic> spp. from Argentina</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>2179</fpage>&#x02013;<lpage>2184</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01600-06</pub-id><pub-id pub-id-type="pmid">17420213</pub-id></citation></ref>
<ref id="B246"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Dortet</surname> <given-names>L.</given-names></name> <name><surname>Bernabeu</surname> <given-names>S.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2011a</year>). <article-title>Genetic features of blaNDM-1-positive Enterobacteriaceae</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>44</volume>, <fpage>5403</fpage>&#x02013;<lpage>5407</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00585-11</pub-id></citation></ref>
<ref id="B247"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Schrenzel</surname> <given-names>J.</given-names></name> <name><surname>Cherkaoui</surname> <given-names>A.</given-names></name> <name><surname>Bernabeu</surname> <given-names>S.</given-names></name> <name><surname>Renzi</surname> <given-names>G.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2011b</year>). <article-title>Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1730</fpage>&#x02013;<lpage>1733</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkq428</pub-id></citation></ref>
<ref id="B248"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Figueiredo</surname> <given-names>S.</given-names></name> <name><surname>Cattoir</surname> <given-names>V.</given-names></name> <name><surname>Carattoli</surname> <given-names>A.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2008a</year>). <article-title><italic>Acinetobacter radioresistens</italic> as a silent source of carbapenem resistance for <italic>Acinetobacter</italic> spp</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>1252</fpage>&#x02013;<lpage>1256</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00978-07</pub-id></citation></ref>
<ref id="B249"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Mansour</surname> <given-names>W.</given-names></name> <name><surname>Bouallegue</surname> <given-names>O.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2008b</year>). <article-title>Carbapenem-resistant <italic>Acinetobacter baumannii</italic> isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>52</volume>, <fpage>1613</fpage>&#x02013;<lpage>1617</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00978-07</pub-id></citation></ref>
<ref id="B250"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Lagrutta</surname> <given-names>E.</given-names></name> <name><surname>Taylor</surname> <given-names>P.</given-names></name> <name><surname>Pham</surname> <given-names>J.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Emergence of metallo-&#x003B2;-lactamase NDM-1-producing multidrug-resistant <italic>Escherichia coli</italic> in Australia</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>4914</fpage>&#x02013;<lpage>4916</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00859-09</pub-id><pub-id pub-id-type="pmid">20823289</pub-id></citation></ref>
<ref id="B251"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Lebessi</surname> <given-names>E.</given-names></name> <name><surname>H&#x000E9;ritier</surname> <given-names>C.</given-names></name> <name><surname>Patsoura</surname> <given-names>A.</given-names></name> <name><surname>Foustoukou</surname> <given-names>M.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Nosocomial spread of OXA-58-positive carbapenem-resistant <italic>Acinetobacter baumannii</italic> isolates in a paediatric hospital in Greece</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>12</volume>, <fpage>1138</fpage>&#x02013;<lpage>1141</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2006.01531.x</pub-id><pub-id pub-id-type="pmid">17002616</pub-id></citation></ref>
<ref id="B252"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Menuteau</surname> <given-names>O.</given-names></name> <name><surname>Agoli</surname> <given-names>N.</given-names></name> <name><surname>Cattoen</surname> <given-names>C.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Outbreak of extended-spectrum &#x003B2;-lactamase VEB-1-producing isolates of <italic>Acinetobacter baumannii</italic> in a French hospital</article-title>. <source>J. Clin. Microbiol.</source> <volume>41</volume>, <fpage>3542</fpage>&#x02013;<lpage>3547</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.41.8.3542-3547.2003</pub-id><pub-id pub-id-type="pmid">12904353</pub-id></citation></ref>
<ref id="B253"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Mugnier</surname> <given-names>P. D.</given-names></name> <name><surname>Toleman</surname> <given-names>M. A.</given-names></name> <name><surname>Walsh</surname> <given-names>T. R.</given-names></name> <name><surname>Rapoport</surname> <given-names>M. J.</given-names></name> <name><surname>Petroni</surname> <given-names>A.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>ISCR2, another vehicle for blaVEB gene acquisition</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>4940</fpage>&#x02013;<lpage>4943</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00414-09</pub-id><pub-id pub-id-type="pmid">19704129</pub-id></citation></ref>
<ref id="B254"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2006a</year>). <article-title>Carbapenem resistance in <italic>Acinetobacter baumannii</italic>: mechanisms and epidemiology</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>12</volume>, <fpage>826</fpage>&#x02013;<lpage>836</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2006.01531.x</pub-id></citation></ref>
<ref id="B255"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2006b</year>). <article-title>Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>50</volume>, <fpage>1442</fpage>&#x02013;<lpage>1448</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.50.4.1525-1527.2006</pub-id></citation></ref>
<ref id="B256"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Post</surname> <given-names>V.</given-names></name> <name><surname>Hall</surname> <given-names>R. M.</given-names></name></person-group> (<year>2009</year>). <article-title>AbaR5, a large multiple-antibiotic resistance region found in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>2667</fpage>&#x02013;<lpage>2671</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01407-08</pub-id><pub-id pub-id-type="pmid">19364869</pub-id></citation></ref>
<ref id="B257"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Post</surname> <given-names>V.</given-names></name> <name><surname>White</surname> <given-names>P. A.</given-names></name> <name><surname>Hall</surname> <given-names>R. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>65</volume>, <fpage>1162</fpage>&#x02013;<lpage>1170</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkq095</pub-id><pub-id pub-id-type="pmid">20375036</pub-id></citation></ref>
<ref id="B258"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potron</surname> <given-names>A.</given-names></name> <name><surname>Munoz-Price</surname> <given-names>L. S.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Cleary</surname> <given-names>T.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Genetic features of CTX-M-15-producing <italic>Acinetobacter baumannii</italic> from Haiti</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>5946</fpage>&#x02013;<lpage>5948</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.05124-11</pub-id><pub-id pub-id-type="pmid">21930877</pub-id></citation></ref>
<ref id="B259"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potron</surname> <given-names>A.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Croize</surname> <given-names>J.</given-names></name> <name><surname>Chanteperdrix</surname> <given-names>V.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Genetic and biochemical characterization of the first extended-spectrum CARB-type &#x003B2;-lactamase, RTG-4, from <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>3010</fpage>&#x02013;<lpage>3016</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01164-08</pub-id><pub-id pub-id-type="pmid">19380596</pub-id></citation></ref>
<ref id="B260"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pournaras</surname> <given-names>S.</given-names></name> <name><surname>Markogiannakis</surname> <given-names>A.</given-names></name> <name><surname>Ikonomidis</surname> <given-names>A.</given-names></name> <name><surname>Kondyli</surname> <given-names>L.</given-names></name> <name><surname>Bethimouti</surname> <given-names>K.</given-names></name> <name><surname>Maniatis</surname> <given-names>A. N.</given-names></name> <name><surname>Legakis</surname> <given-names>N. J.</given-names></name> <name><surname>Tsakris</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Outbreak of multiple clones of imipenem-resistant <italic>Acinetobacter baumannii</italic> isolates expressing OXA-58 carbapenemase in an intensive care unit</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>57</volume>, <fpage>557</fpage>&#x02013;<lpage>561</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkl004</pub-id><pub-id pub-id-type="pmid">16431857</pub-id></citation></ref>
<ref id="B261"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Principe</surname> <given-names>L.</given-names></name> <name><surname>D&#x02019;Arezzo</surname> <given-names>S.</given-names></name> <name><surname>Capone</surname> <given-names>A.</given-names></name> <name><surname>Petrosillo</surname> <given-names>N.</given-names></name> <name><surname>Visca</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Ann. Clin. Microbiol. Antimicrob.</source> <volume>21</volume>, <fpage>8</fpage>&#x02013;<lpage>18</lpage>.</citation></ref>
<ref id="B262"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname> <given-names>C.</given-names></name> <name><surname>Malczynski</surname> <given-names>M.</given-names></name> <name><surname>Parker</surname> <given-names>M.</given-names></name> <name><surname>Scheetz</surname> <given-names>M. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Characterization of genetic diversity of carbapenem-resistant <italic>Acinetobacter baumannii</italic> clinical strains collected from 2004 to 2007</article-title>. <source>J. Clin. Microbiol.</source> <volume>46</volume>, <fpage>1106</fpage>&#x02013;<lpage>1109</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.01877-07</pub-id><pub-id pub-id-type="pmid">18216212</pub-id></citation></ref>
<ref id="B263"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quale</surname> <given-names>J.</given-names></name> <name><surname>Bratu</surname> <given-names>S.</given-names></name> <name><surname>Landman</surname> <given-names>D.</given-names></name> <name><surname>Heddurshetti</surname> <given-names>R.</given-names></name></person-group> (<year>2003</year>). <article-title>Molecular epidemiology and mechanisms of carbapenem resistance in <italic>Acinetobacter baumannii</italic> endemic in New York City</article-title>. <source>Clin. Infect. Dis.</source> <volume>37</volume>, <fpage>214</fpage>&#x02013;<lpage>220</lpage>.<pub-id pub-id-type="doi">10.1086/375821</pub-id><pub-id pub-id-type="pmid">12856214</pub-id></citation></ref>
<ref id="B264"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Queenan</surname> <given-names>A. M.</given-names></name> <name><surname>Bush</surname> <given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Carbapenemases: the versatile &#x003B2;-lactamases</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>20</volume>, <fpage>440</fpage>&#x02013;<lpage>458</lpage>.<pub-id pub-id-type="doi">10.1128/CMR.00001-07</pub-id><pub-id pub-id-type="pmid">17630334</pub-id></citation></ref>
<ref id="B265"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quinteira</surname> <given-names>S.</given-names></name> <name><surname>Grosso</surname> <given-names>F.</given-names></name> <name><surname>Ramos</surname> <given-names>H.</given-names></name> <name><surname>Peixe</surname> <given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Molecular epidemiology of imipenem-resistant <italic>Acinetobacter haemolyticus</italic> and <italic>Acinetobacter baumannii</italic> isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>3465</fpage>&#x02013;<lpage>3466</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00267-07</pub-id><pub-id pub-id-type="pmid">17606684</pub-id></citation></ref>
<ref id="B266"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajamohan</surname> <given-names>G.</given-names></name> <name><surname>Srinivasan</surname> <given-names>V. B.</given-names></name> <name><surname>Gebreyes</surname> <given-names>W. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>65</volume>, <fpage>1919</fpage>&#x02013;<lpage>1925</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkp427</pub-id><pub-id pub-id-type="pmid">20573661</pub-id></citation></ref>
<ref id="B267"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ED;rez</surname> <given-names>M. S.</given-names></name> <name><surname>Bello</surname> <given-names>H.</given-names></name> <name><surname>Gonz&#x000E1;lez Rocha</surname> <given-names>G.</given-names></name> <name><surname>M&#x000E1;rquez</surname> <given-names>C.</given-names></name> <name><surname>Centr&#x000F3;n</surname> <given-names>D.</given-names></name></person-group> (<year>2010a</year>). <article-title>Tn7::In2-8 dispersion in multidrug resistant isolates of <italic>Acinetobacter baumannii</italic> from Chile</article-title>. <source>Rev. Argent. Microbiol.</source> <volume>42</volume>, <fpage>138</fpage>&#x02013;<lpage>140</lpage>.</citation></ref>
<ref id="B268"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ED;rez</surname> <given-names>M. S.</given-names></name> <name><surname>Pi&#x000F1;eiro</surname> <given-names>S.</given-names></name> <name><surname>Centr&#x000F3;n</surname> <given-names>D.</given-names></name></person-group> (<year>2010b</year>). <article-title>Novel insights about class 2 integrons from experimental and genomic epidemiology</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>54</volume>, <fpage>699</fpage>&#x02013;<lpage>706</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01392-08</pub-id></citation></ref>
<ref id="B269"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasko</surname> <given-names>D. A.</given-names></name> <name><surname>Sperandio</surname> <given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>Anti-virulence strategies to combat bacteria-mediated disease</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>9</volume>, <fpage>117</fpage>&#x02013;<lpage>128</lpage>.<pub-id pub-id-type="doi">10.1038/nrd3013</pub-id><pub-id pub-id-type="pmid">20081869</pub-id></citation></ref>
<ref id="B270"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ravasi</surname> <given-names>P.</given-names></name> <name><surname>Limansky</surname> <given-names>A. S.</given-names></name> <name><surname>Rodriguez</surname> <given-names>R. E.</given-names></name> <name><surname>Viale</surname> <given-names>A. M.</given-names></name> <name><surname>Mussi</surname> <given-names>M. A.</given-names></name></person-group> (<year>2011</year>). <article-title>ISAba825, a functional insertion sequence modulating genomic plasticity and blaOXA-58 expression in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>917</fpage>&#x02013;<lpage>920</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00491-10</pub-id><pub-id pub-id-type="pmid">21098239</pub-id></citation></ref>
<ref id="B271"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribera</surname> <given-names>A.</given-names></name> <name><surname>Roca</surname> <given-names>I.</given-names></name> <name><surname>Ruiz</surname> <given-names>J.</given-names></name> <name><surname>Gibert</surname> <given-names>I.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2003a</year>). <article-title>Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>52</volume>, <fpage>477</fpage>&#x02013;<lpage>480</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkg344</pub-id></citation></ref>
<ref id="B272"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribera</surname> <given-names>A.</given-names></name> <name><surname>Ruiz</surname> <given-names>J.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2003b</year>). <article-title>Presence of the Tet M determinant in a clinical isolate of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>47</volume>, <fpage>2310</fpage>&#x02013;<lpage>2312</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.47.7.2310-2312.2003</pub-id></citation></ref>
<ref id="B273"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riccio</surname> <given-names>M. L.</given-names></name> <name><surname>Franceschini</surname> <given-names>N.</given-names></name> <name><surname>Boschi</surname> <given-names>L.</given-names></name> <name><surname>Caravelli</surname> <given-names>B.</given-names></name> <name><surname>Cornaglia</surname> <given-names>G.</given-names></name> <name><surname>Fontana</surname> <given-names>R.</given-names></name> <name><surname>Amicosante</surname> <given-names>G.</given-names></name> <name><surname>Rossolini</surname> <given-names>G. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Characterization of the metallo-&#x003B2;-lactamase determinant of <italic>Acinetobacter baumannii</italic> AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>44</volume>, <fpage>1229</fpage>&#x02013;<lpage>1235</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.44.5.1229-1235.2000</pub-id><pub-id pub-id-type="pmid">10770756</pub-id></citation></ref>
<ref id="B274"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>A. P.</given-names></name> <name><surname>Chandler</surname> <given-names>M.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name> <name><surname>Guedon</surname> <given-names>G.</given-names></name> <name><surname>Mullany</surname> <given-names>P.</given-names></name> <name><surname>Pembroke</surname> <given-names>T.</given-names></name> <name><surname>Rood</surname> <given-names>J. I.</given-names></name> <name><surname>Smith</surname> <given-names>C. J.</given-names></name> <name><surname>Summers</surname> <given-names>A. O.</given-names></name> <name><surname>Tsuda</surname> <given-names>M.</given-names></name> <name><surname>Berg</surname> <given-names>D. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Revised nomenclature for transposable genetic elements</article-title>. <source>Plasmid</source> <volume>60</volume>, <fpage>167</fpage>&#x02013;<lpage>173</lpage>.<pub-id pub-id-type="doi">10.1016/j.plasmid.2008.08.001</pub-id><pub-id pub-id-type="pmid">18778731</pub-id></citation></ref>
<ref id="B275"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robledo</surname> <given-names>I. E.</given-names></name> <name><surname>Aquino</surname> <given-names>E. E.</given-names></name> <name><surname>Sant&#x000E9;</surname> <given-names>M. I.</given-names></name> <name><surname>Santana</surname> <given-names>J. L.</given-names></name> <name><surname>Otero</surname> <given-names>D. M.</given-names></name> <name><surname>Le&#x000F3;n</surname> <given-names>C. F.</given-names></name> <name><surname>V&#x000E1;zquez</surname> <given-names>G. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Detection of KPC in <italic>Acinetobacter</italic> spp. in Puerto Rico</article-title>. <source>Antimicrob. Agents Chemother</source>. <volume>54</volume>, <fpage>1354</fpage>&#x02013;<lpage>1357</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00899-09</pub-id><pub-id pub-id-type="pmid">20038618</pub-id></citation></ref>
<ref id="B276"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roca</surname> <given-names>I.</given-names></name> <name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Marti</surname> <given-names>S.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>First identification and characterization of an AdeABC-like efflux pump in <italic>Acinetobacter</italic> genomospecies 13TU</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>1285</fpage>&#x02013;<lpage>1286</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01142-10</pub-id><pub-id pub-id-type="pmid">21199925</pub-id></citation></ref>
<ref id="B277"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roca</surname> <given-names>I.</given-names></name> <name><surname>Marti</surname> <given-names>S.</given-names></name> <name><surname>Espinal</surname> <given-names>P.</given-names></name> <name><surname>Martinez</surname> <given-names>P.</given-names></name> <name><surname>Gibert</surname> <given-names>I.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>4013</fpage>&#x02013;<lpage>4014</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00584-09</pub-id><pub-id pub-id-type="pmid">19581458</pub-id></citation></ref>
<ref id="B278"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ED;guez-Ba&#x000F1;o</surname> <given-names>J.</given-names></name> <name><surname>Mart&#x000ED;</surname> <given-names>S.</given-names></name> <name><surname>Soto</surname> <given-names>S.</given-names></name> <name><surname>Fern&#x000E1;ndez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Miguel Cisneros</surname> <given-names>J.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name> <name><surname>Pascual</surname> <given-names>A.</given-names></name> <name><surname>Mart&#x000ED;nez-Mart&#x000ED;nez</surname> <given-names>L.</given-names></name> <name><surname>McQueary</surname> <given-names>C.</given-names></name> <name><surname>Actis</surname> <given-names>L.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name> <collab>Spanish Group for the Study of Nosocomial Infections (GEIH).</collab></person-group> (<year>2008</year>). <article-title>Biofilm formation in <italic>Acinetobacter baumannii</italic>: associated features and clinical implications</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>14</volume>, <fpage>276</fpage>&#x02013;<lpage>278</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01916.x</pub-id></citation></ref>
<ref id="B279"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ED;guez-Hern&#x000E1;ndez</surname> <given-names>M. J.</given-names></name> <name><surname>Cuberos</surname> <given-names>L.</given-names></name> <name><surname>Pichardo</surname> <given-names>C.</given-names></name> <name><surname>Caballero</surname> <given-names>F. J.</given-names></name> <name><surname>Moreno</surname> <given-names>I.</given-names></name> <name><surname>Jim&#x000E9;nez-Mej&#x000ED;as</surname> <given-names>M. E.</given-names></name> <name><surname>Garc&#x000ED;a-Curiel</surname> <given-names>A.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Sulbactam efficacy in experimental models caused by susceptible and intermediate <italic>Acinetobacter baumannii</italic> strains</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>47</volume>, <fpage>479</fpage>&#x02013;<lpage>482</lpage>.<pub-id pub-id-type="doi">10.1093/jac/47.4.479</pub-id><pub-id pub-id-type="pmid">11266426</pub-id></citation></ref>
<ref id="B280"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ED;guez-Hern&#x000E1;ndez</surname> <given-names>M. J.</given-names></name> <name><surname>Saugar</surname> <given-names>J.</given-names></name> <name><surname>Docobo-Per&#x000E9;z</surname> <given-names>F.</given-names></name> <name><surname>de la Torre</surname> <given-names>B. G.</given-names></name> <name><surname>Pach&#x000F3;n-Ib&#x000E1;nez</surname> <given-names>M. E.</given-names></name> <name><surname>Garc&#x000ED;a-Curiel</surname> <given-names>A.</given-names></name> <name><surname>Fern&#x000E1;ndez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Andreu</surname> <given-names>D.</given-names></name> <name><surname>Rivas</surname> <given-names>L.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>58</volume>, <fpage>95</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkl145</pub-id><pub-id pub-id-type="pmid">16636085</pub-id></citation></ref>
<ref id="B281"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rolain</surname> <given-names>J. M.</given-names></name> <name><surname>Roch</surname> <given-names>A.</given-names></name> <name><surname>Castanier</surname> <given-names>M.</given-names></name> <name><surname>Papazian</surname> <given-names>L.</given-names></name> <name><surname>Raoult</surname> <given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Acinetobacter baumannii</italic> resistant to colistin with impaired virulence: a case report from France</article-title>. <source>J. Infect. Dis.</source> <volume>204</volume>, <fpage>1146</fpage>&#x02013;<lpage>1147</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jir475</pub-id><pub-id pub-id-type="pmid">21881132</pub-id></citation></ref>
<ref id="B282"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>TnAbaR1: a novel Tn7-related transposon in <italic>Acinetobacter baumannii</italic> that contributes to the accumulation and dissemination of large repertoires of resistance genes</article-title>. <source>Biosci. Horizons</source> <volume>3</volume>, <fpage>40</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1093/biohorizons/hzq006</pub-id></citation></ref>
<ref id="B283"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossolini</surname> <given-names>G. M.</given-names></name> <name><surname>Mantengoli</surname> <given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>Antimicrobial resistance in Europe and its potential impact on empirical therapy</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>14</volume>(<issue>Suppl. 6</issue>), <fpage>2</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2008.01992.x</pub-id><pub-id pub-id-type="pmid">19040461</pub-id></citation></ref>
<ref id="B284"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname> <given-names>M.</given-names></name> <name><surname>Marti</surname> <given-names>S.</given-names></name> <name><surname>Fernandez-Cuenca</surname> <given-names>F.</given-names></name> <name><surname>Pascual</surname> <given-names>A.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated <italic>Acinetobacter baumannii</italic> clinical isolates in Spain</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>13</volume>, <fpage>1192</fpage>&#x02013;<lpage>1198</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01825.x</pub-id><pub-id pub-id-type="pmid">17850347</pub-id></citation></ref>
<ref id="B285"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rumbo</surname> <given-names>C.</given-names></name> <name><surname>Fernandez-Moreira</surname> <given-names>E.</given-names></name> <name><surname>Merino</surname> <given-names>M.</given-names></name> <name><surname>Poza</surname> <given-names>M.</given-names></name> <name><surname>Mendez</surname> <given-names>J. A.</given-names></name> <name><surname>Soares</surname> <given-names>N. C.</given-names></name> <name><surname>Mosquera</surname> <given-names>A.</given-names></name> <name><surname>Chaves</surname> <given-names>F.</given-names></name> <name><surname>Bou</surname> <given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>3084</fpage>&#x02013;<lpage>3090</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00929-10</pub-id><pub-id pub-id-type="pmid">21518847</pub-id></citation></ref>
<ref id="B286"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname> <given-names>T. A.</given-names></name> <name><surname>Luke</surname> <given-names>N. R.</given-names></name> <name><surname>Beanan</surname> <given-names>J. M.</given-names></name> <name><surname>Olson</surname> <given-names>R.</given-names></name> <name><surname>Sauberan</surname> <given-names>S. L.</given-names></name> <name><surname>MacDonald</surname> <given-names>U.</given-names></name> <name><surname>Schultz</surname> <given-names>L. W.</given-names></name> <name><surname>Umland</surname> <given-names>T. C.</given-names></name> <name><surname>Campagnari</surname> <given-names>A. A.</given-names></name></person-group> (<year>2010</year>). <article-title>The K1 capsular polysaccharide of <italic>Acinetobacter baumannii</italic> strain 307-0294 is a major virulence factor</article-title>. <source>Infect. Immun.</source> <volume>78</volume>, <fpage>3993</fpage>&#x02013;<lpage>4000</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00366-10</pub-id><pub-id pub-id-type="pmid">20643860</pub-id></citation></ref>
<ref id="B287"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname> <given-names>T. A.</given-names></name> <name><surname>MacDonald</surname> <given-names>U.</given-names></name> <name><surname>Beanan</surname> <given-names>J. M.</given-names></name> <name><surname>Olson</surname> <given-names>R.</given-names></name> <name><surname>MacDonald</surname> <given-names>I. J.</given-names></name> <name><surname>Sauberan</surname> <given-names>S. L.</given-names></name> <name><surname>Luke</surname> <given-names>N. R.</given-names></name> <name><surname>Schultz</surname> <given-names>L. W.</given-names></name> <name><surname>Umland</surname> <given-names>T. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Penicillin-binding protein 7/8 contributes to the survival of <italic>Acinetobacter baumannii</italic> in vitro and in vivo</article-title>. <source>J. Infect. Dis.</source> <volume>199</volume>, <fpage>513</fpage>&#x02013;<lpage>521</lpage>.<pub-id pub-id-type="doi">10.1086/596317</pub-id><pub-id pub-id-type="pmid">19143563</pub-id></citation></ref>
<ref id="B288"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname> <given-names>T. A.</given-names></name> <name><surname>Page</surname> <given-names>M. G.</given-names></name> <name><surname>Beanan</surname> <given-names>J. M.</given-names></name> <name><surname>Olson</surname> <given-names>R.</given-names></name> <name><surname>Hujer</surname> <given-names>A. M.</given-names></name> <name><surname>Hujer</surname> <given-names>K. M.</given-names></name> <name><surname>Jacobs</surname> <given-names>M.</given-names></name> <name><surname>Bajaksouzian</surname> <given-names>S.</given-names></name> <name><surname>Endimiani</surname> <given-names>A.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>867</fpage>&#x02013;<lpage>873</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr013</pub-id><pub-id pub-id-type="pmid">21393224</pub-id></citation></ref>
<ref id="B289"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruzin</surname> <given-names>A.</given-names></name> <name><surname>Keeney</surname> <given-names>D.</given-names></name> <name><surname>Bradford</surname> <given-names>P. A.</given-names></name></person-group> (<year>2007</year>). <article-title>AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in <italic>Acinetobacter calcoaceticus</italic>-<italic>Acinetobacter baumannii</italic> complex</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>59</volume>, <fpage>1001</fpage>&#x02013;<lpage>1004</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkm058</pub-id><pub-id pub-id-type="pmid">17363424</pub-id></citation></ref>
<ref id="B290"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname> <given-names>S.</given-names></name> <name><surname>Chakraborty</surname> <given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Quorum sensing in metal tolerance of <italic>Acinetobacter junii</italic> BB1A is associated with biofilm production</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>282</volume>, <fpage>160</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.2008.01104.x</pub-id><pub-id pub-id-type="pmid">18397291</pub-id></citation></ref>
<ref id="B291"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname> <given-names>F. G.</given-names></name> <name><surname>Mulvey</surname> <given-names>M. A.</given-names></name> <name><surname>Schilling</surname> <given-names>J. D.</given-names></name> <name><surname>Martinez</surname> <given-names>J. J.</given-names></name> <name><surname>Hultgren</surname> <given-names>S. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Bacterial pili: molecular mechanisms of pathogenesis</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>3</volume>, <fpage>65</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/S1369-5274(99)00053-3</pub-id><pub-id pub-id-type="pmid">10679419</pub-id></citation></ref>
<ref id="B292"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saugar</surname> <given-names>J. M.</given-names></name> <name><surname>Alarc&#x000F3;n</surname> <given-names>T.</given-names></name> <name><surname>L&#x000F3;pez-Hern&#x000E1;ndez</surname> <given-names>S.</given-names></name> <name><surname>L&#x000F3;pez-Brea</surname> <given-names>M.</given-names></name> <name><surname>Andreu</surname> <given-names>D.</given-names></name> <name><surname>Rivas</surname> <given-names>L.</given-names></name></person-group> (<year>2002</year>). <article-title>Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>46</volume>, <fpage>875</fpage>&#x02013;<lpage>878</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.46.3.875-878.2002</pub-id><pub-id pub-id-type="pmid">11850277</pub-id></citation></ref>
<ref id="B293"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sauvage</surname> <given-names>E.</given-names></name> <name><surname>Kerff</surname> <given-names>F.</given-names></name> <name><surname>Terrak</surname> <given-names>M.</given-names></name> <name><surname>Ayala</surname> <given-names>J. A.</given-names></name> <name><surname>Charlier</surname> <given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>32</volume>, <fpage>234</fpage>&#x02013;<lpage>258</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6976.2008.00115.x</pub-id><pub-id pub-id-type="pmid">18266856</pub-id></citation></ref>
<ref id="B294"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schild</surname> <given-names>S.</given-names></name> <name><surname>Nelson</surname> <given-names>E. J.</given-names></name> <name><surname>Camilli</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Immunization with <italic>Vibrio cholerae</italic> outer membrane vesicles induces protective immunity in mice</article-title>. <source>Infect. Immun.</source> <volume>76</volume>, <fpage>4554</fpage>&#x02013;<lpage>4563</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00532-08</pub-id><pub-id pub-id-type="pmid">18678672</pub-id></citation></ref>
<ref id="B295"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seward</surname> <given-names>R. J.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Molecular epidemiology of quinolone resistance in <italic>Acinetobacter</italic> spp</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>4</volume>, <fpage>248</fpage>&#x02013;<lpage>254</lpage>.<pub-id pub-id-type="pmid">11864339</pub-id></citation></ref>
<ref id="B296"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaikh</surname> <given-names>F.</given-names></name> <name><surname>Spence</surname> <given-names>R. P.</given-names></name> <name><surname>Levi</surname> <given-names>K.</given-names></name> <name><surname>Ou</surname> <given-names>H. Y.</given-names></name> <name><surname>Deng</surname> <given-names>Z.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name> <name><surname>Rajakumar</surname> <given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>ATPase genes of diverse multidrug-resistant <italic>Acinetobacter baumannii</italic> isolates frequently harbour integrated DNA</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>63</volume>, <fpage>260</fpage>&#x02013;<lpage>264</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkn481</pub-id><pub-id pub-id-type="pmid">19022777</pub-id></citation></ref>
<ref id="B297"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shakil</surname> <given-names>S.</given-names></name> <name><surname>Khan</surname> <given-names>A. U.</given-names></name></person-group> (<year>2010</year>). <article-title>Detection of CTX-M-15-producing and carbapenem-resistant <italic>Acinetobacter baumannii</italic> strains from urine from an Indian hospital</article-title>. <source>J. Chemother.</source> <volume>22</volume>, <fpage>324</fpage>&#x02013;<lpage>327</lpage>.<pub-id pub-id-type="pmid">21123155</pub-id></citation></ref>
<ref id="B298"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siguier</surname> <given-names>P.</given-names></name> <name><surname>Perochon</surname> <given-names>J.</given-names></name> <name><surname>Lestrade</surname> <given-names>L.</given-names></name> <name><surname>Mahillon</surname> <given-names>J.</given-names></name> <name><surname>Chandler</surname> <given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>ISfinder: the reference centre for bacterial insertion sequences</article-title>. <source>Nucleic Acids Res.</source> <volume>34</volume>, <fpage>D32</fpage>&#x02013;<lpage>D36</lpage>.<pub-id pub-id-type="doi">10.1093/nar/gkj409</pub-id><pub-id pub-id-type="pmid">16381877</pub-id></citation></ref>
<ref id="B299"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siroy</surname> <given-names>A.</given-names></name> <name><surname>Cosette</surname> <given-names>P.</given-names></name> <name><surname>Seyer</surname> <given-names>D.</given-names></name> <name><surname>Lemaitre-Guillier</surname> <given-names>C.</given-names></name> <name><surname>Vallenet</surname> <given-names>D.</given-names></name> <name><surname>Van Dorsselaer</surname> <given-names>A.</given-names></name> <name><surname>Boyer-Mariotte</surname> <given-names>S.</given-names></name> <name><surname>Jouenne</surname> <given-names>T.</given-names></name> <name><surname>D&#x000E9;</surname> <given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Global comparison of the membrane subproteomes between a multidrug-resistant <italic>Acinetobacter baumannii</italic> strain and a reference strain</article-title>. <source>J. Proteome Res.</source> <volume>5</volume>, <fpage>3385</fpage>&#x02013;<lpage>3398</lpage>.<pub-id pub-id-type="doi">10.1021/pr060372s</pub-id><pub-id pub-id-type="pmid">17137340</pub-id></citation></ref>
<ref id="B300"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siroy</surname> <given-names>A.</given-names></name> <name><surname>Molle</surname> <given-names>V.</given-names></name> <name><surname>Lemaitre-Guillier</surname> <given-names>C.</given-names></name> <name><surname>Vallenet</surname> <given-names>D.</given-names></name> <name><surname>Pestel-Caron</surname> <given-names>M.</given-names></name> <name><surname>Cozzone</surname> <given-names>A. J.</given-names></name> <name><surname>Jouenne</surname> <given-names>T.</given-names></name> <name><surname>D&#x000E9;</surname> <given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>4876</fpage>&#x02013;<lpage>4883</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.12.4876-4883.2005</pub-id><pub-id pub-id-type="pmid">16304148</pub-id></citation></ref>
<ref id="B301"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>C. A.</given-names></name> <name><surname>Baker</surname> <given-names>E. N.</given-names></name></person-group> (<year>2002</year>). <article-title>Aminoglycoside antibiotic resistance by enzymatic deactivation</article-title>. <source>Curr. Drug Targets Infect. Disord.</source> <volume>2</volume>, <fpage>143</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="doi">10.2174/1568005023342533</pub-id><pub-id pub-id-type="pmid">12462145</pub-id></citation></ref>
<ref id="B302"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>M. G.</given-names></name> <name><surname>Des Etages</surname> <given-names>S. G.</given-names></name> <name><surname>Snyder</surname> <given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Microbial synergy via an ethanol-triggered pathway</article-title>. <source>Mol. Cell. Biol.</source> <volume>24</volume>, <fpage>3874</fpage>&#x02013;<lpage>3884</lpage>.<pub-id pub-id-type="doi">10.1128/MCB.24.21.9274-9285.2004</pub-id><pub-id pub-id-type="pmid">15082781</pub-id></citation></ref>
<ref id="B303"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>M. G.</given-names></name> <name><surname>Gianoulis</surname> <given-names>T. A.</given-names></name> <name><surname>Pukatzki</surname> <given-names>S.</given-names></name> <name><surname>Mekalanos</surname> <given-names>J. J.</given-names></name> <name><surname>Ornston</surname> <given-names>L. N.</given-names></name> <name><surname>Gerstein</surname> <given-names>M.</given-names></name> <name><surname>Snyder</surname> <given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>New insights into <italic>Acinetobacter baumannii</italic> pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis</article-title>. <source>Genes Dev.</source> <volume>21</volume>, <fpage>601</fpage>&#x02013;<lpage>614</lpage>.<pub-id pub-id-type="doi">10.1101/gad.1559407</pub-id><pub-id pub-id-type="pmid">17344419</pub-id></citation></ref>
<ref id="B304"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Snitkin</surname> <given-names>E. S.</given-names></name> <name><surname>Zelazny</surname> <given-names>A. M.</given-names></name> <name><surname>Montero</surname> <given-names>C. I.</given-names></name> <name><surname>Stock</surname> <given-names>F.</given-names></name> <name><surname>Mijares</surname> <given-names>L.</given-names></name> <name><surname>Program</surname> <given-names>N. C. S.</given-names></name> <name><surname>Murray</surname> <given-names>P. R.</given-names></name> <name><surname>Segre</surname> <given-names>J. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Genome-wide recombination drives diversification of epidemic strains of <italic>Acinetobacter baumannii</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>108</volume>, <fpage>13758</fpage>&#x02013;<lpage>13763</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1104404108</pub-id><pub-id pub-id-type="pmid">21825119</pub-id></citation></ref>
<ref id="B305"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sol&#x000E9;</surname> <given-names>M.</given-names></name> <name><surname>Pitart</surname> <given-names>C.</given-names></name> <name><surname>Roca</surname> <given-names>I.</given-names></name> <name><surname>F&#x000E0;brega</surname> <given-names>A.</given-names></name> <name><surname>Salvador</surname> <given-names>P.</given-names></name> <name><surname>Mu&#x000F1;oz</surname> <given-names>L.</given-names></name> <name><surname>Oliveira</surname> <given-names>I.</given-names></name> <name><surname>Gasc&#x000F3;n</surname> <given-names>J.</given-names></name> <name><surname>Marco</surname> <given-names>F.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>First description of an <italic>Escherichia coli</italic> strain producing NDM-1 carbapenemase in Spain</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>4402</fpage>&#x02013;<lpage>4404</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00642-11</pub-id><pub-id pub-id-type="pmid">21730115</pub-id></citation></ref>
<ref id="B306"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname> <given-names>R. P.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>52</volume>, <fpage>687</fpage>&#x02013;<lpage>690</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkg424</pub-id><pub-id pub-id-type="pmid">12951327</pub-id></citation></ref>
<ref id="B307"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>V. B.</given-names></name> <name><surname>Rajamohan</surname> <given-names>G.</given-names></name> <name><surname>Gebreyes</surname> <given-names>W. A.</given-names></name></person-group> (<year>2009a</year>). <article-title>Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>5312</fpage>&#x02013;<lpage>5316</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00748-09</pub-id></citation></ref>
<ref id="B308"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>V. B.</given-names></name> <name><surname>Rajamohan</surname> <given-names>G.</given-names></name> <name><surname>Pancholi</surname> <given-names>P.</given-names></name> <name><surname>Stevenson</surname> <given-names>K.</given-names></name> <name><surname>Tadesse</surname> <given-names>D.</given-names></name> <name><surname>Patchanee</surname> <given-names>P.</given-names></name> <name><surname>Marcon</surname> <given-names>M.</given-names></name> <name><surname>Gebreyes</surname> <given-names>W. A.</given-names></name></person-group> (<year>2009b</year>). <article-title>Genetic relatedness and molecular characterization of multidrug resistant <italic>Acinetobacter baumannii</italic> isolated in central Ohio, USA</article-title>. <source>Ann. Clin. Microbiol. Antimicrob.</source> <volume>8</volume>, <fpage>21</fpage>.<pub-id pub-id-type="doi">10.1186/1476-0711-8-21</pub-id></citation></ref>
<ref id="B309"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname> <given-names>N.</given-names></name> <name><surname>Lazazzera</surname> <given-names>B. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Environmental signals and regulatory pathways that influence biofilm formation</article-title>. <source>Mol. Microbiol.</source> <volume>52</volume>, <fpage>917</fpage>&#x02013;<lpage>924</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04036.x</pub-id><pub-id pub-id-type="pmid">15130114</pub-id></citation></ref>
<ref id="B310"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>X. Z.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Mizushima</surname> <given-names>T.</given-names></name> <name><surname>Kuroda</surname> <given-names>T.</given-names></name> <name><surname>Tsuchiya</surname> <given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>AbeM, an H&#x0002B;-coupled <italic>Acinetobacter baumannii</italic> multidrug efflux pump belonging to the MATE family of transporters</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>49</volume>, <fpage>4362</fpage>&#x02013;<lpage>4364</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.49.10.4362-4364.2005</pub-id><pub-id pub-id-type="pmid">16189122</pub-id></citation></ref>
<ref id="B311"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname> <given-names>I.</given-names></name></person-group> (<year>2001</year>). <article-title>Biofilm exopolysaccharides: a strong and sticky framework</article-title>. <source>Microbiology</source> <volume>147</volume>, <fpage>3</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">11160795</pub-id></citation></ref>
<ref id="B312"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taneja</surname> <given-names>N.</given-names></name> <name><surname>Singh</surname> <given-names>G.</given-names></name> <name><surname>Singh</surname> <given-names>M.</given-names></name> <name><surname>Sharma</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Emergence of tigecycline &#x00026; colistin resistant <italic>Acinetobacter baumanii</italic> in patients with complicated urinary tract infections in north India</article-title>. <source>Indian J. Med. Res.</source> <volume>133</volume>, <fpage>681</fpage>&#x02013;<lpage>684</lpage>.<pub-id pub-id-type="pmid">21727671</pub-id></citation></ref>
<ref id="B313"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname> <given-names>G. B.</given-names></name> <name><surname>Adams-Haduch</surname> <given-names>J. M.</given-names></name> <name><surname>Bogdanovich</surname> <given-names>T.</given-names></name> <name><surname>Pasculle</surname> <given-names>A. W.</given-names></name> <name><surname>Quinn</surname> <given-names>J. P.</given-names></name> <name><surname>Wang</surname> <given-names>H. N.</given-names></name> <name><surname>Doi</surname> <given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from <italic>Acinetobacter baumannii</italic> in Pennsylvania</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>429</fpage>&#x02013;<lpage>432</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01660-10</pub-id><pub-id pub-id-type="pmid">21041501</pub-id></citation></ref>
<ref id="B314"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toleman</surname> <given-names>M. A.</given-names></name> <name><surname>Bennett</surname> <given-names>P. M.</given-names></name> <name><surname>Walsh</surname> <given-names>T. R.</given-names></name></person-group> (<year>2006</year>). <article-title>ISCR elements: novel gene-capturing systems of the 21st century?</article-title> <source>Microbiol. Mol. Biol. Rev.</source> <volume>70</volume>, <fpage>296</fpage>&#x02013;<lpage>316</lpage>.<pub-id pub-id-type="doi">10.1128/MMBR.00048-05</pub-id><pub-id pub-id-type="pmid">16760305</pub-id></citation></ref>
<ref id="B315"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomaras</surname> <given-names>A.</given-names></name> <name><surname>Dorsey</surname> <given-names>C.</given-names></name> <name><surname>Edelmann</surname> <given-names>R.</given-names></name> <name><surname>Actis</surname> <given-names>L.</given-names></name></person-group> (<year>2003</year>). <article-title>Attachment to and biofilm formation on abiotic surfaces by <italic>Acinetobacter baumannii</italic>: involvement of a novel chaperone-usher pili assembly system</article-title>. <source>Microbiology</source> <volume>149</volume>, <fpage>3473</fpage>&#x02013;<lpage>3484</lpage>.<pub-id pub-id-type="doi">10.1099/mic.0.26541-0</pub-id><pub-id pub-id-type="pmid">14663080</pub-id></citation></ref>
<ref id="B316"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Towner</surname> <given-names>K. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Acinetobacter: an old friend, but a new enemy</article-title>. <source>J. Hosp. Infect.</source> <volume>73</volume>, <fpage>355</fpage>&#x02013;<lpage>363</lpage>.<pub-id pub-id-type="doi">10.1016/j.jhin.2009.03.032</pub-id><pub-id pub-id-type="pmid">19700220</pub-id></citation></ref>
<ref id="B317"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Towner</surname> <given-names>K. J.</given-names></name> <name><surname>Gee</surname> <given-names>T.</given-names></name> <name><surname>Boswell</surname> <given-names>T.</given-names></name></person-group> (<year>2002</year>). <article-title>An unwanted import to the UK: a carbapenem-resistant clinical isolate of <italic>Acinetobacter baumannii</italic> producing metallo-&#x003B2;-lactamase</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>50</volume>, <fpage>1092</fpage>&#x02013;<lpage>1093</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkg012</pub-id><pub-id pub-id-type="pmid">12461042</pub-id></citation></ref>
<ref id="B318"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsakris</surname> <given-names>A.</given-names></name> <name><surname>Ikonomidis</surname> <given-names>A.</given-names></name> <name><surname>Poulou</surname> <given-names>A.</given-names></name> <name><surname>Spanakis</surname> <given-names>N.</given-names></name> <name><surname>Vrizas</surname> <given-names>D.</given-names></name> <name><surname>Diomidous</surname> <given-names>M.</given-names></name> <name><surname>Pournaras</surname> <given-names>S.</given-names></name> <name><surname>Markou</surname> <given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Clusters of imipenem-resistant <italic>Acinetobacter baumannii</italic> clones producing different carbapenemases in an intensive care unit</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>14</volume>, <fpage>588</fpage>&#x02013;<lpage>594</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2008.01996.x</pub-id><pub-id pub-id-type="pmid">18397334</pub-id></citation></ref>
<ref id="B319"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsakris</surname> <given-names>A.</given-names></name> <name><surname>Ikonomidis</surname> <given-names>A.</given-names></name> <name><surname>Pournaras</surname> <given-names>S.</given-names></name> <name><surname>Tzouvelekis</surname> <given-names>L. S.</given-names></name> <name><surname>Sofianou</surname> <given-names>D.</given-names></name> <name><surname>Legakis</surname> <given-names>N. J.</given-names></name> <name><surname>Maniatis</surname> <given-names>A. N.</given-names></name></person-group> (<year>2006</year>). <article-title>VIM-1 metallo-&#x003B2;-lactamase in <italic>Acinetobacter baumannii</italic></article-title>. <source>Emerging Infect. Dis.</source> <volume>12</volume>, <fpage>981</fpage>&#x02013;<lpage>983</lpage>.<pub-id pub-id-type="pmid">16707056</pub-id></citation></ref>
<ref id="B320"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turton</surname> <given-names>J. F.</given-names></name> <name><surname>Ward</surname> <given-names>M. E.</given-names></name> <name><surname>Woodford</surname> <given-names>N.</given-names></name> <name><surname>Kaufmann</surname> <given-names>M. E.</given-names></name> <name><surname>Pike</surname> <given-names>R.</given-names></name> <name><surname>Livermore</surname> <given-names>D. M.</given-names></name> <name><surname>Pitt</surname> <given-names>T. L.</given-names></name></person-group> (<year>2006</year>). <article-title>The role of ISAba1 in expression of OXA carbapenemase genes in <italic>Acinetobacter baumannii</italic></article-title>. <source>FEMS Microbiol. Lett.</source> <volume>258</volume>, <fpage>72</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.2006.00195.x</pub-id><pub-id pub-id-type="pmid">16630258</pub-id></citation></ref>
<ref id="B321"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname> <given-names>C.</given-names></name> <name><surname>Go</surname> <given-names>E.</given-names></name> <name><surname>Mariano</surname> <given-names>N.</given-names></name> <name><surname>Rahal</surname> <given-names>J. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and -susceptible <italic>Acinetobacter baumannii</italic></article-title>. <source>FEMS Microbiol. Lett.</source> <volume>125</volume>, <fpage>193</fpage>&#x02013;<lpage>197</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.1995.tb07357.x</pub-id></citation></ref>
<ref id="B322"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vahaboglu</surname> <given-names>H.</given-names></name> <name><surname>Ozturk</surname> <given-names>R.</given-names></name> <name><surname>Aygun</surname> <given-names>G.</given-names></name> <name><surname>Coskunkan</surname> <given-names>F.</given-names></name> <name><surname>Yaman</surname> <given-names>A.</given-names></name> <name><surname>Kaygusuz</surname> <given-names>A.</given-names></name> <name><surname>Leblebicioglu</surname> <given-names>H.</given-names></name> <name><surname>Balik</surname> <given-names>I.</given-names></name> <name><surname>Aydin</surname> <given-names>K.</given-names></name> <name><surname>Otkun</surname> <given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Widespread detection of PER-1-type extended-spectrum &#x003B2;-lactamases among nosocomial <italic>Acinetobacter</italic> and <italic>Pseudomonas aeruginosa</italic> isolates in Turkey: a nationwide multicenter study</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>41</volume>, <fpage>2265</fpage>&#x02013;<lpage>2269</lpage>.<pub-id pub-id-type="pmid">9333059</pub-id></citation></ref>
<ref id="B323"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valentine</surname> <given-names>S. C.</given-names></name> <name><surname>Contreras</surname> <given-names>D.</given-names></name> <name><surname>Tan</surname> <given-names>S.</given-names></name> <name><surname>Real</surname> <given-names>L. J.</given-names></name> <name><surname>Chu</surname> <given-names>S.</given-names></name> <name><surname>Xu</surname> <given-names>H. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Phenotypic and molecular characterization of <italic>Acinetobacter baumannii</italic> clinical isolates from nosocomial outbreaks in Los Angeles County, California</article-title>. <source>J. Clin. Microbiol.</source> <volume>46</volume>, <fpage>2499</fpage>&#x02013;<lpage>2507</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.00367-08</pub-id><pub-id pub-id-type="pmid">18524965</pub-id></citation></ref>
<ref id="B324"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vallenet</surname> <given-names>D.</given-names></name> <name><surname>Nordmann</surname> <given-names>P.</given-names></name> <name><surname>Barbe</surname> <given-names>V.</given-names></name> <name><surname>Poirel</surname> <given-names>L.</given-names></name> <name><surname>Mangenot</surname> <given-names>S.</given-names></name> <name><surname>Bataille</surname> <given-names>E.</given-names></name> <name><surname>Dossat</surname> <given-names>C.</given-names></name> <name><surname>Gas</surname> <given-names>S.</given-names></name> <name><surname>Kreimeyer</surname> <given-names>A.</given-names></name> <name><surname>Lenoble</surname> <given-names>P.</given-names></name> <name><surname>Oztas</surname> <given-names>S.</given-names></name> <name><surname>Poulain</surname> <given-names>J.</given-names></name> <name><surname>Segurens</surname> <given-names>B.</given-names></name> <name><surname>Robert</surname> <given-names>C.</given-names></name> <name><surname>Abergel</surname> <given-names>C.</given-names></name> <name><surname>Claverie</surname> <given-names>J. M.</given-names></name> <name><surname>Raoult</surname> <given-names>D.</given-names></name> <name><surname>Medigue</surname> <given-names>C.</given-names></name> <name><surname>Weissenbach</surname> <given-names>J.</given-names></name> <name><surname>Cruveiller</surname> <given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Comparative analysis of <italic>Acinetobacters</italic>: three genomes for three lifestyles</article-title>. <source>PLoS ONE</source> <volume>3</volume>, <fpage>e1805</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0001805</pub-id><pub-id pub-id-type="pmid">18350144</pub-id></citation></ref>
<ref id="B325"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname> <given-names>R.</given-names></name> <name><surname>Dom&#x000ED;nguez</surname> <given-names>M.</given-names></name> <name><surname>Urrutia</surname> <given-names>H.</given-names></name> <name><surname>Bello</surname> <given-names>H.</given-names></name> <name><surname>Gonz&#x000E1;lez</surname> <given-names>G.</given-names></name> <name><surname>Garc&#x000ED;a</surname> <given-names>A.</given-names></name> <name><surname>Zemelman</surname> <given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Biofilm formation by <italic>Acinetobacter baumannii</italic></article-title>. <source>Microbios</source> <volume>86</volume>, <fpage>49</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">8771775</pub-id></citation></ref>
<ref id="B326"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname> <given-names>J.</given-names></name> <name><surname>Mart&#x000ED;</surname> <given-names>S.</given-names></name> <name><surname>S&#x000E1;nchez-C&#x000E9;spedes</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Porins, efflux pumps and multidrug resistance in <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>59</volume>, <fpage>1210</fpage>&#x02013;<lpage>1215</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkl509</pub-id><pub-id pub-id-type="pmid">17324960</pub-id></citation></ref>
<ref id="B327"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname> <given-names>J.</given-names></name> <name><surname>Navia</surname> <given-names>M.</given-names></name> <name><surname>Ruiz</surname> <given-names>J.</given-names></name> <name><surname>Casals</surname> <given-names>C.</given-names></name></person-group> (<year>1997a</year>). <article-title>Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived &#x003B2;-lactamase in <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>41</volume>, <fpage>2757</fpage>&#x02013;<lpage>2759</lpage>.</citation></ref>
<ref id="B328"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname> <given-names>J.</given-names></name> <name><surname>Ruiz</surname> <given-names>J.</given-names></name> <name><surname>Goni</surname> <given-names>P.</given-names></name> <name><surname>Jimenez de Anta</surname> <given-names>T.</given-names></name></person-group> (<year>1997b</year>). <article-title>Quinolone-resistance mutations in the topoisomerase IV parC gene of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>39</volume>, <fpage>757</fpage>&#x02013;<lpage>762</lpage>.<pub-id pub-id-type="doi">10.1093/jac/39.6.757</pub-id></citation></ref>
<ref id="B329"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname> <given-names>J.</given-names></name> <name><surname>Ruiz</surname> <given-names>J.</given-names></name> <name><surname>Goni</surname> <given-names>P.</given-names></name> <name><surname>Marcos</surname> <given-names>A.</given-names></name> <name><surname>Jimenez de Anta</surname> <given-names>T.</given-names></name></person-group> (<year>1995</year>). <article-title>Mutation in the gyrA gene of quinolone-resistant clinical isolates of <italic>Acinetobacter baumannii</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>39</volume>, <fpage>1201</fpage>&#x02013;<lpage>1203</lpage>.<pub-id pub-id-type="pmid">7625818</pub-id></citation></ref>
<ref id="B330"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname> <given-names>J.</given-names></name> <name><surname>S&#x000E1;nchez-C&#x000E9;spedes</surname> <given-names>J.</given-names></name> <name><surname>Sierra</surname> <given-names>J. M.</given-names></name> <name><surname>Piqueras</surname> <given-names>M.</given-names></name> <name><surname>Nicol&#x000E1;s</surname> <given-names>E.</given-names></name> <name><surname>Freixas</surname> <given-names>J.</given-names></name> <name><surname>Giralt</surname> <given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria</article-title>. <source>Int. J. Antimicrob. Agents</source> <volume>28</volume>, <fpage>19</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.02.013</pub-id><pub-id pub-id-type="pmid">16781123</pub-id></citation></ref>
<ref id="B331"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vila-Farr&#x000E9;s</surname> <given-names>X.</given-names></name> <name><surname>Garc&#x000ED;a de la Maria</surname> <given-names>C.</given-names></name> <name><surname>L&#x000F3;pez-Rojas</surname> <given-names>R.</given-names></name> <name><surname>Pach&#x000F3;n</surname> <given-names>J.</given-names></name> <name><surname>Giralt</surname> <given-names>E.</given-names></name> <name><surname>Vila</surname> <given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Clin. Microbiol. Infect.</source> <volume>18</volume>, <fpage>383</fpage>&#x02013;<lpage>387</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03581.x</pub-id><pub-id pub-id-type="pmid">21672084</pub-id></citation></ref>
<ref id="B332"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname> <given-names>J. L.</given-names></name> <name><surname>Rello</surname> <given-names>J.</given-names></name> <name><surname>Marshall</surname> <given-names>J.</given-names></name> <name><surname>Silva</surname> <given-names>E.</given-names></name> <name><surname>Anzueto</surname> <given-names>A.</given-names></name> <name><surname>Martin</surname> <given-names>C. D.</given-names></name> <name><surname>Moreno</surname> <given-names>R.</given-names></name> <name><surname>Lipman</surname> <given-names>J.</given-names></name> <name><surname>Gomersall</surname> <given-names>C.</given-names></name> <name><surname>Sakr</surname> <given-names>Y.</given-names></name> <name><surname>Reinhart</surname> <given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>International study of the prevalence and outcomes of infection in intensive care units</article-title>. <source>JAMA</source> <volume>302</volume>, <fpage>2323</fpage>&#x02013;<lpage>2329</lpage>.<pub-id pub-id-type="doi">10.1001/jama.2009.1606</pub-id><pub-id pub-id-type="pmid">19952319</pub-id></citation></ref>
<ref id="B333"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visca</surname> <given-names>P.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Acinetobacter infection &#x02013; an emerging threat to human health</article-title>. <source>IUBMB Life</source> <volume>63</volume>, <fpage>1048</fpage>&#x02013;<lpage>1054</lpage>.<pub-id pub-id-type="doi">10.1002/iub.534</pub-id><pub-id pub-id-type="pmid">22006724</pub-id></citation></ref>
<ref id="B334"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Guo</surname> <given-names>P.</given-names></name> <name><surname>Sun</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Chen</surname> <given-names>M.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Zhu</surname> <given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Molecular epidemiology of clinical isolates of carbapenem-resistant <italic>Acinetobacter</italic> spp. from Chinese hospitals</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>51</volume>, <fpage>4022</fpage>&#x02013;<lpage>4028</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01259-06</pub-id><pub-id pub-id-type="pmid">17846127</pub-id></citation></ref>
<ref id="B335"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wareham</surname> <given-names>D. W.</given-names></name> <name><surname>Gordon</surname> <given-names>N. C.</given-names></name> <name><surname>Hornsey</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>1047</fpage>&#x02013;<lpage>1051</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr069</pub-id><pub-id pub-id-type="pmid">21393131</pub-id></citation></ref>
<ref id="B336"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>M.</given-names></name> <name><surname>Iyobe</surname> <given-names>S.</given-names></name> <name><surname>Inoue</surname> <given-names>M.</given-names></name> <name><surname>Mitsuhashi</surname> <given-names>S.</given-names></name></person-group> (<year>1991</year>). <article-title>Transferable imipenem resistance in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>35</volume>, <fpage>147</fpage>&#x02013;<lpage>151</lpage>.<pub-id pub-id-type="pmid">1901695</pub-id></citation></ref>
<ref id="B337"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wendt</surname> <given-names>C.</given-names></name> <name><surname>Dietze</surname> <given-names>B.</given-names></name> <name><surname>Dietz</surname> <given-names>E.</given-names></name> <name><surname>Ruden</surname> <given-names>H.</given-names></name></person-group> (<year>1997</year>). <article-title>Survival of <italic>Acinetobacter baumannii</italic> on dry surfaces</article-title>. <source>J. Clin. Microbiol.</source> <volume>35</volume>, <fpage>1394</fpage>&#x02013;<lpage>1397</lpage>.<pub-id pub-id-type="pmid">9163451</pub-id></citation></ref>
<ref id="B338"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitehead</surname> <given-names>N. A.</given-names></name> <name><surname>Barnard</surname> <given-names>A. M.</given-names></name> <name><surname>Slater</surname> <given-names>H.</given-names></name> <name><surname>Simpson</surname> <given-names>N. J.</given-names></name> <name><surname>Salmond</surname> <given-names>G. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Quorum-sensing in Gram-negative bacteria</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>25</volume>, <fpage>365</fpage>&#x02013;<lpage>404</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6976.2001.tb00583.x</pub-id><pub-id pub-id-type="pmid">11524130</pub-id></citation></ref>
<ref id="B339"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wisplinghoff</surname> <given-names>H.</given-names></name> <name><surname>Bischoff</surname> <given-names>T.</given-names></name> <name><surname>Tallent</surname> <given-names>S. M.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name> <name><surname>Wenzel</surname> <given-names>R. P.</given-names></name> <name><surname>Edmond</surname> <given-names>M. B.</given-names></name></person-group> (<year>2004</year>). <article-title>Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study</article-title>. <source>Clin. Infect. Dis.</source> <volume>39</volume>, <fpage>309</fpage>&#x02013;<lpage>317</lpage>.<pub-id pub-id-type="doi">10.1086/421946</pub-id><pub-id pub-id-type="pmid">15306996</pub-id></citation></ref>
<ref id="B340"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wisplinghoff</surname> <given-names>H.</given-names></name> <name><surname>Decker</surname> <given-names>M.</given-names></name> <name><surname>Haefs</surname> <given-names>C.</given-names></name> <name><surname>Krut</surname> <given-names>O.</given-names></name> <name><surname>Plum</surname> <given-names>G.</given-names></name> <name><surname>Seifert</surname> <given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>51</volume>, <fpage>177</fpage>&#x02013;<lpage>180</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkf254</pub-id><pub-id pub-id-type="pmid">12493807</pub-id></citation></ref>
<ref id="B341"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>E. W.</given-names></name> <name><surname>Yusof</surname> <given-names>M. Y.</given-names></name> <name><surname>Mansor</surname> <given-names>M. B.</given-names></name> <name><surname>Anbazhagan</surname> <given-names>D.</given-names></name> <name><surname>Ong</surname> <given-names>S. Y.</given-names></name> <name><surname>Sekaran</surname> <given-names>S. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Disruption of adeB gene has a greater effect on resistance to meropenems than adeA gene in <italic>Acinetobacter</italic> spp. isolated from University Malaya Medical Centre</article-title>. <source>Singapore Med. J.</source> <volume>50</volume>, <fpage>822</fpage>&#x02013;<lpage>826</lpage>.<pub-id pub-id-type="pmid">19710984</pub-id></citation></ref>
<ref id="B342"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wroblewska</surname> <given-names>M.</given-names></name> <name><surname>Sawicka-Grzelak</surname> <given-names>A.</given-names></name> <name><surname>Luczak</surname> <given-names>M.</given-names></name> <name><surname>Sivan</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Biofilm production by clinical strains of <italic>Acinetobacter baumannii</italic> isolated from patients hospitalized in two tertiary care hospitals</article-title>. <source>FEMS Immunol. Med. Microbiol.</source> <volume>53</volume>, <fpage>140</fpage>&#x02013;<lpage>144</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-695X.2008.00403.x</pub-id><pub-id pub-id-type="pmid">18400015</pub-id></citation></ref>
<ref id="B343"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wroblewska</surname> <given-names>M. M.</given-names></name> <name><surname>Towner</surname> <given-names>K. J.</given-names></name> <name><surname>Marchel</surname> <given-names>H.</given-names></name> <name><surname>Luczak</surname> <given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Emergence and spread of carbapenem-resistant strains of <italic>Acinetobacter baumannii</italic> in a tertiary-care hospital in Poland</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>13</volume>, <fpage>490</fpage>&#x02013;<lpage>496</lpage>.<pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01694.x</pub-id><pub-id pub-id-type="pmid">17331123</pub-id></citation></ref>
<ref id="B344"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>M.</given-names></name> <name><surname>Nagao</surname> <given-names>M.</given-names></name> <name><surname>Matsumura</surname> <given-names>Y.</given-names></name> <name><surname>Matsushima</surname> <given-names>A.</given-names></name> <name><surname>Ito</surname> <given-names>Y.</given-names></name> <name><surname>Takakura</surname> <given-names>S.</given-names></name> <name><surname>Ichiyama</surname> <given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among <italic>Acinetobacter</italic> species in Japan</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>66</volume>, <fpage>2480</fpage>&#x02013;<lpage>2483</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkr336</pub-id><pub-id pub-id-type="pmid">21862476</pub-id></citation></ref>
<ref id="B345"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>S.</given-names></name> <name><surname>Okujo</surname> <given-names>N.</given-names></name> <name><surname>Sakakibara</surname> <given-names>Y.</given-names></name></person-group> (<year>1994</year>). <article-title>Isolation and structure elucidation of acinetobactin, a novel siderophore from <italic>Acinetobacter baumannii</italic></article-title>. <source>Arch. Microbiol.</source> <volume>162</volume>, <fpage>249</fpage>&#x02013;<lpage>254</lpage>.<pub-id pub-id-type="doi">10.1007/s002030050133</pub-id><pub-id pub-id-type="pmid">7802543</pub-id></citation></ref>
<ref id="B346"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname> <given-names>K.</given-names></name> <name><surname>Wachino</surname> <given-names>J.</given-names></name> <name><surname>Doi</surname> <given-names>Y.</given-names></name> <name><surname>Kurokawa</surname> <given-names>H.</given-names></name> <name><surname>Arakawa</surname> <given-names>Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Global spread of multiple aminoglycoside resistance genes</article-title>. <source>Emerging Infect. Dis.</source> <volume>11</volume>, <fpage>951</fpage>&#x02013;<lpage>953</lpage>.<pub-id pub-id-type="doi">10.3201/eid1106.040924</pub-id><pub-id pub-id-type="pmid">15963295</pub-id></citation></ref>
<ref id="B347"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>X. L.</given-names></name> <name><surname>Hou</surname> <given-names>T. W.</given-names></name> <name><surname>Xu</surname> <given-names>S. B.</given-names></name> <name><surname>Ma</surname> <given-names>C. Q.</given-names></name> <name><surname>Yao</surname> <given-names>Z. Y.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Wei</surname> <given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Detection of drug resistance-associated genes of multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Microb. Drug Resist.</source> <volume>14</volume>, <fpage>145</fpage>&#x02013;<lpage>150</lpage>.<pub-id pub-id-type="doi">10.1089/mdr.2008.0799</pub-id><pub-id pub-id-type="pmid">18489241</pub-id></citation></ref>
<ref id="B348"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname> <given-names>D.</given-names></name> <name><surname>Toleman</surname> <given-names>M. A.</given-names></name> <name><surname>Giske</surname> <given-names>C. G.</given-names></name> <name><surname>Cho</surname> <given-names>H. S.</given-names></name> <name><surname>Sundman</surname> <given-names>K.</given-names></name> <name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Walsh</surname> <given-names>T. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Characterization of a new metallo-&#x003B2;-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in <italic>Klebsiella pneumoniae</italic> sequence type 14 from India</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>53</volume>, <fpage>5046</fpage>&#x02013;<lpage>5054</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.00774-09</pub-id><pub-id pub-id-type="pmid">19770275</pub-id></citation></ref>
<ref id="B349"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>Y. S.</given-names></name> <name><surname>Zhou</surname> <given-names>H.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Chen</surname> <given-names>Y. G.</given-names></name> <name><surname>Li</surname> <given-names>L. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant <italic>Acinetobacter baumannii</italic> isolates in China</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>60</volume>, <fpage>454</fpage>&#x02013;<lpage>455</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkm208</pub-id><pub-id pub-id-type="pmid">17561497</pub-id></citation></ref>
<ref id="B350"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yum</surname> <given-names>J. H.</given-names></name> <name><surname>Yi</surname> <given-names>K.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Yong</surname> <given-names>D.</given-names></name> <name><surname>Lee</surname> <given-names>K.</given-names></name> <name><surname>Kim</surname> <given-names>J. M.</given-names></name> <name><surname>Rossolini</surname> <given-names>G. M.</given-names></name> <name><surname>Chong</surname> <given-names>Y.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecular characterization of metallo-&#x003B2;-lactamase-producing <italic>Acinetobacter baumannii</italic> and <italic>Acinetobacter</italic> genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>49</volume>, <fpage>837</fpage>&#x02013;<lpage>840</lpage>.<pub-id pub-id-type="doi">10.1093/jac/dkf043</pub-id><pub-id pub-id-type="pmid">12003980</pub-id></citation></ref>
<ref id="B351"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname> <given-names>S. H.</given-names></name> <name><surname>Choi</surname> <given-names>C. W.</given-names></name> <name><surname>Kwon</surname> <given-names>S. O.</given-names></name> <name><surname>Park</surname> <given-names>G. W.</given-names></name> <name><surname>Cho</surname> <given-names>K.</given-names></name> <name><surname>Kwon</surname> <given-names>K. H.</given-names></name> <name><surname>Kim</surname> <given-names>J. Y.</given-names></name> <name><surname>Yoo</surname> <given-names>J. S.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name> <name><surname>Choi</surname> <given-names>J. S.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Kim</surname> <given-names>S. I.</given-names></name></person-group> (<year>2011</year>). <article-title>Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>J. Proteome Res.</source> <volume>10</volume>, <fpage>459</fpage>&#x02013;<lpage>469</lpage>.<pub-id pub-id-type="doi">10.1021/pr101012s</pub-id><pub-id pub-id-type="pmid">21053951</pub-id></citation></ref>
<ref id="B352"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zarrilli</surname> <given-names>R.</given-names></name> <name><surname>Crispino</surname> <given-names>M.</given-names></name> <name><surname>Bagattini</surname> <given-names>M.</given-names></name> <name><surname>Barretta</surname> <given-names>E.</given-names></name> <name><surname>Di Popolo</surname> <given-names>A.</given-names></name> <name><surname>Triassi</surname> <given-names>M.</given-names></name> <name><surname>Villari</surname> <given-names>P.</given-names></name></person-group> (<year>2004</year>). <article-title>Molecular epidemiology of sequential outbreaks of <italic>Acinetobacter baumannii</italic> in an intensive care unit shows the emergence of carbapenem resistance</article-title>. <source>J. Clin. Microbiol.</source> <volume>42</volume>, <fpage>946</fpage>&#x02013;<lpage>953</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.42.3.946-953.2004</pub-id><pub-id pub-id-type="pmid">15004037</pub-id></citation></ref>
<ref id="B353"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>W. H.</given-names></name> <name><surname>Hu</surname> <given-names>Z. Q.</given-names></name></person-group> (<year>2011</year>). <article-title>IMP-type metallo-&#x003B2;-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>37</volume>, <fpage>214</fpage>&#x02013;<lpage>226</lpage>.<pub-id pub-id-type="doi">10.3109/1040841X.2011.559944</pub-id><pub-id pub-id-type="pmid">21707466</pub-id></citation></ref>
<ref id="B354"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>W. H.</given-names></name> <name><surname>Hu</surname> <given-names>Z. Q.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Acinetobacter</italic>: a potential reservoir and dispenser for &#x003B2;-lactamases</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>38</volume>, <fpage>30</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.3109/1040841X.2011.621064</pub-id><pub-id pub-id-type="pmid">22007992</pub-id></citation></ref>
<ref id="B355"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>T.</given-names></name> <name><surname>Yu</surname> <given-names>D.</given-names></name> <name><surname>Pi</surname> <given-names>B.</given-names></name> <name><surname>Yang</surname> <given-names>Q.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name> <name><surname>Hu</surname> <given-names>S.</given-names></name> <name><surname>Yu</surname> <given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Genomic analysis of the multidrug-resistant <italic>Acinetobacter baumannii</italic> strain MDR-ZJ06 widely spread in China</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>55</volume>, <fpage>4506</fpage>&#x02013;<lpage>4512</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.01101-10</pub-id><pub-id pub-id-type="pmid">21788470</pub-id></citation></ref>
<ref id="B356"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimbler</surname> <given-names>D. L.</given-names></name> <name><surname>Penwell</surname> <given-names>W. F.</given-names></name> <name><surname>Gaddy</surname> <given-names>J. A.</given-names></name> <name><surname>Menke</surname> <given-names>S. M.</given-names></name> <name><surname>Tomaras</surname> <given-names>A. P.</given-names></name> <name><surname>Connerly</surname> <given-names>P. L.</given-names></name> <name><surname>Actis</surname> <given-names>L. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Iron acquisition functions expressed by the human pathogen <italic>Acinetobacter baumannii</italic></article-title>. <source>Biometals</source> <volume>22</volume>, <fpage>23</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1007/s10534-008-9202-3</pub-id><pub-id pub-id-type="pmid">19130255</pub-id></citation></ref>
</ref-list>
</back>
</article>
